Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016543	li-leuk	e6/l (e6/l)	7125	10260	2.03%
3016543	li-leuk	— (—)	2197	2999	100.00%	Distribution not available
3016543	li-leuk-3	e6/l (e6/l)	227	243	0.00%
3016543	li-leukosyytit,likvor	— (—)	33	35	100.00%	Distribution not available
3016543	li-leukosyytit,likvor	e6/l (e6/l)	23	26	0.00%
3016543	li-leuk-3	— (—)	8	9	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Viral infections of the central nervous system

425

533

9.14

323.31

1.5

1.4

67.22

31.77

e6/l

1.92

357

408

Abnormalities of gait and mobility

460

627

8.04

323.01

1.6

12.66

28.97

e6/l

0.78

369

465

Other headache syndromes

1079

3063

3.65

319.51

1.3

1.4

12.62

38.09

e6/l

3.03

842

2327

Dementia, including avohilmo

982

1668

4.22

316.04

1.2

1.4

12.10

22.99

e6/l

0.94

776

1302

Dementia

905

1444

4.49

315.03

1.2

1.4

12.07

25.46

e6/l

1.10

723

1129

Any mental disorder

2428

4961

2.50

310.36

1.4

1.5

30.92

33.87

e6/l

0.12

1885

3831

Visual disturbances and blindness

1283

4145

3.21

309.02

1.4

1.5

22.56

31.72

e6/l

0.42

1008

3205

Inflammatory diseases of the central nervous system

587

591

11.82

307.65

1.9

1.4

199.41

18.21

e6/l

4.52

466

455

Symptoms and signs involving the nervous and musculoskeletal systems

2106

4442

5.02

307.65

1.4

1.5

15.34

30.87

e6/l

1.50

1744

3362

Episodal and paroxysmal disorders

2636

5036

2.74

307.65

1.4

1.5

19.38

38.24

e6/l

2.48

2078

3838

Concussion

991

1474

5.98

307.65

1.5

1.4

21.01

19.31

e6/l

0.07

773

1064

Other demyelinating diseases of the central nervous system

327

266

15.56

307.65

1.2

1.5

9.18

12.06

e6/l

0.36

250

213

Encephalitis

297

184

21.89

307.65

1.7

1.4

53.52

8.77

e6/l

4.55

228

142

Neurological diseases

2623

2063

6.64

307.65

1.5

20.29

25.07

e6/l

0.46

2057

1500

Psychiatric diseases

2493

4676

2.73

307.65

1.4

1.5

30.54

34.60

e6/l

0.18

1942

3605

Cerebrovascular diseases (FINNGEN)

1142

1796

4.79

307.65

1.9

1.3

33.03

24.05

e6/l

0.75

901

1346

Any dementia, excluding more controls

817

1128

5.25

307.65

1.2

1.4

8.94

26.32

e6/l

1.62

646

880

Implicit Sepsis

1874

4512

3.34

307.65

1.4

18.76

28.56

e6/l

0.85

1466

3472

STROKE

1496

3288

3.26

307.65

1.8

1.3

28.72

29.37

e6/l

0.04

1175

2495

Organic, including symptomatic, mental disorders

1383

2031

5.16

307.65

1.3

1.4

13.90

36.47

e6/l

1.71

1085

1572

Condition for Implicit Sepsis (Organ dysfunction codes)

2414

4839

3.76

307.65

1.4

15.65

37.03

e6/l

2.67

1833

3747

Demyelinating diseases of the central nervous system

641

645

11.84

307.65

1.2

1.4

31.47

25.88

e6/l

0.10

509

488

Other encephalitis

285

172

22.74

307.65

1.7

1.4

51.68

8.47

e6/l

4.23

218

134

Neurological diseases, wide definition

1058

506

10.93

307.65

1.7

1.5

23.13

11.38

e6/l

1.69

820

359

General symptoms and signs

3011

4099

3.79

307.65

1.4

33.68

24.50

e6/l

0.69

2378

3087

Headache

2491

3598

6.11

307.65

1.5

1.4

28.98

25.16

e6/l

0.22

2003

2698

Dizziness and giddiness

1579

4309

3.05

307.65

1.4

1.5

14.84

39.18

e6/l

3.40

1266

3372

Convulsions, not elsewhere classified

760

1308

6.05

307.65

1.7

1.4

32.24

17.46

e6/l

0.40

582

975

Malaise and fatigue

1198

2382

4.34

307.65

1.4

18.08

24.46

e6/l

0.41

937

1821

Epilepsy

987

2070

5.00

307.65

1.7

1.6

23.41

32.94

e6/l

0.45

787

1556

Other neurological diseases

2450

4077

5.09

307.65

1.7

1.3

25.67

34.54

e6/l

0.55

1984

3096

MS-disease / Multiple Sclerosis

528

532

11.78

307.65

1.1

1.4

36.36

22.03

e6/l

0.25

422

406

Hydrocephalus

855

375

31.63

307.65

2.4

1.4

19.99

22.85

e6/l

0.07

732

281

Other symptoms and signs involving the nervous and musculoskeletal systems

1519

3130

5.15

307.65

1.4

1.5

16.22

34.72

e6/l

1.26

1283

2366

Disturbances of skin sensation

926

2271

4.31

307.65

1.2

1.4

8.55

30.62

e6/l

2.90

719

1745

Other symptoms and signs involving cognitive functions and awareness

1860

2307

8.17

307.65

1.3

1.4

17.80

37.19

e6/l

1.50

1376

1815

Symptoms and signs involving cognition, perception, emotional state and behaviour

3061

5303

4.22

307.65

1.3

1.5

15.81

39.13

e6/l

3.83

2353

4110

Normal-pressure hydrocephalus

589

220

40.17

307.65

1.9

1.2

6.86

55.15

e6/l

1.00

512

163

Fever of other and unknown origin

1232

3111

3.78

307.65

1.9

1.4

47.77

24.46

e6/l

1.08

1000

2358

Intracranial trauma

1212

1524

6.11

307.65

1.5

1.4

21.22

19.66

e6/l

0.07

939

1098

Other degenerative diseases of the nervous system

1345

529

21.19

307.65

1.2

20.76

25.54

e6/l

0.13

1053

382

Postprocedural disorders of nervous system

508

483

12.38

307.65

1.3

1.2

15.20

24.77

e6/l

0.55

413

364

Alzheimer’s disease, wide definition, excluding more controls

482

161

21.68

307.65

1.2

1.1

5.33

59.65

e6/l

0.86

373

113

Migraine

1285

3255

3.47

307.65

1.3

1.5

13.85

36.77

e6/l

2.86

1027

2482

Alzheimer disease, excluding more controls

540

187

20.55

307.65

1.2

1.1

11.97

51.42

e6/l

0.67

419

134

Cerebrovascular diseases

1739

3980

3.23

307.65

1.8

1.3

34.53

29.86

e6/l

0.27

1374

3055

Mood disorders, excluding more controls

2081

4798

2.70

307.65

1.4

30.12

34.42

e6/l

0.20

1597

3716

Visual disturbances

1227

3873

3.29

307.61

1.4

1.5

23.31

29.66

e6/l

0.26

966

2987

Alzheimer’s disease (Late onset), excluding more controls

333

138

16.85

303.04

1.2

1.1

6.93

66.84

e6/l

0.83

257

100

Alzheimer’s disease (Early onset), excluding more controls

184

48.06

298.80

1.1

2.15

16.71

e6/l

0.50

146

Other mental disorders due to brain damage and dysfunction and to physical disease

407

542

8.17

291.24

1.3

1.4

3.38

27.55

e6/l

1.46

330

420

Degenerative diseases of the nervous system

752

1239

4.76

288.78

1.2

1.4

10.46

21.99

e6/l

0.93

578

977

Any dementia

827

1358

4.46

287.43

1.2

1.4

8.85

21.60

e6/l

1.27

654

1066

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

767

735

5.34

282.53

1.6

1.5

27.04

35.92

e6/l

0.35

585

546

Disorders of optic nerve and visual pathways

456

717

7.07

281.95

1.4

1.6

16.93

27.66

e6/l

0.52

359

549

Focal epilepsy

693

1584

4.64

279.45

1.6

1.7

19.04

22.23

e6/l

0.21

557

1201

Anxiety disorders, excluding more controls

1778

4530

2.66

279.25

1.4

35.39

33.42

e6/l

0.06

1339

3492

Polyneuropathies and other disorders of the peripheral nervous system

653

1426

4.86

278.95

1.7

1.4

16.04

23.22

e6/l

0.51

524

1081

Stroke, including SAH

1344

3350

3.06

278.01

1.9

1.3

38.47

31.28

e6/l

0.38

1077

2583

Focal epilepsy, strict definition

646

1457

4.71

265.18

1.6

1.7

19.84

22.68

e6/l

0.17

522

1110

Abnormal findings on diagnostic imaging of central nervous system

302

318

11.32

264.97

1.4

1.9

49.35

22.02

e6/l

0.28

229

252

Cerebral cysts

309

334

10.57

263.97

1.5

1.2

10.05

33.07

e6/l

0.73

261

255

Mood [affective] disorders

2227

6565

2.28

251.13

1.4

29.15

31.86

e6/l

0.13

1702

5085

Mood disorders

2227

6567

2.27

250.02

1.4

29.11

31.85

e6/l

0.13

1703

5087

Depression

2099

6369

2.32

249.08

1.4

29.48

30.96

e6/l

0.07

1614

4919

Other antidepressants

2192

4968

2.34

248.65

1.3

1.4

19.04

36.70

e6/l

1.55

1684

3827

Unspecific neurodegenerative disorder

806

1415

4.06

248.25

1.2

1.3

13.37

22.93

e6/l

0.65

640

1111

Delirium, not induced by alcohol and other psychoactive substances

351

473

7.95

247.45

1.3

1.4

21.69

30.98

e6/l

0.22

261

371

Focal epilepsy, mode (most common among epilepsy diagnosis)

609

1391

4.65

246.07

1.6

1.7

21.26

19.59

e6/l

0.10

487

1066

Other and unspecified hydrocephalus

186

106

23.97

238.42

3.1

1.3

26.58

7.82

e6/l

1.41

158

Meningitis

292

353

9.56

229.33

1.9

1.4

323.66

24.36

e6/l

3.66

239

272

Benign intracranial hypertension

151

42.08

227.18

1.4

1.2

9.65

4.10

e6/l

0.54

130

Aneurysms, operations, SAH

486

1006

5.12

221.40

2.5

1.3

59.18

23.45

e6/l

3.19

404

771

Alzheimer disease, including avohilmo

672

1189

4.22

221.11

1.2

1.3

15.23

22.57

e6/l

0.37

530

947

Depression or dysthymia

1377

2868

2.74

218.18

1.4

21.89

40.43

e6/l

1.46

1070

2191

Other and unspecified polyneuropathies, also in other diseases

529

1194

4.68

216.82

1.4

18.64

24.59

e6/l

0.32

423

911

Viral encephalitis, not elsewhere classified/unspecified

181

121

19.56

213.34

1.8

1.4

44.99

11.05

e6/l

2.98

155

Alzheimer’s disease, wide definition

493

845

5.07

212.31

1.2

1.3

5.59

24.00

e6/l

1.73

379

673

Viral Sepsis

517

1176

4.62

209.39

1.6

1.3

29.68

21.51

e6/l

0.32

414

902

N06DA Anticholinesterases

619

1250

4.15

207.01

1.2

1.3

11.11

24.60

e6/l

1.00

495

990

Use of anticholinesterases

619

1250

4.15

207.01

1.2

1.3

11.11

24.60

e6/l

1.00

495

990

Implicit viral Sepsis

513

1171

4.60

206.83

1.6

1.3

29.95

21.61

e6/l

0.32

410

897

Infections, IBD-co-morbidities

308

265

8.72

205.90

1.8

1.3

11.80

9.11

e6/l

0.20

245

185

Communicating hydrocephalus

177

121

18.70

205.60

3.9

1.7

37.03

7.00

e6/l

1.95

146

Pain, not elsewhere classified

591

1503

4.06

205.31

1.4

14.43

25.73

e6/l

0.66

482

1137

Nontraumatic intracranial haemmorrhage

492

1094

4.70

204.60

2.8

1.3

69.20

26.32

e6/l

3.15

407

840

Traumatic subdural haemorrhage

236

239

10.08

203.50

1.7

1.1

32.82

36.86

e6/l

0.05

180

176

Implicit bacterial Sepsis

785

2208

3.36

201.22

1.6

1.4

18.08

27.54

e6/l

0.48

624

1718

Anxiety disorders

1908

6287

2.19

200.69

1.4

33.76

29.21

e6/l

0.17

1435

4862

Syncope and collapse

821

2286

3.26

199.97

1.5

1.3

19.06

23.69

e6/l

0.20

644

1758

Alzheimer disease

574

1029

4.35

199.27

1.2

1.3

11.78

21.68

e6/l

0.57

442

815

Stroke, excluding SAH

1141

3142

2.77

198.79

1.7

1.3

28.95

33.73

e6/l

0.21

903

2434

Neurotic, stress-related and somatoform disorders

1889

6247

2.19

198.55

1.4

27.27

31.32

e6/l

0.19

1421

4832

Bacterial Sepsis

868

2589

3.06

190.15

1.6

1.4

35.49

25.44

e6/l

0.38

690

2012

Dorsalgia

2020

5199

2.14

187.45

1.3

1.4

19.03

32.67

e6/l

1.90

1629

3946

Other soft tissue disorders, not elsewhere classified

1898

5523

2.16

186.73

1.5

25.77

30.12

e6/l

0.21

1486

4248

Care involving use of rehabilitation procedures

1351

5478

2.39

185.46

1.5

26.47

29.42

e6/l

0.12

1103

4181

Symptoms and signs involving the skin and subcutaneous tissue

1411

6207

2.31

180.42

1.4

14.55

32.51

e6/l

2.64

1095

4793

Migraine without aura

527

1376

3.99

177.09

1.3

1.6

12.64

36.95

e6/l

1.58

416

1041

Alzheimer’s disease (Early onset)

184

167

12.10

176.53

1.1

1.3

2.15

40.75

e6/l

1.35

146

138

Anxiety (asthma-related co-morbidities)

1294

4325

2.41

173.58

1.3

1.4

25.77

32.94

e6/l

0.27

958

3360

Recurrent or chronic depression

843

2068

3.01

170.59

1.4

26.90

38.42

e6/l

0.49

655

1574

Subarachnoid haemorrhage

327

602

5.80

170.56

3.0

1.3

78.23

26.35

e6/l

3.29

280

463

Diplopia

398

876

4.83

168.81

1.4

16.82

27.57

e6/l

0.63

317

675

Migraine with aura

575

1645

3.62

168.66

1.2

1.4

12.83

44.30

e6/l

1.97

466

1247

General examination and investigation of persons without complaint and reported diagnosis

1328

2925

2.46

168.42

1.5

1.4

24.56

37.58

e6/l

0.80

1128

2138

Obstructive hydrocephalus

135

21.41

166.89

2.5

1.9

31.27

7.02

e6/l

1.17

111

Optic neuritis

229

307

8.48

164.71

1.3

1.4

9.13

13.01

e6/l

0.50

172

248

Autoimmune diseases excluding thyroid diseases

2080

5853

2.00

163.83

1.3

1.5

24.89

33.20

e6/l

0.50

1627

4480

Other dorsopathies, not elsewhere classified

1991

5238

2.03

161.83

1.3

1.4

25.91

32.56

e6/l

0.39

1599

3975

Pain in limb

1557

5283

2.17

160.87

1.5

29.23

30.29

e6/l

0.04

1217

4060

Parkinson's disease, excluding more controls

198

215

9.25

160.14

1.4

1.1

4.09

41.97

e6/l

0.78

163

151

Low back pain

1413

4975

2.23

157.81

1.3

1.4

18.86

33.44

e6/l

1.99

1122

3769

Autoimmune diseases excluding thyroid diseases, strict definition

2010

5690

2.00

157.58

1.3

1.5

22.00

30.83

e6/l

0.59

1573

4362

Other meningitis

142

109

16.90

154.85

2.0

1.2

376.28

5.11

e6/l

2.34

118

Autoimmune diseases related-to ILD

1663

7252

2.05

154.61

1.3

1.4

38.17

28.55

e6/l

0.39

1312

5592

Lower back pain or/and sciatica

1953

7011

1.96

153.16

1.3

1.4

19.12

33.75

e6/l

2.28

1560

5374

Cerebral palsy and other paralytic syndromes

365

814

4.77

152.39

1.6

15.66

24.50

e6/l

0.46

270

625

Viral meningitis

203

261

8.89

151.44

1.4

103.03

6.33

e6/l

11.04

181

203

Pain (limb, back, neck, head abdominally)

1389

3065

2.30

150.85

1.6

1.5

17.80

38.06

e6/l

1.94

1073

2316

All anxiety disorders

1308

4775

2.25

150.79

1.3

1.4

25.65

32.74

e6/l

0.27

969

3703

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

233

351

7.39

150.33

1.9

1.4

55.97

35.66

e6/l

0.33

183

285

Papilloedema, unspecified

162

161

12.27

148.78

1.5

1.3

22.21

11.71

e6/l

0.38

137

127

Disorders of thyroid, IBD co-morbidities

276

312

6.59

148.13

1.5

1.3

52.91

10.43

e6/l

1.13

211

221

Medical observation and evaluation for suspected diseases and conditions

1312

2926

2.33

147.35

1.5

1.4

14.79

37.57

e6/l

2.09

1074

2139

Nerve, nerve root and plexus disorders

1974

6482

1.94

147.06

1.3

1.4

33.16

30.39

e6/l

0.12

1581

4969

Certain infectious and parasitic diseases

1922

4883

2.00

146.93

1.6

1.4

48.20

23.77

e6/l

1.47

1506

3713

Depression medications

705

1097

3.30

146.81

1.4

1.1

15.72

10.61

e6/l

0.80

526

846

Parkinson's disease, strict definition, excluding more controls

177

191

9.35

144.95

1.4

1.1

4.38

47.71

e6/l

0.78

146

132

Other disorders of optic [2nd] nerve and visual pathways

261

457

6.28

144.86

1.6

1.7

22.67

32.65

e6/l

0.27

212

355

Bacterial infection, other or unspecified

976

3622

2.48

144.20

1.9

1.4

49.64

20.86

e6/l

1.13

780

2797

Ischaemic Stroke, excluding all haemorrhages

976

2990

2.52

142.98

1.5

1.3

23.59

36.40

e6/l

0.72

776

2314

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

267

490

5.90

140.41

1.9

1.4

51.51

29.44

e6/l

0.46

207

390

Sequelae of cerebrovascular disease

620

1790

3.12

140.07

2.0

1.3

35.91

21.47

e6/l

1.06

511

1384

Anaemias

512

949

3.68

137.63

1.8

1.2

13.83

10.43

e6/l

0.48

389

728

Persons encountering health services for specific procedures and health care

2043

6841

1.88

137.04

1.5

1.4

26.56

29.95

e6/l

0.24

1625

5220

Status epilepticus

165

185

9.97

136.71

1.8

24.84

58.04

e6/l

0.48

138

142

ILD medications

2163

6487

1.85

136.31

1.7

1.4

39.30

25.45

e6/l

0.69

1710

4961

ILD medications: immunosuppressive drugs

1229

5545

2.17

133.85

1.9

1.4

29.17

27.06

e6/l

0.07

976

4239

Used for control exclusion in common control thyroid runs

1998

5459

1.88

128.66

1.4

1.5

17.01

30.71

e6/l

2.29

1554

4173

Dorsopathies

1938

5288

1.89

128.11

1.3

1.4

24.68

32.34

e6/l

0.66

1545

4016

Examination and observation for other reasons

1091

2899

2.32

127.85

1.5

1.4

27.27

37.79

e6/l

0.35

866

2121

Other anxiety disorders

969

3731

2.35

126.65

1.4

29.10

31.87

e6/l

0.07

722

2889

Primary_lymphoid and hematopoietic malignant neoplasms

518

1663

3.23

126.64

3.3

1.3

28.83

23.43

e6/l

0.18

420

1274

Pain in joint

1019

2902

2.36

126.53

1.2

1.4

20.28

39.96

e6/l

1.52

791

2192

Use of donepezil

345

808

4.25

126.01

1.2

1.3

4.23

24.35

e6/l

1.97

277

641

Opioids

1894

5330

1.89

125.24

1.3

1.4

29.88

28.91

e6/l

0.03

1473

4112

Malignant neoplasm of brain

171

225

8.66

125.10

2.0

1.4

65.12

10.62

e6/l

1.20

141

182

Subjective visual disturbances

547

1826

3.10

125.08

1.4

13.23

30.61

e6/l

1.29

429

1393

Intracranial injury

1087

4844

2.21

124.68

1.6

1.5

22.89

31.60

e6/l

0.52

831

3760

Primary_lymphoid and hematopoietic malignant neoplasms

518

1678

3.20

124.62

3.3

1.3

28.83

23.43

e6/l

0.18

420

1316

Selective serotonin reuptake inhibitors

1800

5007

1.92

124.20

1.3

1.4

19.39

36.69

e6/l

2.18

1403

3855

Other special examinations and investigations of persons without complaint or reported diagnosis

1251

2926

2.19

122.04

1.5

1.4

31.93

37.57

e6/l

0.22

1006

2139

Sciatica+with lumbago

937

3925

2.31

119.39

1.3

1.4

17.06

34.33

e6/l

1.93

755

2939

Dementia in Alzheimer disease

281

504

4.91

118.69

1.2

1.3

19.25

31.11

e6/l

0.32

243

404

Abnormal involuntary movements

322

789

4.27

118.61

1.5

1.4

6.74

32.24

e6/l

2.12

249

595

Memory loss

240

467

5.45

117.72

1.3

1.4

15.78

33.58

e6/l

0.51

145

358

Spirochaetal infections, other/unspecified

268

576

4.99

117.60

1.2

1.4

33.71

27.10

e6/l

0.23

196

444

Other bacterial diseases

1661

6154

1.89

117.43

1.8

1.4

49.23

27.08

e6/l

1.28

1323

4716

Extrapyramidal and movement disorders

678

2627

2.65

116.54

1.3

1.4

7.03

31.86

e6/l

3.60

501

2044

Parasetamol

1521

3952

1.99

115.90

1.4

27.26

28.84

e6/l

0.08

1198

2979

Malignant neoplasm of eye, brain and central nervous system

186

291

7.09

115.82

2.0

1.3

61.36

20.61

e6/l

0.78

151

223

Cardiovascular diseases

1306

3464

2.09

114.54

1.6

1.4

23.69

21.18

e6/l

0.15

1020

2620

Motor neuron disease

32.33

113.98

1.1

1.0

9.18

226.50

e6/l

0.47

Diseases of the eye and adnexa

1615

4227

1.94

113.75

1.5

1.4

26.07

33.28

e6/l

0.48

1257

3233

Cardiovascular diseases (excluding rheumatic etc)

1348

3877

2.04

113.08

1.6

1.4

29.84

22.51

e6/l

0.47

1073

2923

Alzheimer’s disease (Late onset)

342

751

4.01

112.42

1.2

1.3

7.23

24.19

e6/l

1.21

261

601

First line medication for Crohn's disease

2050

6375

1.78

112.36

1.8

1.4

41.55

24.04

e6/l

1.04

1618

4874

Guillain-Barre syndrome

112

13.82

111.26

1.4

1.2

10.04

9.81

e6/l

0.01

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

552

1987

2.85

109.51

1.3

1.4

15.78

29.48

e6/l

1.47

408

1540

Bleeding

1407

5335

1.95

109.40

1.9

1.4

40.15

30.36

e6/l

0.63

1104

4102

Autoimmune diseases

2025

5894

1.77

109.29

1.3

1.5

25.54

33.00

e6/l

0.43

1572

4512

Motor neuron disease (with DMD)

27.36

109.16

1.1

1.5

9.11

195.19

e6/l

0.47

GASTRO-related operations

1552

4072

1.94

109.13

1.8

1.2

22.59

33.92

e6/l

0.84

1196

3142

Any gastric operation

1552

4072

1.94

109.13

1.8

1.2

22.59

33.92

e6/l

0.84

1196

3142

Nausea and vomiting

542

1902

2.88

109.05

1.8

1.6

19.82

34.17

e6/l

0.83

418

1456

Substance abuse, excluding more controls

917

3623

2.25

108.61

1.4

33.77

36.90

e6/l

0.08

703

2788

Bell's palsy

314

811

4.06

107.82

1.5

1.4

35.75

22.17

e6/l

0.38

241

607

Tramadol

1406

4703

1.95

106.92

1.3

1.4

23.03

30.05

e6/l

0.33

1091

3629

Pain in throat and chest

1559

5122

1.88

106.25

1.3

1.4

19.50

39.38

e6/l

2.37

1204

3921

Metabolic disorders

1652

5632

1.85

105.93

1.4

1.5

34.65

31.69

e6/l

0.11

1259

4376

Codeine

1724

5226

1.84

105.58

1.3

1.4

33.91

28.91

e6/l

0.18

1335

4026

Other intervertebral disc disorders

1425

4609

1.92

102.35

1.3

1.4

23.62

34.59

e6/l

0.56

1168

3486

Alzheimer’s disease (Atypical or mixed), excluding more controls

106

13.30

102.25

1.3

1.1

35.76

94.15

e6/l

0.33

Use of rivastigmine

255

590

4.48

100.65

1.2

1.3

21.79

26.76

e6/l

0.11

202

468

Personality disorders, excluding more controls

512

1855

2.83

100.47

1.3

1.4

7.77

29.56

e6/l

4.86

387

1436

Any reimbursement code in KELA

1191

2924

2.07

100.35

1.7

1.3

23.48

29.11

e6/l

0.32

923

2209

Spondylopathies

1319

4150

1.96

100.23

1.4

32.06

35.43

e6/l

0.15

1064

3127

ILD medications: prednisolone, methylprednisolone, prednisone

1935

6353

1.74

100.23

1.5

1.4

37.62

25.63

e6/l

0.61

1517

4862

Injuries to the head

1925

7347

1.73

99.85

1.5

1.4

22.82

31.62

e6/l

0.87

1486

5679

Explicit Sepsis

692

2793

2.42

98.52

2.3

1.4

48.10

26.40

e6/l

0.94

556

2168

Other reaction to severe stress, and adjustment disorders

745

3265

2.33

97.80

1.5

1.4

20.43

30.78

e6/l

0.55

575

2526

Other disorders of fluid, electrolyte and acid-base balance

528

1898

2.75

97.31

1.5

39.43

28.03

e6/l

0.20

435

1504

Disorders of ocular muscles, binocular movement, accommodation and refraction

916

4354

2.13

95.97

1.6

1.5

32.24

31.51

e6/l

0.02

722

3332

Migraine without aura and triptan purchases

406

1335

3.16

95.61

1.3

1.4

14.03

24.69

e6/l

1.03

320

1028

Hard cardiovascular diseases

1307

4425

1.92

95.61

1.6

1.4

22.12

32.52

e6/l

1.00

1039

3389

Hypothyroidism (congenital or acquired)

520

1032

2.95

95.38

1.3

1.2

26.88

10.11

e6/l

0.95

412

795

Benzodiazepine use

1737

7170

1.74

95.18

1.4

27.68

31.11

e6/l

0.15

1338

5554

Other diseases of urinary system

1775

5786

1.75

92.88

1.4

34.07

27.64

e6/l

0.25

1365

4498

Other disorders of urethra and urinary system

1186

4644

1.94

92.20

1.4

26.94

26.62

e6/l

0.01

903

3611

Hypothyroidism and >3 levothyroxin purchases

511

1028

2.91

91.80

1.3

1.2

26.07

10.12

e6/l

0.87

406

793

Hypothyroidism, levothyroxine purchases

511

1028

2.91

91.80

1.3

1.2

26.07

10.12

e6/l

0.87

406

793

Schizophrenia or delusion, excluding more controls

543

2104

2.61

91.59

1.2

1.4

52.19

37.04

e6/l

0.23

409

1628

Symptoms and signs involving the circulatory and respiratory systems

1862

5460

1.73

91.56

1.4

1.5

21.72

37.94

e6/l

1.24

1456

4182

Persons encountering health services in other circumstances, wide

2087

6557

1.67

91.17

1.5

1.4

24.39

31.44

e6/l

0.62

1583

5104

Soft tissue disorders

1848

5641

1.72

90.17

1.5

30.14

30.00

e6/l

0.01

1426

4337

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

304

877

3.61

88.73

1.9

1.3

41.60

26.40

e6/l

0.34

255

676

Benign neoplasm of meninges

251

638

4.14

88.33

1.6

1.3

69.58

26.01

e6/l

0.93

193

495

Diffuse large B-cell lymphoma, helper endpoint

155

267

6.34

87.52

1.6

1.2

18.49

38.80

e6/l

0.44

136

219

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

155

267

6.34

87.52

1.6

1.2

18.49

38.80

e6/l

0.44

136

219

Abnormalities of breathing

1592

5424

1.76

87.48

1.4

1.5

20.13

38.12

e6/l

1.28

1274

4157

Viral hepatitis, IBD co-morbidity

103

111

9.61

86.69

1.8

1.3

30.73

7.92

e6/l

1.40

Cerebral aneurysm, nonruptured

226

539

4.42

86.68

1.8

1.3

34.22

27.93

e6/l

0.17

186

415

Diffuse large B-cell lymphoma

155

270

6.27

86.53

1.6

1.4

18.49

39.44

e6/l

0.44

136

213

Paralytic strabismus

205

456

4.79

86.19

1.6

1.5

21.01

28.64

e6/l

0.20

163

351

Benign neoplasm: Cerebral meninges

237

590

4.24

85.91

1.6

1.3

72.45

26.65

e6/l

0.92

182

457

Persons encountering health services for examination and investigation

1142

2926

1.98

85.79

1.5

1.4

19.83

37.57

e6/l

1.21

902

2139

Secondary parkinsonism, excluding more controls

20.76

85.78

1.3

4.98

180.92

e6/l

0.55

Nonorganic sleeping disorders, excluding more controls

364

1197

3.13

85.41

1.3

1.4

4.00

26.85

e6/l

4.11

274

935

Benign neoplasm of meninges

251

655

4.03

85.17

1.6

1.3

69.58

24.66

e6/l

0.99

193

493

Use of teriflunomide

14.00

85.06

1.1

1.3

149.50

9.80

e6/l

0.50

Lumbar disc prolapse

1057

4372

1.95

84.20

1.3

1.4

25.17

35.72

e6/l

0.39

863

3301

Migraine with aura and triptan purchases

367

1227

3.10

84.02

1.2

1.4

10.87

25.20

e6/l

2.11

297

942

Non-follicular lymphoma, hilmo, excluding all cancers

236

598

4.15

83.45

2.0

1.3

23.52

28.02

e6/l

0.11

204

473

Non-follicular lymphoma

236

600

4.14

83.07

2.0

1.4

23.52

25.34

e6/l

0.05

204

464

Non-invasive ventilation

410

1367

2.89

82.55

1.5

1.4

55.18

18.88

e6/l

1.10

355

1050

Benign neoplasm: Cerebral meninges

237

608

4.11

82.47

1.6

1.3

72.45

23.26

e6/l

1.04

182

458

Inflammatory bowel disease treatment related agents

1981

6940

1.64

82.37

1.6

1.4

34.77

27.00

e6/l

0.43

1573

5306

Spondylosis

849

3555

2.08

82.28

1.4

33.90

34.77

e6/l

0.02

683

2693

Hypertensive diseases (excluding secondary)

994

2902

2.02

81.82

1.4

47.59

24.55

e6/l

0.80

761

2185

Transient ischemic attack

769

2997

2.16

81.71

1.4

1.3

11.47

31.90

e6/l

2.52

605

2318

Hypo-osmolality and hyponatraemia

316

978

3.32

81.70

1.4

1.5

25.47

16.51

e6/l

0.38

258

787

Symptoms and signs involving the digestive system and abdomen

1755

5239

1.70

80.83

1.5

21.94

36.61

e6/l

1.55

1361

4024

Oral corticosteroids

1808

6651

1.66

80.62

1.4

31.05

27.55

e6/l

0.16

1446

5080

Unspecified dementia

173

306

5.24

80.52

1.2

1.3

3.71

43.35

e6/l

1.38

149

247

1503

5466

1.74

80.19

1.6

1.4

40.12

26.30

e6/l

0.90

1183

4180

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1503

5466

1.74

80.19

1.6

1.4

40.12

26.30

e6/l

0.90

1183

4180

Speech disturbances, not elsewhere classified

214

522

4.31

79.64

1.3

1.4

22.59

30.14

e6/l

0.15

164

407

Provisional assignment of new diseases of uncertain etiology

820

4066

2.05

78.57

1.5

1.4

13.82

30.33

e6/l

1.76

616

3164

Intracerebral haemorrhage

232

604

3.97

78.44

2.6

1.3

53.03

25.20

e6/l

0.79

182

463

Oedema, not elsewhere classified

429

1602

2.71

78.34

1.3

20.72

22.34

e6/l

0.05

327

1211

Circumscribed brain atrophy

10.73

78.26

1.2

1.3

2.89

67.49

e6/l

0.63

Codes for special purposes

820

4073

2.05

78.19

1.5

1.4

13.82

30.29

e6/l

1.76

616

3169

Codeine or tramadol medication

1935

6657

1.63

77.78

1.3

1.4

32.94

28.42

e6/l

0.18

1495

5158

Neuromuscular dysfunction of bladder

223

572

4.09

77.46

1.5

1.4

28.15

31.09

e6/l

0.07

181

436

Influenza and pneumonia

1791

7250

1.64

77.37

1.6

1.4

34.94

29.18

e6/l

0.32

1416

5556

Asthma (mode)

1326

4081

1.80

77.35

1.3

1.4

39.30

28.67

e6/l

0.34

1038

3084

Hypertension, essential

1347

4358

1.79

76.39

1.4

50.08

28.78

e6/l

0.78

1027

3367

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1853

6538

1.63

76.09

1.4

28.92

31.50

e6/l

0.12

1409

5089

Cystitis

1415

5003

1.75

76.07

1.4

35.43

25.74

e6/l

0.42

1074

3894

Use of other anti-dementia drugs

334

953

3.12

75.95

1.2

1.3

6.10

20.13

e6/l

1.22

277

754

Use of memantine

334

953

3.12

75.95

1.2

1.3

6.10

20.13

e6/l

1.22

277

754

Asthma, excluding more controls

1320

3952

1.80

75.89

1.3

1.4

37.51

28.66

e6/l

0.26

1025

2989

Hemiplegia

160

322

5.30

75.86

1.6

1.4

6.62

37.37

e6/l

0.98

120

253

Septicaemia

648

2856

2.22

75.73

2.3

1.4

50.11

22.26

e6/l

1.29

523

2207

Other/unspecified dorsalgia

628

2838

2.24

75.52

1.3

1.4

14.10

31.42

e6/l

1.90

485

2152

Asthma

1337

4056

1.79

75.22

1.3

1.4

37.27

28.30

e6/l

0.27

1039

3064

Other septicaemia

585

2547

2.30

74.34

2.4

1.4

29.78

20.97

e6/l

0.51

472

1969

Strabismus

542

2343

2.37

73.54

1.6

17.83

22.49

e6/l

0.41

435

1781

Antihypertensive medication - note that there are other indications

1205

3645

1.83

73.53

1.4

1.5

20.94

25.25

e6/l

0.27

933

2795

Other extrapyramidal and movement disorders in other diseases

409

1565

2.69

72.53

1.3

1.4

8.93

35.34

e6/l

2.07

292

1218

Covid-19 confirmed case

527

2272

2.37

72.16

1.7

1.5

15.53

24.74

e6/l

0.59

385

1753

Bacterial meningitis

133

242

6.01

71.03

2.0

1.4

432.47

8.32

e6/l

2.50

109

188

Other and unspecified visual disturbances

230

642

3.75

70.83

1.3

1.5

66.46

26.79

e6/l

0.34

170

491

Traumatic subarachnoid haemorrhage

12.67

70.67

1.5

1.2

15.86

99.00

e6/l

0.41

Enlarged lymph nodes

270

838

3.31

69.82

1.5

1.4

18.00

15.10

e6/l

0.09

212

623

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

154

325

4.95

68.50

1.4

1.3

43.28

36.47

e6/l

0.06

114

257

Complications of surgical and medical care, not elsewhere classified

1574

6981

1.63

68.01

1.6

1.4

38.10

29.22

e6/l

0.41

1239

5377

Cervicobrachial syndrome

404

1593

2.60

67.27

1.3

1.4

13.83

36.83

e6/l

1.34

334

1175

Abdominal and pelvic pain

1683

5235

1.63

67.23

1.4

1.5

23.02

36.61

e6/l

1.36

1318

4023

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1566

6976

1.63

66.32

1.8

1.4

24.26

32.40

e6/l

0.39

1235

5359

Other disorders of central nervous system

12.30

65.62

1.7

1.4

378.69

6.73

e6/l

1.39

COPD/asthma related infections

1739

5476

1.60

65.05

1.5

1.4

47.26

26.25

e6/l

1.03

1353

4189

COPD/asthma/ILD related infections

1739

5476

1.60

65.05

1.5

1.4

47.26

26.25

e6/l

1.03

1353

4189

Other and unspecified degenerative diseases of nervous system

101

9.03

64.39

1.4

1.3

3.52

38.87

e6/l

0.63

Cervicalgia

357

1356

2.69

64.16

1.3

1.4

10.19

27.79

e6/l

0.99

280

1008

Symptoms and signs involving speech and voice

549

2533

2.21

63.87

1.2

1.4

24.81

30.93

e6/l

0.19

419

1959

Second line medication for Crohn's disease

955

5334

1.82

63.69

2.1

1.4

30.87

31.60

e6/l

0.02

769

4103

Fall on same level

1931

7043

1.55

63.01

1.4

1.5

30.12

29.86

e6/l

0.01

1487

5441

Small fibre neuropathy

106

175

6.71

62.80

1.4

5.57

56.13

e6/l

0.84

136

L04AX Other immunosuppressants

931

5183

1.82

62.79

2.0

1.4

19.71

31.07

e6/l

1.13

749

3987

Undefined dementia

173

388

4.20

62.30

1.2

1.3

3.71

36.07

e6/l

1.44

149

313

Invasive ventilation

193

524

3.88

62.15

2.1

1.7

81.17

28.87

e6/l

0.79

155

403

All pneumoniae

1640

7219

1.58

61.92

1.6

1.4

33.67

30.00

e6/l

0.19

1293

5535

Complications of medical and surgical care

1134

6365

1.71

61.29

1.6

1.4

42.17

27.50

e6/l

0.82

876

4933

Migraine, single triptan purchase ok & required. ICD-code if available is included

1329

5463

1.67

61.26

1.3

1.4

29.91

33.63

e6/l

0.13

1036

4179

Triptan medication for migraine, single purchase ok

1329

5463

1.67

61.26

1.3

1.4

29.91

33.63

e6/l

0.13

1036

4179

Other disorders of eye and adnexa

301

1077

2.89

61.12

1.5

14.35

27.97

e6/l

1.06

224

819

Pneumonias (Asthma/COPD co-morbidities)

1625

7196

1.58

60.83

1.6

1.4

33.99

30.05

e6/l

0.20

1280

5519

Somatoform disorder

328

1229

2.75

60.81

1.2

1.4

15.73

27.98

e6/l

0.75

255

937

Sleep disorders (combined)

1593

6629

1.59

60.78

1.4

18.06

33.42

e6/l

2.37

1242

5115

Disorders of lipoprotein metabolism and other lipidaemias

1213

4509

1.71

60.76

1.3

1.4

29.51

31.12

e6/l

0.07

887

3491

Dysphagia

402

1660

2.47

60.69

1.4

40.31

36.64

e6/l

0.07

307

1283

Diseases of the musculoskeletal system and connective tissue

993

2735

1.84

60.64

1.7

1.6

24.59

29.41

e6/l

0.22

772

2065

Systemic atrophies primarily affecting the central nervous system

128

259

5.31

60.58

1.7

1.5

7.03

43.19

e6/l

0.90

106

203

Unspecified mental disorder

732

3823

1.95

60.52

1.2

1.4

50.68

31.71

e6/l

0.40

545

2953

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

948

4981

1.79

59.33

1.4

25.76

31.91

e6/l

0.18

723

3867

Hypertension

1325

4550

1.67

58.90

1.4

1.5

50.20

28.13

e6/l

0.82

1014

3508

Hypertensive diseases

1326

4556

1.66

58.87

1.4

1.5

49.75

28.10

e6/l

0.79

1014

3512

Endovascular or surgical operations to intracerebral aneurysms

159

391

4.28

58.72

2.1

1.2

54.33

35.85

e6/l

0.48

139

303

Asthma (only as main-diagnosis), excluding more controls

1135

3952

1.73

58.59

1.4

30.39

28.66

e6/l

0.05

903

2989

Behavioural syndromes associated with physiological disturbances and physical factors

599

2955

2.07

58.41

1.5

13.71

23.04

e6/l

0.73

460

2272

Asthma (only as main-diagnosis)

1145

4056

1.72

58.31

1.4

30.21

28.30

e6/l

0.06

913

3064

285

1017

2.89

58.13

1.8

1.4

27.13

26.38

e6/l

0.02

209

780

Meningitis, viral

20.38

58.00

1.5

1.3

154.45

2.96

e6/l

4.19

Acute upper respiratory infections of multiple and unspecified sites

1222

5546

1.67

57.91

1.6

1.4

17.93

25.62

e6/l

0.88

976

4238

Bronchitis

1700

7267

1.55

57.76

1.5

1.4

23.51

31.45

e6/l

0.67

1357

5580

Dental caries

477

2146

2.25

57.67

2.7

1.4

31.69

24.92

e6/l

0.19

373

1660

Symptoms and signs concerning food and fluid intake

173

457

3.89

57.29

1.7

1.5

48.31

16.49

e6/l

0.60

145

334

Symptoms and signs involving the urinary system

1165

5412

1.68

57.26

1.5

1.4

24.34

31.86

e6/l

0.46

915

4189

COPD differential diagnosis

1338

4082

1.66

56.93

1.4

32.44

28.66

e6/l

0.13

1034

3085

ILD differential diagnosis

1336

4081

1.65

56.57

1.4

32.50

28.67

e6/l

0.13

1032

3084

Bipolar affective disorders

368

1511

2.49

56.41

1.3

1.4

19.79

23.78

e6/l

0.15

279

1180

1805

6271

1.53

56.23

1.5

1.4

42.00

27.42

e6/l

0.71

1440

4815

Excluding asthma or asthma-COPD overlap

1337

4101

1.65

55.74

1.5

1.4

33.05

28.15

e6/l

0.17

1035

3101

L04AA Selective immunosuppressants

416

1815

2.35

55.72

1.8

1.5

51.47

31.29

e6/l

0.27

331

1376

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1565

7117

1.56

55.68

1.6

1.4

33.46

30.18

e6/l

0.16

1234

5464

Pneumonia, organism unspecified

1414

6483

1.59

55.37

1.6

1.4

33.09

29.91

e6/l

0.14

1117

4974

Other pulmonary diagnosis

1335

4101

1.65

55.34

1.4

37.12

28.15

e6/l

0.32

1039

3101

Sleep disorders

422

1863

2.32

54.96

1.3

1.4

14.73

26.01

e6/l

0.60

323

1428

Asthma, unspecified (mode), excluding more controls

813

3507

1.84

54.92

1.4

55.10

25.96

e6/l

0.69

621

2654

Myalgia

404

1751

2.36

54.78

1.3

1.4

17.68

37.61

e6/l

1.24

314

1342

Other disorders of lacrimal gland

550

2696

2.08

54.69

1.5

1.4

20.91

31.11

e6/l

0.69

446

2065

Somnolence, stupor and coma

113

224

5.32

54.47

1.7

1.6

11.21

45.83

e6/l

0.65

169

Acute upper respiratory infections

1640

6724

1.54

54.28

1.5

1.4

43.20

27.87

e6/l

0.68

1304

5160

Asthma, unspecified (mode)

818

3594

1.83

53.78

1.4

54.85

25.72

e6/l

0.69

624

2718

Endocrine, nutritional and metabolic diseases

1429

4576

1.60

53.64

1.5

23.28

29.09

e6/l

0.42

1101

3530

Other lack of coordination

8.99

53.59

1.4

6.93

14.35

e6/l

0.39

Viral infections characterized by skin and mucous membrane lesions

690

3681

1.90

53.46

1.7

1.5

33.09

28.77

e6/l

0.26

540

2840

Use of hypnotics and sedatives

1704

6504

1.53

53.41

1.4

29.38

30.45

e6/l

0.04

1336

5015

Factors influencing health status and contact with health services

518

1188

2.21

52.15

1.5

1.3

28.30

48.32

e6/l

0.46

404

861

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

552

2759

2.04

52.11

1.3

1.4

15.78

23.07

e6/l

0.72

408

2136

Other specific joint derangements/joint disorders

1232

5127

1.63

52.04

1.3

1.5

18.99

29.01

e6/l

1.06

962

3912

Other general symptoms and signs

114

234

5.04

51.80

1.9

2.0

13.40

16.59

e6/l

0.20

170

Diarrhoea and gastroenteritis of presumed infectious origin

1122

6282

1.64

51.41

1.4

29.38

28.14

e6/l

0.04

874

4820

Other diseases of spinal cord

157

6.22

51.21

2.5

1.2

42.54

39.90

e6/l

0.02

123

Temporomandibular joint disorders

255

917

2.84

51.00

1.3

1.4

61.36

36.94

e6/l

0.21

205

689

Tick-borne viral encephalitis

23.49

50.96

1.1

97.42

3.47

e6/l

2.22

Exclusions for E4_PCOS_BROAD

348

1462

2.45

50.88

1.5

1.8

57.49

22.88

e6/l

0.47

268

1110

Other spirochaetal diseases

434

2003

2.21

50.71

1.3

1.4

33.88

32.19

e6/l

0.06

319

1543

Non-selective monoamine reuptake inhibitors

544

2646

2.02

50.36

1.4

14.40

40.23

e6/l

2.90

424

2038

Benign neoplasm of brain and other parts of central nervous system

160

442

3.80

50.27

1.9

1.3

44.93

28.55

e6/l

0.27

123

343

Radiculopathy

270

1009

2.74

50.26

1.3

1.4

28.47

30.97

e6/l

0.04

223

751

Mental and behavioural disorders due to psychoactive substance use

941

5270

1.70

50.25

1.4

33.10

33.16

e6/l

0.00

720

4069

Intestinal infectious diseases

1471

7508

1.54

50.23

1.5

1.4

27.33

29.83

e6/l

0.10

1160

5769

Substance abuse

917

5175

1.71

50.01

1.4

33.77

33.21

e6/l

0.01

703

3990

Systemic connective tissue disorders

542

2731

2.02

49.92

1.3

1.4

14.80

30.97

e6/l

1.52

423

2122

Lyme disease

429

1985

2.21

49.82

1.3

1.4

33.08

32.45

e6/l

0.02

315

1528

Kela-code for severe mental illness

636

3389

1.91

49.64

1.2

1.4

46.88

29.23

e6/l

0.34

472

2610

Visual field defects

178

531

3.49

49.57

1.7

1.4

16.92

28.34

e6/l

0.45

145

416

Pure hypercholesterolaemia

1019

4097

1.69

49.37

1.3

1.4

25.74

30.71

e6/l

0.26

752

3195

Disorders of adult personality and behaviour

539

2733

2.01

48.91

1.3

1.4

7.72

25.55

e6/l

5.36

406

2114

Fibromyalgia

185

572

3.35

48.58

1.2

1.3

8.33

29.63

e6/l

1.80

145

433

Post-traumatic stress disorder

188

589

3.31

48.34

1.3

1.4

38.65

19.22

e6/l

0.27

136

465

Benign neoplasm of brain and other parts of central nervous system

160

459

3.66

47.55

1.9

1.5

44.93

31.50

e6/l

0.22

123

351

Personality disorders

512

2576

2.03

47.54

1.3

1.4

7.77

25.47

e6/l

4.90

387

1990

Spinal stenosis

673

2859

1.87

47.53

1.4

18.83

36.24

e6/l

1.31

542

2158

Shoulder lesions

1153

4390

1.62

47.49

1.4

21.69

33.14

e6/l

0.90

938

3381

Other diseases of intestines

1716

6764

1.49

47.36

1.4

1.5

24.41

32.15

e6/l

0.43

1318

5231

Poisoning by drugs, medicaments and biological substances

452

2178

2.12

47.27

1.3

1.4

12.69

23.24

e6/l

1.50

325

1683

Asthma-related infections

896

5260

1.69

47.20

1.4

1.5

46.33

25.15

e6/l

0.55

713

4062

Asthma, hospital admission 2, infections

896

5260

1.69

47.20

1.4

1.5

46.33

25.15

e6/l

0.55

713

4062

Diseases of the myoneural junction and muscle

230

821

2.89

47.03

1.6

1.5

13.73

23.70

e6/l

0.56

186

639

Dentinal caries

410

1896

2.20

47.01

2.0

1.4

34.95

25.74

e6/l

0.23

322

1462

Complications of other internal prosthetic devices, implants and grafts

108

236

4.87

46.63

2.9

1.5

17.99

26.13

e6/l

0.22

190

Dissociative [conversion] disorders

112

252

4.70

46.57

1.2

1.5

14.57

11.39

e6/l

0.12

196

Exposure to unspecified factor

1504

7816

1.51

46.51

1.4

1.5

29.28

29.92

e6/l

0.02

1098

6106

Herpesviral [herpes simplex] infections

234

854

2.83

45.91

1.6

1.5

47.45

26.66

e6/l

1.09

198

661

Poisoning by medicine

417

1974

2.16

45.75

1.2

1.4

10.79

24.54

e6/l

2.20

297

1529

Brain meningioma

130

333

4.13

45.64

1.8

1.3

111.87

25.62

e6/l

1.15

110

256

Diagnoses used for exclusion with ILD

401

1870

2.18

45.59

1.5

1.4

52.89

22.54

e6/l

0.46

311

1452

Mental and behavioural disorders due to alcohol, excluding acute intoxication

695

3906

1.80

45.45

1.3

1.4

36.75

33.20

e6/l

0.07

538

2976

Nonorganic sleeping disorders

364

1639

2.27

45.34

1.3

1.4

4.00

25.42

e6/l

4.78

274

1256

Brain meningioma, excluding all cancers (controls excluding all cancers)

134

353

4.01

45.24

1.8

1.3

108.46

21.62

e6/l

1.23

114

276

Persons encountering health services in other circumstances

599

3225

1.88

45.13

1.5

18.59

35.34

e6/l

1.46

448

2526

Disorders of eyelid, lacrimal system and orbit

1245

6331

1.56

44.98

1.5

1.4

23.30

31.25

e6/l

0.69

964

4924

Pain in thoracic spine

260

1015

2.62

44.46

1.3

1.5

9.28

31.75

e6/l

0.98

214

744

Renal tubulo-interstitial diseases

1285

6447

1.54

44.34

1.4

43.52

26.87

e6/l

0.59

998

4981

Mental and behavioural disorders due to alcohol

790

4516

1.72

44.18

1.3

1.4

33.20

34.04

e6/l

0.02

608

3475

Certain disorders involving the immune mechanism

345

1538

2.30

44.04

2.5

1.5

44.96

22.68

e6/l

0.27

269

1174

Psychotic depression

113

267

4.37

43.79

1.5

5.00

51.39

e6/l

1.39

214

Gastrointestinal diseases

1078

3334

1.63

43.78

1.7

1.4

21.18

34.55

e6/l

0.95

823

2598

severe traumatic brain injury, does not include concussion

328

1434

2.33

43.68

1.7

1.4

27.19

24.02

e6/l

0.09

242

1104

Retention of urine

472

1987

2.04

43.63

1.5

1.4

22.10

20.59

e6/l

0.06

372

1549

All influenza

409

1956

2.13

43.58

1.6

1.5

27.99

23.58

e6/l

0.13

332

1498

Alcohol use disorder, Swedish definition

836

4643

1.69

43.32

1.3

1.4

33.32

33.75

e6/l

0.01

643

3573

Neoplasms

1352

4748

1.54

43.31

2.0

1.3

32.50

25.81

e6/l

0.35

1009

3714

Disorders of lacrimal system

624

3455

1.83

43.15

1.5

1.4

21.26

34.22

e6/l

1.02

506

2664

Specific personality disorders

441

2182

2.06

42.99

1.3

1.4

8.64

23.82

e6/l

3.64

341

1686

Other functional intestinal disorders

677

3651

1.79

42.97

1.4

1.6

15.59

32.11

e6/l

2.11

525

2834

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

885

5379

1.66

42.96

1.7

1.3

48.35

26.04

e6/l

1.14

688

4180

Falls/tendency to fall

1780

6171

1.45

42.86

1.4

1.5

30.43

29.56

e6/l

0.03

1389

4753

703

4005

1.76

42.81

1.5

54.03

26.74

e6/l

0.57

568

3098

Schizophrenia, schizotypal and delusional disorders

546

2910

1.91

42.72

1.2

1.4

51.95

29.04

e6/l

0.39

411

2228

Other and unspecified nonorganic psychotic disorders

372

1731

2.20

42.70

1.2

1.4

53.07

23.47

e6/l

0.39

281

1337

Acute sinusitis

825

4606

1.69

42.63

1.4

49.18

27.91

e6/l

0.64

657

3532

Sixth [abducent] nerve palsy

214

4.90

42.48

1.5

28.70

47.92

e6/l

0.25

165

Other acute disseminated demyelination

8.54

42.36

1.3

1.2

8.47

7.58

e6/l

0.07

Schizophrenia or delusion

543

2899

1.90

42.27

1.2

1.4

52.19

28.68

e6/l

0.41

409

2220

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

103

156

4.93

42.20

1.1

1.3

35.92

10.21

e6/l

0.71

113

Benign neoplasm: Pituitary gland, craniopharyngeal duct

129

348

3.90

42.07

1.5

1.3

161.59

31.86

e6/l

0.66

100

279

Third [oculomotor] nerve palsy

101

7.19

42.07

1.4

16.51

9.86

e6/l

0.35

Dyspnoea

1304

6632

1.52

42.03

1.4

21.48

30.19

e6/l

0.42

1052

5101

Follow-up examination after treatment for conditions other than malignant neoplasms

635

2276

1.85

42.01

1.3

1.4

17.45

36.82

e6/l

1.41

480

1673

Progressive vascular leukoencephalopathy

120

6.34

41.83

1.2

1.3

3.75

77.61

e6/l

0.92

Rare circulating lymphoid malignancy

201

5.02

41.81

10.6

1.3

10.84

34.28

e6/l

0.44

163

Acute lymphocytic leukaemia, helper endpoint

10.85

41.74

13.3

1.2

10.02

6.54

e6/l

0.15

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

10.85

41.74

13.3

1.2

10.02

6.54

e6/l

0.15

873

4895

1.66

41.73

1.3

1.4

32.32

33.24

e6/l

0.02

667

3778

Acute tubulo-interstitial nephritis

906

4949

1.64

41.62

1.5

38.56

23.60

e6/l

0.50

713

3834

Any operation in hilmo

11.01

41.56

1.2

1.0

11.48

29.00

e6/l

0.34

Complications of procedures, not elsewhere classified

1178

6659

1.54

41.53

1.6

1.4

32.09

27.59

e6/l

0.22

922

5137

917

5083

1.63

41.38

1.3

1.4

30.80

32.47

e6/l

0.04

702

3931

Paraplegia, diplegia of upper limbs

130

6.17

41.05

1.8

1.4

35.72

11.67

e6/l

0.60

102

Cluster headache, strict

176

5.20

41.03

1.4

1.2

4.28

15.97

e6/l

1.34

134

Speech and linguistic disorders, excluding more controls

169

517

3.17

40.35

2.2

2.1

20.63

20.32

e6/l

0.01

131

402

Acute lymphocytic leukaemia

10.29

40.14

13.3

1.9

10.02

6.40

e6/l

0.16

Asthma (diagnoses ohter than nonallergic)

1304

7505

1.50

40.10

1.4

1.5

42.23

24.72

e6/l

0.66

1016

5796

Other disorders of binocular movement

162

5.48

40.10

1.5

174.77

16.24

e6/l

0.51

120

Other diseases of blood and blood-forming organs, wide

358

1684

2.17

39.99

2.3

1.5

41.46

23.00

e6/l

0.25

302

1291

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

209

4.82

39.90

10.6

1.2

10.84

41.40

e6/l

0.59

179

Alcohol use disorder, ICD-based

633

3606

1.78

39.78

1.3

1.4

37.85

30.39

e6/l

0.14

486

2743

Generalized anxiety disorder

284

1217

2.39

39.78

1.2

1.4

12.65

29.58

e6/l

1.70

208

948

Ocular pain

178

609

3.04

39.56

1.5

1.6

11.98

23.38

e6/l

0.82

139

471

Benign neoplasm: Pituitary gland, craniopharyngeal duct

129

366

3.70

39.10

1.5

1.4

161.59

33.61

e6/l

0.65

100

288

Unknown and unspecified causes of morbidity

124

342

3.73

38.82

1.3

1.5

23.70

12.12

e6/l

0.46

106

260

Oxycodone

486

2490

1.91

38.48

1.6

1.4

14.44

30.45

e6/l

1.62

397

1938

Cluster headache, wide

194

4.80

38.41

1.3

1.2

4.97

14.71

e6/l

1.13

148

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

6.97

38.36

1.8

1.1

44.20

4.99

e6/l

1.21

Cervical disc disorders

510

2758

1.87

38.08

1.5

1.4

31.82

33.30

e6/l

0.04

421

2056

Unspecified fall

702

4132

1.71

38.03

1.4

1.5

20.51

29.67

e6/l

0.71

530

3206

Constipation

1251

6013

1.50

37.96

1.4

1.5

39.05

28.94

e6/l

0.30

946

4671

Cervicocranial syndrome

192

698

2.82

37.95

1.3

1.4

12.95

18.90

e6/l

0.39

155

530

Encephalopathy

10.61

37.94

1.3

1.4

3.50

10.56

e6/l

0.56

Disorders of vestibular function (Vertigo)

640

3684

1.75

37.82

1.3

1.4

30.77

32.74

e6/l

0.05

520

2838

Zoster [herpes zoster]

272

1170

2.38

37.78

1.8

1.4

18.32

26.41

e6/l

0.52

209

903

Dementia in other diseases classified elsewhere

197

4.72

37.67

1.2

1.3

2.52

53.15

e6/l

1.03

157

Other sleep disorders

178

624

2.92

37.61

1.2

1.3

29.68

28.19

e6/l

0.02

149

477

Asthma, including avohilmo

1799

7471

1.41

37.58

1.3

1.5

33.42

28.63

e6/l

0.18

1394

5767

Postviral fatigue syndrome

10.23

37.30

1.2

1.6

0.97

2.20

e6/l

1.40

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

499

2670

1.88

37.30

2.5

1.4

11.48

27.85

e6/l

2.07

380

2073

Other systemic involvement of connective tissue (FG)

384

1889

2.05

37.25

1.3

1.4

15.32

29.20

e6/l

0.82

292

1463

Disorders of other endocrine glands

659

3806

1.72

37.15

1.5

38.76

29.49

e6/l

0.19

507

2940

Use of peginterferon beta-1a

17.18

37.12

1.0

1.2

13.68

2.95

e6/l

1.82

Other complications of surgical and medical care, not elsewhere classified

191

704

2.80

36.90

1.6

1.4

37.26

20.49

e6/l

0.44

156

543

Other and unspecified nerve root and plexus disorders, also in other diseases

302

1376

2.24

36.60

1.3

1.4

56.03

22.91

e6/l

0.41

251

1028

Insomnia

294

1327

2.27

36.56

1.3

1.5

19.07

26.99

e6/l

0.24

221

1019

Diseases of the ear and mastoid process

1846

6713

1.40

36.36

1.5

1.4

45.77

24.01

e6/l

1.21

1448

5138

Panic disorder

269

1172

2.35

36.31

1.3

1.4

8.07

22.98

e6/l

3.28

207

919

Brain glioblastoma and astrocytoma

104

6.56

36.21

1.8

1.2

44.20

13.16

e6/l

0.81

Other viral diseases

508

2784

1.85

36.19

1.8

1.6

24.26

24.56

e6/l

0.01

397

2138

Other acute lower respiratory infections

766

4487

1.65

36.16

1.6

1.5

22.61

30.47

e6/l

0.46

602

3466

Alcohol abuse, main dg, excluding more controls

228

924

2.52

36.11

1.2

1.4

65.56

27.38

e6/l

0.29

167

733

Suicide or other Intentional self-harm

427

2231

1.95

35.68

1.2

1.4

12.37

22.83

e6/l

1.50

302

1719

Other external causes of accidental injury

1324

4500

1.48

35.47

1.4

1.5

30.18

33.61

e6/l

0.11

1006

3484

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

511

2831

1.83

35.45

1.5

1.6

65.37

27.66

e6/l

0.72

382

2192

Triptan medication for migraine, min. 3 purchases

905

4556

1.58

35.43

1.3

1.4

27.74

28.65

e6/l

0.02

715

3482

Hypothyroidism, drug reimbursement

220

609

2.62

35.32

1.4

1.2

43.33

7.43

e6/l

0.84

169

473

External causes of morbidity and mortality

1097

3593

1.54

35.08

1.5

1.4

24.08

34.83

e6/l

0.66

834

2762

Focal brain injury

138

5.25

34.75

1.8

1.1

21.96

49.11

e6/l

0.29

Other joint disorders

1423

5263

1.45

34.36

1.3

1.5

26.76

28.72

e6/l

0.07

1126

4017

Genitourinary diseases

1001

3234

1.56

34.18

1.5

1.6

28.14

27.02

e6/l

0.04

768

2486

Injuries to the abdomen, lower back, lumbar spine and pelvis

553

3160

1.76

33.63

1.4

14.29

29.19

e6/l

1.74

419

2466

Phobic anxiety disorders

242

1043

2.37

33.52

1.5

11.04

26.61

e6/l

1.36

187

814

Accidents

1311

4500

1.47

33.46

1.4

1.5

29.76

33.61

e6/l

0.13

988

3484

Diseases of inner ear

723

4385

1.63

33.11

1.3

1.4

30.53

32.58

e6/l

0.06

585

3355

Alzheimer’s disease (Atypical or mixed)

107

298

3.66

32.86

1.3

35.76

39.36

e6/l

0.04

246

Rotator cuff syndrome

838

3963

1.58

32.70

1.3

1.4

32.71

31.73

e6/l

0.02

685

3061

Use of levodopa decarboxylase inhibitor

186

719

2.65

32.62

1.3

3.67

25.18

e6/l

1.83

156

558

Hypopituitarism

159

570

2.90

32.56

1.6

2.3

24.64

27.60

e6/l

0.08

135

428

Lymphoid leukaemia

116

347

3.48

32.40

8.9

1.3

7.91

30.94

e6/l

0.74

281

Other CVD (FINNGEN)

177

513

2.78

32.30

1.5

1.2

8.60

14.78

e6/l

0.36

141

380

Parkinson's disease, including avohilmo

220

926

2.43

32.18

1.4

1.3

3.97

26.57

e6/l

2.33

181

716

Benign neoplasm of other and unspecified endocrine glands

215

898

2.46

32.11

1.4

1.3

106.15

25.52

e6/l

0.63

156

697

Sarcoidosis

236

1028

2.35

32.04

1.6

1.4

61.43

26.71

e6/l

0.29

181

786

Other intracranial haemorrhages

142

5.11

31.99

2.2

1.3

47.91

66.94

e6/l

0.14

113

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

793

5067

1.58

31.91

1.7

1.4

53.03

26.03

e6/l

1.31

616

3928

Other strabismus

375

1946

1.96

31.79

1.6

1.7

17.12

22.13

e6/l

0.40

302

1478

Diseases of the respiratory system

1010

3322

1.53

31.77

1.5

1.4

28.96

29.09

e6/l

0.00

779

2508

Finngen Rheumatological endpoints

1508

6144

1.41

31.55

1.3

1.4

28.66

30.10

e6/l

0.07

1178

4728

Hypothyroidism, strict autoimmune

1005

4444

1.51

30.90

1.3

1.4

14.75

33.18

e6/l

3.33

791

3409

Secondary parkinsonism+Parkinsonism in other disease

139

5.10

30.83

1.3

4.89

45.22

e6/l

0.60

116

Other systemic involvement of connective tissue

388

2063

1.91

30.76

1.3

1.4

15.13

33.46

e6/l

1.26

296

1598

Hyperkinetic disorders, excluding more controls

179

681

2.62

30.54

1.2

1.9

12.42

21.17

e6/l

0.84

135

541

Lymphoid leukaemia

116

362

3.34

30.31

8.9

1.3

7.91

33.77

e6/l

0.88

287

Persistent mood disorders

293

1425

2.09

30.07

1.3

1.4

25.33

24.30

e6/l

0.03

217

1110

Diseases of oesophagus, stomach and duodenum

1559

6880

1.39

29.99

1.3

1.5

28.76

32.14

e6/l

0.13

1208

5319

Secondary parkinsonism

139

5.02

29.86

1.3

4.98

45.42

e6/l

0.61

116

ILD medications: azathioprine

254

1175

2.21

29.78

1.6

1.4

17.43

25.31

e6/l

0.39

202

892

Brachial plexus disorders

175

689

2.61

29.72

1.2

1.4

12.58

28.28

e6/l

0.76

145

520

Other medical care

519

2966

1.73

29.66

1.6

1.4

44.32

26.26

e6/l

0.59

404

2282

Asthma-related pneumonia or sepsis

478

2735

1.77

29.59

1.6

20.07

23.43

e6/l

0.20

378

2130

Asthma, hospital admissions 3, pneumonia

478

2735

1.77

29.59

1.6

20.07

23.43

e6/l

0.20

378

2130

Other necrotizing vasculopathies (FG)

114

357

3.31

29.56

1.3

1.4

16.54

10.13

e6/l

0.31

269

Obesity related asthma

484

2788

1.76

29.50

1.3

1.4

72.53

28.69

e6/l

0.66

392

2151

Agranulocytosis

196

817

2.46

29.49

2.7

1.5

67.62

31.08

e6/l

0.28

167

619

Other heart diseases

720

2982

1.61

29.43

1.4

1.5

38.70

24.46

e6/l

0.56

557

2260

Arthropathies

1453

5297

1.40

29.36

1.3

1.5

24.70

28.68

e6/l

0.26

1136

4041

Asthma-related pneumonia

476

2728

1.76

29.31

1.6

20.12

22.90

e6/l

0.16

377

2125

Polyuria

310

1554

2.03

29.30

1.3

1.4

34.10

17.90

e6/l

0.39

248

1202

Frontotemporal dementia, wide, incl. Pick's disease

11.26

29.29

1.1

1.2

1.56

3.37

e6/l

1.72

Emotionally unstable personality disorder

237

1075

2.26

29.26

1.2

1.4

10.02

20.16

e6/l

1.77

180

827

Hypotension

205

876

2.38

28.97

1.5

1.4

7.85

20.79

e6/l

1.05

162

683

Benign neoplasm of other and unspecified endocrine glands

215

941

2.34

28.93

1.4

106.15

24.00

e6/l

0.65

156

719

Osteopathies and chondropathies

744

4547

1.57

28.76

1.6

1.4

19.70

32.60

e6/l

1.26

586

3515

Non-Hodgkin lymphoma, all

217

4.00

28.38

1.8

1.3

99.55

42.77

e6/l

0.42

173

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

299

1502

2.03

28.22

1.2

1.4

11.50

25.07

e6/l

1.44

212

1167

Sequelae of external causes of morbidity and mortality

353

1874

1.91

28.21

1.6

1.4

60.11

25.03

e6/l

0.51

267

1437

Other degenerative diseases of the basal ganglia

6.36

27.99

1.3

2.44

103.96

e6/l

0.88

Other symptoms and signs involving general sensations and perceptions

197

4.12

27.94

1.2

1.5

20.66

54.23

e6/l

0.51

148

Coxibs

418

1199

1.87

27.90

1.3

1.5

12.06

44.17

e6/l

2.34

316

926

Asthma, hospital admissions , main diagnosis only

1189

7563

1.42

27.86

1.4

1.5

29.64

29.15

e6/l

0.02

951

5798

Abnormalities of heart beat

484

2808

1.73

27.75

1.3

1.4

10.03

38.73

e6/l

4.06

380

2172

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

165

654

2.60

27.71

1.3

1.4

9.40

19.32

e6/l

0.71

130

508

Other and unspecified mood [affective] disorders

137

497

2.83

27.39

1.3

1.5

36.94

23.18

e6/l

0.42

101

391

Other and unspecified myopathies

143

532

2.76

27.26

1.8

1.5

14.57

28.06

e6/l

0.53

117

419

Disorders of sclera, cornea, iris and ciliary body

762

5016

1.53

27.00

1.3

1.4

37.42

28.18

e6/l

0.39

612

3859

Frontotemporal dementia

12.15

26.95

1.1

1.2

1.57

3.64

e6/l

1.67

Type 2 diabetes, wide definition

1079

4899

1.45

26.84

1.4

31.72

34.92

e6/l

0.13

841

3774

Cough

562

3314

1.64

26.64

1.7

1.5

14.98

40.39

e6/l

3.12

429

2525

Optic atrophy

106

5.46

26.62

1.9

1.7

25.53

13.11

e6/l

0.27

Leukaemia of unspecified cell type

8.29

26.48

7.9

1.2

1.46

2.97

e6/l

1.10

Injury, poisoning and certain other consequences of external causes

855

2827

1.53

26.41

1.6

1.4

23.13

37.52

e6/l

0.76

652

2129

Persons with potential health hazards related to communicable diseases

608

3800

1.60

26.20

1.7

1.5

20.39

25.85

e6/l

0.44

442

2934

Chronic lower respiratory diseases

1801

7368

1.33

26.15

1.4

1.5

31.47

29.21

e6/l

0.08

1403

5675

Benign neoplasms

1212

4880

1.41

26.10

1.4

1.3

27.03

22.71

e6/l

0.29

932

3816

Disorders of refraction and accommodation

413

2349

1.78

26.06

1.7

1.6

20.79

22.80

e6/l

0.13

318

1790

Acute bronchitis

548

3302

1.64

26.01

1.5

22.26

24.07

e6/l

0.08

427

2564

Azathioprine

254

1242

2.08

25.86

1.6

1.4

17.43

19.68

e6/l

0.11

202

942

Other problems related to primary support group, including family circumstances

221

998

2.21

25.86

4.1

1.5

12.34

19.45

e6/l

0.71

173

761

Open wound of head

670

4262

1.56

25.82

1.5

19.10

33.68

e6/l

1.22

518

3319

Abnormal findings on examination of blood, without diagnosis

594

3487

1.61

25.82

1.4

55.97

24.73

e6/l

0.70

447

2707

Rheumatism, unspecified

214

980

2.23

25.80

1.3

1.4

19.93

40.18

e6/l

0.73

167

747

Parkinson's disease

198

879

2.30

25.72

1.4

1.3

4.09

27.24

e6/l

2.26

163

687

Cardiac arrhythmias

877

3923

1.49

25.43

1.3

1.4

43.01

30.53

e6/l

0.43

683

2974

Sleep apnoea, including avohilmo

1356

6440

1.38

25.35

1.4

24.09

32.76

e6/l

0.77

1053

4966

Leukaemia of unspecified cell type

7.81

25.19

7.9

1.2

1.46

3.52

e6/l

1.35

Injuries to the neck

359

1989

1.83

25.15

1.3

1.4

9.02

23.60

e6/l

2.81

282

1540

Sleep apnoea

1260

6199

1.39

25.09

1.4

21.89

34.38

e6/l

1.38

982

4766

Other disorders of nervous system

110

372

3.05

25.06

1.7

1.2

16.58

26.16

e6/l

0.22

277

Injuries to the thorax

577

3635

1.60

24.88

1.3

1.4

18.01

29.37

e6/l

0.61

440

2813

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

342

1697

1.86

24.87

1.8

1.7

17.58

18.48

e6/l

0.06

266

1308

Other necrotizing vasculopathies

126

462

2.81

24.79

1.3

1.4

17.68

29.26

e6/l

0.34

356

Cramp and spasm

104

344

3.15

24.79

1.4

4.90

38.90

e6/l

1.22

267

Other CVD

228

1097

2.11

24.17

1.5

1.4

10.18

25.00

e6/l

1.30

180

859

Benign neoplasm: Brain, supratentorial

108

5.19

24.11

2.2

1.6

16.16

11.91

e6/l

0.16

Paracetamol of NSAID medication

288

719

2.04

24.10

1.7

14.29

52.22

e6/l

1.54

230

554

Other and unspecified anaemias

487

2870

1.66

24.00

1.8

1.4

37.97

26.39

e6/l

0.18

374

2225

Other disorders of bladder

168

717

2.39

23.99

1.3

11.92

31.64

e6/l

0.99

135

556

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

651

2653

1.57

23.91

1.4

1.3

30.15

20.06

e6/l

0.41

518

1997

Drug-induced neutropenia

132

506

2.69

23.86

2.1

1.4

12.40

31.40

e6/l

0.77

118

384

Other metabolic disorders

205

956

2.19

23.69

1.5

1.4

49.88

25.56

e6/l

0.42

155

754

Transport accidents

653

3780

1.54

23.66

1.3

1.4

13.29

33.86

e6/l

2.53

504

2931

Viral pneumonia

197

905

2.22

23.64

1.5

1.6

26.57

15.94

e6/l

0.39

160

698

Use of glatiramer acetate

118

4.91

23.56

1.1

1.7

8.00

5.02

e6/l

0.95

Other and unspecified drugs and medicaments

149

609

2.52

23.54

1.4

1.5

10.07

26.02

e6/l

0.76

120

469

Functional dyspepsia

372

2125

1.77

23.48

1.4

8.58

25.11

e6/l

3.02

291

1640

Benign paroxysmal vertigo

368

2096

1.78

23.47

1.4

32.44

32.04

e6/l

0.01

301

1613

Other anaemias

489

2894

1.65

23.46

1.8

1.4

37.94

26.63

e6/l

0.18

375

2244

Irregular menses

712

3841

1.52

23.44

1.4

1.3

23.22

27.23

e6/l

0.24

558

2952

Disorders of psychological development

225

1011

2.11

23.22

2.0

16.54

19.38

e6/l

0.17

176

774

Parkinson's disease, strict definition

177

784

2.30

23.18

1.4

1.3

4.38

28.93

e6/l

2.06

146

611

Diseases of pulp and periapical tissues

496

3069

1.63

23.16

1.6

1.4

33.23

29.88

e6/l

0.10

399

2373

Disorders of the thyroid gland

1343

6510

1.36

23.15

1.4

33.14

28.93

e6/l

0.15

1050

5024

Aplastic and other anaemias

526

3124

1.61

23.10

1.7

1.4

36.05

25.65

e6/l

0.18

404

2423

Substance use, excluding alcohol

305

1653

1.87

23.00

1.5

1.4

27.26

26.06

e6/l

0.04

224

1278

Hypothyroidism, other/unspecified

1257

6101

1.37

22.96

1.3

1.4

34.79

28.17

e6/l

0.24

979

4712

Irritable bowel syndrome

400

2348

1.72

22.92

1.2

1.4

7.42

29.30

e6/l

4.04

305

1826

Brain glioblastoma

6.01

22.72

1.9

1.2

48.06

16.42

e6/l

0.54

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

6.01

22.72

1.9

1.1

48.06

5.60

e6/l

0.86

Cluster headache, strict, including avohilmo

103

356

3.00

22.71

1.4

3.77

14.72

e6/l

2.03

271

Other viral diseases, not elsewhere classified

303

1642

1.87

22.69

2.0

1.7

30.16

21.67

e6/l

0.29

237

1267

Benign neoplasm: Brain, supratentorial

114

4.91

22.64

2.2

1.1

16.16

3.38

e6/l

0.89

Persons encountering health services for specific procedures, not carried out

135

538

2.58

22.50

1.3

1.5

14.78

30.93

e6/l

0.65

409

Statin medication

1024

4076

1.42

22.44

1.4

24.13

35.69

e6/l

0.85

782

3133

Hypothyreosis and Thyroxine purchase for inclusion criteria

1288

6299

1.36

22.39

1.3

1.4

34.10

27.77

e6/l

0.24

1000

4870

Temporomandibular joint disorders, including avohilmo

617

4041

1.54

22.39

1.4

40.27

26.38

e6/l

0.29

475

3136

Supplementary factors related to causes of morbidity and mortality classified elsewhere

433

2614

1.68

22.35

1.6

1.5

28.69

26.82

e6/l

0.05

348

2008

Trigeminal neuralgia

106

375

2.91

22.34

1.4

1.5

10.57

12.46

e6/l

0.15

281

Superficial injury of head

314

1734

1.83

22.24

1.5

1.6

19.45

22.64

e6/l

0.17

234

1348

Neuralgia and neuritis, unspecified

323

3.07

22.16

1.8

1.3

8.96

39.92

e6/l

0.91

243

Lesion of lateral popliteal nerve

319

3.08

22.03

1.3

1.4

67.63

24.16

e6/l

0.34

240

Diffuse brain injury

5.57

22.02

1.9

1.2

20.68

76.20

e6/l

0.35

Use of galantamine

293

3.15

21.88

1.3

4.24

40.37

e6/l

1.16

242

Dermatitis

812

5655

1.45

21.76

1.5

1.4

23.24

29.03

e6/l

0.37

640

4375

Vocal cord dysfunction

182

774

2.21

21.66

1.5

64.47

21.09

e6/l

0.65

139

596

Dementia due to Parkinsons disease, excluding more controls

11.26

21.63

1.2

1.1

1.69

280.63

e6/l

0.55

Other and unspecified effects of external causes

416

2509

1.68

21.60

1.2

1.6

16.69

22.72

e6/l

0.55

314

1931

Other and unspecified dermatitis

686

4635

1.49

21.57

1.6

1.4

20.76

29.82

e6/l

0.65

536

3568

Other infectious diseases

131

526

2.56

21.51

1.5

11.68

28.61

e6/l

0.73

101

411

Type of accident

400

2395

1.69

21.35

1.6

1.5

30.01

25.92

e6/l

0.11

329

1845

Cluster headache, wide,, including avohilmo

105

380

2.86

21.29

1.4

4.34

17.25

e6/l

2.21

291

Chronic sinusitis

601

3961

1.53

21.28

1.3

1.4

21.89

34.85

e6/l

0.76

465

3035

Secondary and unspecified malignant neoplasm of lymph nodes

136

560

2.49

21.18

1.9

1.4

53.02

25.39

e6/l

0.30

107

433

Hypokalaemia

159

701

2.31

21.12

1.7

1.4

80.09

19.34

e6/l

0.40

132

550

Sequelae of injuries, of poisoning and of other consequences of external causes

343

1976

1.76

21.12

1.6

1.4

53.74

27.45

e6/l

0.36

266

1509

Other symptoms and signs involving the urinary system

158

696

2.32

21.08

1.5

21.08

17.96

e6/l

0.11

121

546

Infections of the skin and subcutaneous tissue

797

5545

1.44

21.01

1.9

1.4

32.14

32.84

e6/l

0.02

631

4256

Bacterial pneumonia (organism specified)

552

3253

1.56

21.00

1.7

1.4

27.72

29.96

e6/l

0.09

434

2529

Bacterial pneumoniae

513

2888

1.59

20.99

1.7

1.4

27.56

25.60

e6/l

0.08

400

2235

Dermatitis and eczema

1537

7736

1.31

20.91

1.5

1.4

24.06

31.13

e6/l

0.62

1201

5963

Bacterial pneumonia, not elsewhere classified

485

2697

1.61

20.89

1.7

1.4

26.57

24.21

e6/l

0.09

378

2082

Other disorders of teeth and supporting structures

298

1654

1.83

20.83

1.5

1.4

27.22

31.12

e6/l

0.16

239

1283

Dislocation, sprain and strain of joints and ligaments at neck level

252

1329

1.93

20.80

1.3

1.5

8.18

23.10

e6/l

1.95

201

1033

Benign neoplasms

1450

6152

1.32

20.65

1.4

29.42

28.58

e6/l

0.04

1119

4774

Fungal Sepsis

213

3.52

20.62

1.8

1.2

4.06

23.75

e6/l

0.74

175

Implicit fungal Sepsis

191

3.65

20.32

1.7

1.2

4.03

26.46

e6/l

0.75

155

Mixed and other personality disorders

147

639

2.36

20.30

1.2

1.4

5.00

20.88

e6/l

2.73

105

480

Speech and linguistic disorders

171

758

2.22

20.25

2.2

2.1

20.48

18.34

e6/l

0.10

132

577

Alcohol dependence

365

2164

1.71

20.24

1.3

1.4

12.76

26.09

e6/l

1.69

283

1671

Vascular dementia

259

3.14

20.23

1.4

3.66

45.71

e6/l

1.18

210

Deposits [accretions] on teeth

136

552

2.45

20.17

5.9

1.5

12.34

32.11

e6/l

0.77

112

418

Congenital malformations of the nervous system

193

3.68

20.16

2.0

3.5

41.67

7.05

e6/l

0.93

138

Thrombocytopenia, unspecified

118

466

2.60

20.12

2.8

1.5

62.14

30.05

e6/l

0.26

361

Other and unspecified tonsillitis

518

2831

1.57

19.97

1.5

1.4

44.48

27.03

e6/l

0.31

391

2177

Propionic acid derivatives

433

1308

1.68

19.90

1.5

1.7

24.10

42.51

e6/l

0.62

341

1013

Other bacterial intestinal infections

236

1237

1.94

19.79

1.8

1.4

16.38

22.77

e6/l

0.31

184

941

Emotional disorders starting during childhood or adolecense, excluding more controls

299

3.00

19.75

3.2

2.0

22.77

18.04

e6/l

0.15

231

Sequelae with surgical and medical care as external cause

263

1433

1.86

19.59

1.7

1.4

71.14

26.41

e6/l

0.48

199

1107

Other enthesopathies

394

2405

1.66

19.53

1.2

1.4

16.01

36.83

e6/l

1.89

310

1843

Enthesopathies of lower limb, excluding foot

285

1592

1.81

19.51

1.3

1.4

19.30

36.31

e6/l

0.81

216

1178

Injuries to the ankle and foot

987

6593

1.37

19.39

1.4

45.19

29.12

e6/l

0.42

772

5072

Fracture of rib(s), sternum and thoracic spine

362

2167

1.69

19.37

1.4

9.36

26.89

e6/l

2.99

285

1684

Undetermined asthma, excluding more controls

180

864

2.12

19.32

1.5

1.4

83.35

17.64

e6/l

0.50

149

664

Heterophoria

147

655

2.30

19.20

1.6

1.8

15.30

21.68

e6/l

0.31

123

502

Manic episode

179

3.66

19.20

1.1

1.4

71.73

10.73

e6/l

0.55

142

Iridocyclitis

314

1816

1.75

19.12

1.4

30.87

16.00

e6/l

0.41

246

1371

Inflammatory diseases of female pelvic organs

838

4500

1.41

19.09

1.3

1.4

12.82

33.51

e6/l

3.63

644

3484

171

3.73

19.03

1.4

1.5

8.59

11.82

e6/l

0.21

135

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

255

3.17

19.02

1.7

1.2

15.30

38.73

e6/l

0.50

210

Volume depletion

122

502

2.48

18.99

1.4

1.6

30.87

14.70

e6/l

0.27

102

400

Allergic asthma (mode), excluding more controls

338

1959

1.71

18.97

1.4

18.88

22.16

e6/l

0.12

269

1476

Pneumonitis due to solids and liquids

114

455

2.56

18.97

1.4

41.56

27.76

e6/l

0.17

359

Speech therapy

349

2082

1.70

18.96

1.4

16.67

27.49

e6/l

0.62

280

1603

Allergic asthma (mode)

338

1962

1.71

18.87

1.4

18.88

22.31

e6/l

0.12

269

1479

Other arthritis (FG)

413

2575

1.62

18.82

1.3

1.4

52.74

28.41

e6/l

0.39

323

1996

Other specified/unspecified arthritis

362

2186

1.67

18.76

1.3

1.5

58.12

23.95

e6/l

0.52

285

1681

KRA_PSY_EATING, excluding more controls

129

547

2.39

18.65

1.2

1.5

13.57

23.05

e6/l

0.64

101

433

Undetermined asthma

180

878

2.08

18.53

1.5

1.4

83.35

18.02

e6/l

0.50

149

674

Restless leg syndrome

177

860

2.10

18.53

1.3

1.4

8.58

24.27

e6/l

1.38

125

666

Injuries to the shoulder and upper arm

1093

6862

1.34

18.51

1.5

1.4

36.04

32.05

e6/l

0.12

873

5277

Dentofacial anomalies [including malocclusion]

414

2565

1.61

18.51

2.3

1.4

47.30

31.14

e6/l

0.23

332

1984

Exclusions for E4_PCOS_CONSORTIUM

1042

4828

1.36

18.41

1.4

1.5

33.27

28.35

e6/l

0.15

808

3725

Diseases of the skin and subcutaneous tissue

1505

5843

1.30

18.39

1.5

1.4

30.25

30.72

e6/l

0.02

1190

4488

Vascular dementia (subcortical)

4.86

18.34

1.4

3.43

24.93

e6/l

1.13

Polyarthropathies

921

4458

1.39

18.34

1.4

1.5

26.43

31.25

e6/l

0.26

734

3396

Diabetes insipidus

6.01

18.32

1.6

1.2

426.35

7.24

e6/l

0.49

Hypersomnia

4.88

18.31

1.2

2.83

14.93

e6/l

0.89

Early lumbar disc prolapse, operated

154

712

2.20

18.31

1.2

1.4

17.60

20.60

e6/l

0.12

126

542

Other and unspecified types of non-Hodgkin lymphoma, hilmo

261

3.10

18.30

1.7

1.3

15.30

42.67

e6/l

0.59

205

Voice disturbances

343

2058

1.69

18.26

1.2

1.4

25.67

32.25

e6/l

0.15

261

1598

Hyperlipidaemia, other/unspecified

430

2578

1.59

18.16

1.3

1.4

36.66

31.88

e6/l

0.10

327

2046

Fracture of lumbar spine and pelvis

254

1400

1.83

18.14

1.5

1.4

12.37

24.33

e6/l

1.02

189

1090

Visual impairment including blindness (binocular or monocular)

101

390

2.65

18.03

1.5

1.6

6.41

31.46

e6/l

0.95

303

Secondary uncertain malignant neoplasm

169

815

2.11

18.03

1.7

1.4

44.49

22.45

e6/l

0.32

140

631

Postprocedural endocrine and metabolic disorders, not elsewhere classified

179

884

2.06

17.93

1.5

1.3

54.61

24.73

e6/l

0.44

131

697

Social phobias

137

610

2.29

17.89

1.6

1.4

9.53

18.85

e6/l

1.41

100

482

Sequelae of injuries of head

376

2.69

17.81

1.6

1.5

6.07

35.73

e6/l

1.16

295

Acute alcohol intoxication

334

2003

1.69

17.81

1.3

1.4

47.84

27.77

e6/l

0.21

244

1551

Injuries to the wrist and hand

1375

7725

1.30

17.78

1.3

1.5

29.43

29.23

e6/l

0.01

1044

5991

Monoplegia

4.63

17.65

1.4

1.2

5.77

12.67

e6/l

0.45

Ptosis of eyelid

151

704

2.19

17.63

1.6

1.5

10.64

21.48

e6/l

0.66

122

540

Other and unspecified paralytic syndromes

5.01

17.58

1.3

1.2

4.91

5.72

e6/l

0.07

Other/unspecified cytomegaloviral diseases

125

4.16

17.58

1.9

1.3

3.34

10.55

e6/l

0.68

100

Other disorders of ear

1216

6184

1.32

17.44

1.5

48.62

25.90

e6/l

0.84

962

4752

Pain and other conditions associated with female genital organs and menstrual cycle

310

1756

1.71

17.43

1.3

10.77

25.06

e6/l

1.84

239

1383

Gastro-oesophageal reflux disease

884

5740

1.37

17.40

1.3

1.5

31.61

29.64

e6/l

0.05

688

4444

Chronic periapical parodontitis

281

1620

1.76

17.36

1.6

1.4

47.95

26.94

e6/l

0.51

230

1245

Immunodeficiency with predominantly antibody defects

178

3.53

17.23

2.5

1.5

6.48

15.14

e6/l

0.61

135

Specific development disorders of speech and language

120

497

2.39

16.98

2.0

2.5

24.03

13.72

e6/l

0.46

372

Intracranial and intraspinal abscess and granuloma

5.82

16.95

3.0

1.3

270.38

15.36

e6/l

0.65

Non-allergic asthma (mode)

252

1403

1.80

16.95

1.3

1.4

20.31

18.41

e6/l

0.09

204

1067

Diseases of pulp and periapical tissues, including avohilmo

1531

6245

1.28

16.91

1.4

1.5

24.88

27.47

e6/l

0.15

1182

4857

Urticaria and erythema

507

3393

1.51

16.89

1.6

1.5

19.37

32.15

e6/l

0.85

401

2620

Need for other prophylactic measures

102

410

2.56

16.89

2.7

1.7

13.72

32.49

e6/l

0.60

318

Somnolence

4.95

16.88

1.7

1.8

4.15

7.61

e6/l

0.39

Problems related to lifestyle

162

790

2.09

16.83

1.5

42.18

19.68

e6/l

0.31

130

614

Fall on and from stairs and steps

331

2016

1.66

16.69

1.3

1.5

24.60

29.81

e6/l

0.17

250

1557

Non-allergic asthma (mode), excluding more controls

252

1410

1.79

16.67

1.3

1.4

20.31

18.64

e6/l

0.08

204

1075

Diaphragmatic hernia

428

2773

1.56

16.59

1.3

1.4

11.80

23.85

e6/l

1.66

322

2163

Adrenocortical insufficiency

239

3.08

16.55

1.5

1.6

28.56

34.05

e6/l

0.08

183

Acetic acid derivatives and related substances

373

1184

1.65

16.52

1.3

1.5

18.01

44.62

e6/l

1.59

282

915

Other shoulder lesions

141

657

2.19

16.51

1.3

1.4

14.79

32.38

e6/l

0.85

105

491

Coagulation defects, purpura and other haemorrhagic conditions

260

1489

1.77

16.50

2.1

1.5

38.82

22.51

e6/l

0.29

217

1138

Cytomegalovirus infection, IBD co-morbidity

140

3.83

16.48

1.8

1.2

3.26

10.18

e6/l

0.76

113

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

277

2.90

16.46

1.5

1.3

14.37

38.18

e6/l

0.53

221

Dental pulpitis 1

1528

6257

1.27

16.40

1.4

1.5

24.96

27.43

e6/l

0.14

1177

4868

Dental pulpitis 4

1528

6257

1.27

16.37

1.4

1.5

24.96

27.43

e6/l

0.14

1177

4868

Unspecified/other endometriosis

158

774

2.08

16.26

1.3

11.31

21.89

e6/l

0.93

120

617

Other disorders of glucose regulation and pancreatic internal secretion

135

623

2.21

16.24

1.7

1.8

19.30

29.40

e6/l

0.32

109

482

Retrobulbar neuritis in diseases classified elsewhere

8.48

16.23

1.0

1.3

8.00

2.44

e6/l

1.53

Fasciculation

5.14

16.21

1.3

1.2

1.53

12.09

e6/l

0.61

Exposure to other specified factors

1004

7122

1.33

16.20

1.5

1.4

38.62

28.80

e6/l

0.31

751

5511

Osteoporosis

278

1551

1.73

16.18

1.8

1.4

19.06

36.75

e6/l

0.85

220

1224

Congenital malformations, deformations and chromosomal abnormalities

830

5851

1.37

16.18

1.5

1.4

30.96

30.10

e6/l

0.03

648

4503

Disorders of speech understanding and production

341

2.68

16.18

1.9

2.9

30.67

11.47

e6/l

0.74

249

Disorders of synovium and tendon

670

4284

1.42

16.09

1.4

31.37

30.92

e6/l

0.02

533

3298

Deforming dorsopathies

336

2073

1.64

16.06

1.3

1.5

8.97

33.10

e6/l

2.18

269

1556

Atypical facial pain

326

2.71

16.03

1.3

1.4

20.49

11.67

e6/l

0.20

242

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1242

5673

1.30

16.01

2.2

1.3

43.08

28.41

e6/l

0.57

921

4414

Inflammatory disease of uterus

223

1233

1.84

16.00

1.2

1.3

8.20

24.57

e6/l

2.46

172

952

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1242

5674

1.30

15.98

2.2

1.3

43.08

28.44

e6/l

0.57

921

4416

Malignant neoplasm, wide definition for exclusion

1242

5675

1.30

15.97

2.2

1.3

43.08

28.43

e6/l

0.57

921

4417

Acute alcohol intoxication, ICD10

281

1661

1.71

15.93

1.3

1.4

53.98

27.07

e6/l

0.24

203

1283

Dental caries 1

1054

4057

1.33

15.89

1.7

1.4

21.36

32.07

e6/l

1.00

806

3172

Monoamine oxidase A inhibitors

153

746

2.08

15.89

1.2

1.3

13.11

28.69

e6/l

0.98

115

576

Vascular syndromes of brain in cerebrovascular disorders

207

3.18

15.89

1.5

1.3

8.40

58.07

e6/l

1.05

165

Bacterial intestinal infections, IBD co-morbidities

228

1272

1.82

15.82

1.7

1.4

13.70

27.50

e6/l

0.85

176

980

Fracture of skull and facial bones

286

1702

1.70

15.79

1.4

21.39

25.32

e6/l

0.23

207

1314

Unspecified acute lower respiratory infection

210

1144

1.86

15.78

1.4

1.5

28.15

22.97

e6/l

0.12

169

898

Other nutritional deficiencies

864

6282

1.35

15.74

1.3

1.4

62.87

22.74

e6/l

1.07

658

4849

Hypermobility syndrome

103

431

2.46

15.66

1.3

1.5

26.13

19.08

e6/l

0.17

328

Dental caries, including avohilmo

1051

4054

1.33

15.65

1.7

1.4

21.34

31.93

e6/l

0.98

804

3170

Mental and behavioural disorders due to opioids

287

2.81

15.47

2.1

1.5

24.20

14.73

e6/l

0.38

229

Nonpyogenic thrombosis of intracranial venous system

5.69

15.44

1.7

1.2

12.76

2.49

e6/l

0.65

Alcohol abuse, main dg

228

1283

1.80

15.43

1.3

1.5

65.56

22.15

e6/l

0.35

167

992

Nystagmus and other irregular eye movements

4.39

15.39

1.8

2.3

17.31

6.42

e6/l

0.62

Malignant immunoproliferative diseases

6.04

15.36

1.5

1.3

8.35

24.22

e6/l

0.50

Any event in cancer register

1291

5982

1.29

15.32

2.1

1.3

59.00

22.70

e6/l

1.55

994

4648

Hypoglycaemia, other or unspecified

113

497

2.33

15.32

1.8

1.9

16.46

28.56

e6/l

0.35

387

Diseases of oral cavity, salivary glands and jaws

1268

5053

1.29

15.29

1.8

1.4

31.15

25.93

e6/l

0.18

963

3934

Superficial injury of abdomen, lower back and pelvis

215

1193

1.83

15.24

1.3

1.5

13.99

25.24

e6/l

0.84

166

909

Cytomegaloviral disease

148

3.61

15.20

1.8

1.3

3.26

9.41

e6/l

0.69

119

Soft tissue disorders related to use, overuse and pressure

316

1949

1.64

15.17

1.2

1.4

22.23

31.64

e6/l

0.32

238

1494

Appendectomy

887

6417

1.34

15.14

1.3

1.4

19.89

31.71

e6/l

1.31

705

4929

Sleep disorders, other/unspecified

225

3.04

15.06

1.2

1.6

5.02

11.08

e6/l

0.69

175

Chorioretinal inflammation

194

3.22

15.03

1.4

10.72

24.74

e6/l

0.39

155

Use of pramipexole

259

1523

1.72

14.99

1.3

1.4

9.63

34.04

e6/l

1.64

194

1188

Lung diseases due to external agents

159

805

2.00

14.89

1.5

1.4

33.25

23.44

e6/l

0.17

122

637

Superficial injury of lower leg

330

2069

1.61

14.86

1.3

1.5

48.07

24.52

e6/l

0.27

248

1593

Anterior Iridocyclitis

276

1656

1.69

14.84

1.3

1.4

33.50

19.59

e6/l

0.33

220

1271

Disorders of muscles

139

672

2.10

14.83

1.2

1.4

7.75

28.92

e6/l

1.39

106

510

Other congenital malformations of nervous system

4.79

14.82

2.2

2.1

78.77

6.51

e6/l

1.02

Venous thromboembolism

611

4217

1.42

14.75

1.5

1.3

25.32

30.36

e6/l

0.22

490

3265

Diseases of male genital organs

695

2509

1.41

14.70

1.3

1.6

32.95

35.14

e6/l

0.05

531

1924

Mental disorders, not otherwise specified

143

703

2.08

14.66

1.1

1.4

53.48

23.17

e6/l

0.33

104

544

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

107

469

2.33

14.61

1.5

1.3

11.59

24.15

e6/l

0.43

372

Cauda equina syndrome

4.57

14.57

1.3

1.1

3.59

6.43

e6/l

0.38

Disturbance of activity and attention

172

891

1.94

14.57

1.2

2.0

12.46

20.86

e6/l

0.75

133

683

Symptoms and signs involving appearance and behaviour

5.93

14.57

1.7

1.2

4.95

8.39

e6/l

0.21

Anti-inflammatory and antirheumatic products, non-steroids

406

1309

1.57

14.55

1.5

1.7

29.53

42.47

e6/l

0.35

315

1014

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

681

4845

1.39

14.49

1.4

26.71

34.37

e6/l

0.32

552

3700

Disorders of skin appendages

632

4550

1.40

14.25

1.4

33.28

29.16

e6/l

0.08

510

3503

Other facial nerve disorders

175

3.26

14.14

1.2

40.63

11.23

e6/l

0.47

131

Agoraphobia

201

3.08

14.11

1.2

1.5

11.07

22.34

e6/l

0.80

157

Acute and subacute iridocyclitis

259

1551

1.69

14.06

1.3

1.4

34.71

15.77

e6/l

0.45

207

1184

Special screening examination for other diseases and disorders

107

476

2.28

14.06

1.4

15.99

31.90

e6/l

0.77

338

Covid-19 suspected case

303

1888

1.62

14.05

1.3

1.5

9.59

22.42

e6/l

1.81

246

1454

Other and unspecified disorders of binocular movement

6.33

14.05

2.1

58.32

2.50

e6/l

0.65

Disorders of conjunctiva

1101

7190

1.29

14.02

1.5

1.4

20.50

31.05

e6/l

1.12

836

5566

Other heart diseases, wide

1324

6517

1.27

14.00

1.4

1.5

33.55

29.52

e6/l

0.18

1036

4988

Myeloid leukaemia

146

3.49

14.00

3.1

1.2

8.31

10.58

e6/l

0.11

116

Diseases of liver

408

2719

1.51

13.99

1.3

1.4

18.26

32.91

e6/l

1.15

300

2110

Lesion of ulnar nerve

181

979

1.88

13.98

1.3

1.4

19.04

25.12

e6/l

0.21

149

734

Excessive vomiting in pregnancy

138

682

2.06

13.97

1.2

1.3

10.96

20.97

e6/l

0.79

100

521

Schizoaffective disorder

129

623

2.12

13.90

1.2

1.4

5.22

23.37

e6/l

1.91

475

Behavioural disorders, excluding more controls

123

3.71

13.79

1.3

1.8

30.43

12.11

e6/l

0.55

Other symptoms and signs involving the circulatory and respiratory systems

431

2.35

13.76

1.3

1.6

16.14

34.27

e6/l

0.55

330

Mental and behavioural disorders due to sedatives or hypnotics

116

541

2.19

13.70

1.3

1.5

13.24

30.79

e6/l

0.80

423

Dystonia

384

2.43

13.63

1.4

1.5

3.67

16.73

e6/l

2.42

297

Viral infections of central nervous system, not elsewhere classified/unspecified

4.63

13.58

1.5

1.2

23.64

6.18

e6/l

1.12

Myasthenia gravis

102

4.03

13.55

1.5

1.3

2.84

11.75

e6/l

0.70

Conjunctivitis

1008

6811

1.30

13.54

1.5

21.53

29.80

e6/l

0.75

763

5270

Dental pulpitis 2, only avohilmo

957

3727

1.32

13.53

1.7

1.4

22.96

28.64

e6/l

0.44

732

2924

Dental pulpitis 4, only avohilmo

1525

6427

1.24

13.45

1.3

1.5

25.23

28.22

e6/l

0.17

1167

5008

Other and unspecified iron deficiency

370

2435

1.53

13.45

1.3

1.5

47.19

22.82

e6/l

0.33

288

1874

Acute appendicitis, no complications

762

5692

1.34

13.42

1.4

15.74

34.33

e6/l

2.59

599

4366

Protozoal diseases

176

3.19

13.39

1.7

1.3

4.59

43.29

e6/l

0.73

140

Disorders of brain, other and unspecified

5.44

13.38

2.3

1.2

26.18

3.00

e6/l

0.93

Paralytic ileus and intestinal obstruction

291

1816

1.62

13.37

1.4

8.94

26.79

e6/l

2.19

232

1410

Contact with and exposure to communicable diseases

463

3184

1.46

13.31

1.4

1.5

22.18

26.31

e6/l

0.25

350

2465

Other diseases of upper respiratory tract

1515

6383

1.24

13.26

1.3

1.5

26.62

33.46

e6/l

0.45

1182

4888

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

119

568

2.14

13.25

1.8

1.5

39.56

17.85

e6/l

0.91

447

Diseases of the digestive system

523

3685

1.43

13.24

1.4

1.5

31.63

27.93

e6/l

0.09

401

2846

Fourth [trochlear] nerve palsy

137

3.50

13.20

2.0

1.2

9.24

34.47

e6/l

0.54

107

Dental pulpitis 1, only avohilmo

1526

6447

1.24

13.19

1.3

1.5

24.76

28.27

e6/l

0.21

1169

5023

Other obstetric conditions, not elsewhere classified

480

2145

1.47

13.19

1.3

20.01

23.97

e6/l

0.20

369

1685

Intestinal stricture

342

2224

1.55

13.18

1.5

1.4

10.16

28.94

e6/l

1.95

274

1716

Other disorders of optic disc

4.21

13.16

1.3

1.1

21.44

9.26

e6/l

0.29

Pneumonia due to other infectious organisms, not elsewhere classified

188

3.08

13.16

1.7

1.5

51.15

13.48

e6/l

0.59

155

Purpura and other haemorrhagic conditions

179

985

1.84

13.14

2.4

1.5

45.26

26.07

e6/l

0.23

151

762

Carpal tunnel syndrome

715

4794

1.35

13.13

1.3

1.4

42.33

28.77

e6/l

0.32

586

3649

Erysipelas

605

3995

1.39

13.10

1.4

1.3

46.68

24.80

e6/l

0.76

482

3080

Other disorders of eyelid

475

3192

1.45

13.04

1.4

25.57

31.10

e6/l

0.20

362

2483

Other noninfective gastroenteritis and colitis

318

2039

1.57

13.03

1.4

1.7

15.65

29.42

e6/l

0.83

244

1562

Injuries to the knee and lower leg

1616

7555

1.23

13.01

1.3

1.4

25.01

31.20

e6/l

0.31

1260

5839

Degeneration of the brain due to alcohol

124

3.61

12.95

1.1

1.4

13.09

76.27

e6/l

0.71

Asthma and allergy, excluding more controls

186

1026

1.81

12.94

1.4

26.85

20.61

e6/l

0.14

156

765

Asthma and allergy

186

1026

1.81

12.94

1.4

26.85

21.18

e6/l

0.12

156

763

Keratitis

440

3026

1.47

12.93

1.3

1.4

42.37

24.11

e6/l

0.70

355

2311

Other/unspecified disorders of vestibular function

245

2.78

12.93

1.3

1.4

89.82

15.32

e6/l

0.60

193

Thiamine deficiency

6.59

12.90

1.1

1.2

1.54

10.13

e6/l

0.60

Disorders of choroid and retina

949

5335

1.30

12.87

1.4

25.72

33.56

e6/l

0.25

714

4143

Malignant immunoproliferative diseases

5.11

12.86

1.5

1.2

8.35

58.13

e6/l

0.45

Dental pulpitis 2

932

3646

1.32

12.84

1.7

1.4

21.85

26.27

e6/l

0.33

708

2863

Other disorders of bone

273

1697

1.63

12.84

1.4

25.69

23.77

e6/l

0.07

215

1307

All influenza (not pneumonia)

208

1205

1.75

12.80

1.5

1.6

43.33

17.70

e6/l

0.50

166

913

Spondyloarthritis

228

1357

1.70

12.69

1.3

65.41

19.10

e6/l

1.02

186

1028

Alcohol withdrawal state with delirium

105

486

2.21

12.67

1.2

1.4

3.71

24.01

e6/l

0.99

382

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

468

2097

1.46

12.66

1.3

20.25

24.35

e6/l

0.20

362

1649

Use of dimethyl fumarate

4.76

12.66

1.0

1.1

13.79

4.59

e6/l

1.75

Giant cell arteritis

248

2.74

12.63

1.2

24.17

41.78

e6/l

0.27

196

Urticaria

410

2796

1.48

12.62

1.6

1.5

13.04

29.19

e6/l

1.61

318

2152

Pulmonary heart disease

316

2039

1.56

12.62

1.6

1.4

12.63

30.30

e6/l

1.45

252

1564

Pulmonary embolism

316

2039

1.56

12.62

1.6

1.4

12.63

30.23

e6/l

1.44

252

1565

Hyperkinetic disorders

179

985

1.82

12.61

1.2

2.1

12.42

19.94

e6/l

0.68

135

761

Excessive, frequent and irregular menstruation

561

2217

1.42

12.57

1.3

1.4

18.83

24.91

e6/l

0.50

436

1742

Giant cell arteritis with polymyalgia rheumatica

221

2.85

12.53

1.2

26.23

44.76

e6/l

0.25

177

Other specified disorders of muscle

147

3.29

12.43

1.2

1.3

3.86

26.72

e6/l

0.53

111

Temporal arteritis

222

2.84

12.43

1.2

26.23

45.01

e6/l

0.26

178

Algoneurodystrophy

239

2.77

12.43

1.3

1.6

18.95

7.35

e6/l

0.32

182

Other disorders of adrenal gland

333

2.47

12.42

1.6

1.7

33.84

27.51

e6/l

0.11

250

Use of fingolimod

4.66

12.42

1.2

1.7

12.61

4.58

e6/l

1.49

Ovarian cyst

520

2116

1.43

12.41

1.3

26.52

25.32

e6/l

0.05

400

1669

Disorders of mineral metabolism

110

523

2.14

12.38

1.3

1.5

19.43

17.08

e6/l

0.07

412

Disorders of lens

815

3900

1.33

12.32

1.4

13.50

36.22

e6/l

3.45

644

2981

Explicit bacterial Sepsis

119

583

2.07

12.31

2.2

1.5

136.55

22.24

e6/l

1.14

451

Malignant neoplasm

1198

5660

1.26

12.26

2.2

1.3

43.15

28.69

e6/l

0.53

893

4408

Disturbances of smell and taste

212

2.85

12.26

1.5

16.04

48.39

e6/l

0.53

160

Myeloid leukaemia

159

3.20

12.26

3.1

1.2

8.31

57.79

e6/l

0.77

133

Dental caries 1, only avohilmo

1054

4214

1.28

12.23

1.4

1.5

21.42

31.09

e6/l

0.90

805

3297

Abnormal blood-pressure reading, without diagnosis

305

2.52

12.22

1.3

1.5

15.11

41.17

e6/l

0.62

237

Noninfective enteritis and colitis

594

4345

1.37

12.18

1.4

1.5

32.61

32.22

e6/l

0.01

453

3368

Leisure time condition

235

1429

1.66

12.12

1.6

1.5

12.83

22.42

e6/l

0.76

196

1099

Disorders of optic nerve, not elsewhere classified

125

3.51

12.10

1.5

1.2

3.09

10.98

e6/l

0.78

101

Dental caries 3

1093

4400

1.28

11.97

1.5

22.25

34.10

e6/l

1.07

832

3424

Nutritional anaemias

537

3772

1.39

11.97

1.4

36.85

24.44

e6/l

0.23

428

2926

Insulin, intermediate and long-acting

647

4720

1.35

11.97

1.4

20.95

30.09

e6/l

0.79

527

3653

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

185

1059

1.77

11.93

1.7

1.3

39.98

23.78

e6/l

0.23

147

828

Trochanteric bursitis

162

892

1.84

11.89

1.2

1.3

14.88

42.08

e6/l

1.09

120

683

Other disorders of skin and subcutaneous tissue

802

5635

1.31

11.86

1.6

1.4

28.70

30.38

e6/l

0.08

617

4371

Pneumocystosis

103

3.79

11.83

1.9

1.2

4.41

9.79

e6/l

0.39

Haemorrhage from respiratory passages

379

2387

1.48

11.81

1.5

18.72

33.56

e6/l

1.18

293

1854

Other congenital malformations of circulatory system

179

3.02

11.79

2.6

1.3

18.76

10.55

e6/l

0.24

139

DVT of lower extremities and pulmonary embolism

443

3097

1.44

11.73

1.5

1.4

23.23

32.45

e6/l

0.34

357

2409

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

504

3613

1.40

11.71

1.3

1.5

23.04

29.35

e6/l

0.22

390

2761

Oter anti-inflammatory and antirheumatic agents, non-steroids

267

913

1.63

11.68

1.2

1.4

21.17

51.68

e6/l

1.34

207

718

Hypothyroidism, strict autoimmune, 3 medication purchases required

1084

5873

1.26

11.64

1.3

1.4

14.41

28.64

e6/l

3.13

855

4547

Maternal care for other conditions predominantly related to pregnancy

296

1894

1.56

11.64

1.3

12.43

26.35

e6/l

0.89

217

1457

Abnormal weight loss

119

597

2.03

11.63

1.3

1.6

39.16

26.84

e6/l

0.17

459

Diverticular disease of intestine

817

4158

1.31

11.62

1.3

1.4

31.59

34.38

e6/l

0.06

626

3225

Amenorrhoea

116

577

2.05

11.61

1.4

1.3

43.11

27.30

e6/l

0.31

458

Weight loss

130

673

1.97

11.61

1.7

1.6

35.36

27.80

e6/l

0.11

108

516

Other diseases of hard tissues of teeth

845

4863

1.30

11.60

1.9

1.4

27.92

26.61

e6/l

0.03

642

3784

Adverse effects, not elsewhere classified

271

1728

1.59

11.52

1.3

1.6

19.65

25.76

e6/l

0.37

212

1323

Panniculitis affecting regions of neck and back

231

2.71

11.50

1.3

1.4

30.18

21.95

e6/l

0.14

174

Iron deficiency anaemia

455

3188

1.42

11.48

1.4

1.5

41.39

24.68

e6/l

0.27

356

2486

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

5.25

11.42

2.2

1.1

10.13

4.32

e6/l

0.42

Oxicams

286

1027

1.60

11.42

1.3

1.5

12.13

47.05

e6/l

2.17

230

808

Other disorders of peripheral nervous system

6.02

11.41

1.2

1.1

1.47

2.56

e6/l

0.83

SLE (Finngen)

204

2.82

11.39

1.3

1.7

15.76

20.53

e6/l

0.20

158

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

6.48

11.36

1.7

1.1

34.29

2.19

e6/l

1.23

Other gastritis (incl. Duodenitis)

257

1624

1.60

11.33

1.5

1.4

6.97

25.12

e6/l

3.06

206

1264

Hypermetropia

115

576

2.04

11.32

1.8

2.1

8.52

26.92

e6/l

0.96

432

Pulmonary heart disease, diseases of pulmonary circulation

332

2219

1.51

11.31

1.6

1.4

15.61

29.18

e6/l

0.98

264

1710

Internal derangement of knee

478

3414

1.41

11.29

1.3

1.4

11.41

28.93

e6/l

2.46

366

2596

Degeneration of nervous system due to alcohol

136

3.29

11.26

1.1

1.3

13.09

33.09

e6/l

0.37

108

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

103

496

2.11

11.25

1.2

1.5

85.27

28.71

e6/l

0.76

391

Autonomic disorders

111

3.54

11.24

1.4

1.1

41.90

7.69

e6/l

0.54

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

107

524

2.08

11.21

1.3

1.6

10.29

34.45

e6/l

1.19

408

Hernia of abdominal wall, postoperative

193

1138

1.71

11.18

1.4

1.2

18.44

28.40

e6/l

0.29

153

887

Special screening examination for infectious and parasitic diseases

305

1487

1.54

11.16

1.4

1.3

20.06

45.64

e6/l

1.01

204

1064

Asthma/COPD (KELA code 203)

1278

7330

1.23

11.12

1.4

1.5

32.46

29.34

e6/l

0.11

1002

5649

Diabetic neuropathy

125

645

1.96

11.07

1.5

1.4

34.71

20.34

e6/l

0.31

101

490

Metatarsalgia

125

649

1.96

11.07

1.2

1.4

14.53

36.06

e6/l

1.05

489

Beningn neoplasm: Meninges, unspecified

103

3.67

11.05

1.9

1.1

10.86

60.89

e6/l

0.51

Beningn neoplasm: Meninges, unspecified

103

3.67

11.05

1.9

1.2

10.86

14.03

e6/l

0.14

Polycystic ovarian syndrome, consortium definition

936

4430

1.28

10.98

1.4

1.3

33.98

29.31

e6/l

0.13

735

3419

Acute renal failure

216

1319

1.65

10.98

1.4

12.68

21.23

e6/l

0.57

161

1015

Chronic gastritis

299

1969

1.53

10.97

1.2

1.4

10.39

22.24

e6/l

1.33

231

1545

Lagophthalmos

4.51

10.93

1.7

1.2

137.30

7.42

e6/l

0.53

Mouth breathing

508

3694

1.38

10.93

1.4

1.5

10.41

29.91

e6/l

3.35

401

2818

Transplanted organ and tissue status

143

780

1.86

10.92

3.9

1.7

8.17

25.39

e6/l

1.15

104

587

6-mercaptopurine

198

2.81

10.88

10.6

1.6

183.49

20.23

e6/l

0.43

159

Spondylolisthesis/Spondylolysis

200

1202

1.68

10.82

1.2

1.4

7.74

28.40

e6/l

1.15

159

902

Other enthesopathy of foot (+metatarsalgia)

131

700

1.90

10.65

1.2

1.4

14.14

36.70

e6/l

1.21

528

Gingivitis and periodontal diseases

1199

5005

1.24

10.55

1.5

1.4

34.93

26.10

e6/l

0.30

895

3904

Acute pharyngitis

210

1279

1.65

10.52

1.5

9.08

21.75

e6/l

1.32

168

969

Diseases of middle ear and mastoid

771

4896

1.30

10.45

1.6

1.4

50.97

26.54

e6/l

0.70

609

3782

Brain astrocytoma

5.96

10.45

1.7

1.3

34.29

2.11

e6/l

1.24

Mononeuritis multiplex

8.21

10.44

1.4

1.1

477.33

2.50

e6/l

—

Other or unspecified ileus, impaction or obstruction

199

1206

1.67

10.42

1.4

8.12

26.52

e6/l

2.03

158

926

Dental caries 1 and operation codes

1131

4668

1.25

10.41

1.6

1.4

21.39

31.62

e6/l

1.04

859

3638

Other viral hepatitis

102

506

2.06

10.36

1.8

1.4

30.32

17.35

e6/l

0.58

390

Convergence insufficiency and excess

103

3.57

10.33

1.3

1.1

5.07

3.00

e6/l

0.23

L04AD Calcineurin inhibitors

157

897

1.78

10.31

2.7

1.8

7.64

22.61

e6/l

1.08

113

677

Lack of expected normal physiological development

100

3.40

10.29

2.7

2.2

43.50

29.39

e6/l

0.16

Immunodeficiencies

376

2.24

10.25

2.2

1.9

5.40

20.56

e6/l

0.96

285

Mycoses

312

2106

1.49

10.23

1.6

1.4

54.40

24.68

e6/l

0.35

252

1602

Endometriosis

476

2038

1.40

10.16

1.3

16.93

25.70

e6/l

0.88

369

1607

Acute appendicitis

915

6879

1.26

10.10

1.3

1.4

16.19

31.54

e6/l

2.36

713

5283

Dental caries 3, only avohilmo

1101

4535

1.25

10.05

1.5

22.32

33.33

e6/l

0.99

836

3531

Fenamates

191

767

1.69

10.03

1.5

21.07

55.14

e6/l

1.33

151

597

Diseases of appendix

975

7134

1.25

10.01

1.3

1.4

16.65

30.70

e6/l

2.15

758

5498

Chronic diseases of tonsils and adenoids

1092

5592

1.24

9.96

1.3

1.5

15.92

35.03

e6/l

2.69

860

4240

Cutaneous abscess, furuncle and carbuncle

319

2176

1.48

9.94

1.5

1.4

17.30

27.45

e6/l

0.72

255

1669

Fall on same level involving ice and snow

683

5269

1.30

9.91

1.4

39.22

32.85

e6/l

0.13

527

4074

Obesity and other hyperalimentation

783

6083

1.28

9.89

1.3

1.4

66.53

23.28

e6/l

1.06

607

4686

Convergent concomitant strabismus

481

2.06

9.89

1.4

2.0

24.23

18.88

e6/l

0.21

369

Pain associated with micturition

150

856

1.78

9.89

1.5

12.84

21.22

e6/l

0.65

116

653

Chronic rhinitis, nasopharyngitis and pharyngitis

398

2831

1.42

9.87

1.4

1.5

20.23

36.28

e6/l

0.82

313

2165

Symptoms and signs involving emotional state

169

2.86

9.84

1.1

2.1

27.75

11.86

e6/l

0.33

129

Appendicitis, broad definition

966

7100

1.25

9.84

1.3

1.4

16.09

30.73

e6/l

2.31

753

5469

Benign neoplasm: Brain, infratentorial

5.43

9.79

2.3

1.2

24.31

3.30

e6/l

0.62

Arthrosis

917

3996

1.27

9.78

1.3

1.4

42.99

32.68

e6/l

0.28

722

3040

Nephropathy related operations

158

919

1.74

9.75

1.7

1.6

13.22

22.16

e6/l

0.51

114

708

Obesity

778

6055

1.28

9.75

1.3

1.4

66.95

23.36

e6/l

1.06

603

4668

Enterocolitis due to Clostridium difficile

124

671

1.87

9.73

1.9

1.5

4.59

25.20

e6/l

1.55

526

Dental caries 3 and operation codes

1187

4965

1.23

9.71

1.5

20.73

33.61

e6/l

1.39

901

3863

Viral and other specified intestinal infections

284

1856

1.51

9.71

1.5

1.6

19.56

24.80

e6/l

0.28

237

1417

Insulin, combination of fast acting with intermediate-acting or long-acting

715

5122

1.29

9.70

1.4

19.42

29.40

e6/l

1.01

581

3965

Dental operations

838

3370

1.28

9.69

1.5

1.4

20.58

27.87

e6/l

0.56

644

2589

Personal history of risk-factors, not elsewhere classified

3.78

9.69

2.1

1.7

1.70

14.97

e6/l

0.82

Other specified and unspecified personality disorders

134

745

1.83

9.67

1.3

1.4

6.50

31.89

e6/l

2.08

103

572

Emotional disorders starting during childhood or adolescence

435

2.10

9.63

3.2

2.0

22.44

22.80

e6/l

0.01

321

Maltreatment syndromes

412

2.13

9.63

1.1

1.6

6.31

20.92

e6/l

1.57

325

Dialysis, with operation codes

162

953

1.72

9.60

1.7

1.6

13.16

22.16

e6/l

0.53

117

726

TMD related pain

266

2.44

9.59

1.2

1.5

10.78

9.85

e6/l

0.06

202

Mixed connective tissue disease

467

2.05

9.54

1.4

7.50

22.54

e6/l

1.21

356

Early lumbar disc prolapse operation

159

933

1.73

9.53

1.2

1.4

22.73

18.82

e6/l

0.15

131

721

Viral hepatitis

113

600

1.92

9.47

1.8

1.5

27.71

31.45

e6/l

0.10

469

Conjunctivitis (acute, non atopic)

359

2520

1.43

9.45

1.6

26.34

27.35

e6/l

0.03

281

1938

Faecal incontinence

104

538

1.96

9.38

1.7

1.4

6.51

67.76

e6/l

1.68

419

Attention to artificial openings

226

2.54

9.37

3.0

1.8

100.27

48.56

e6/l

0.38

171

Emotional disorders and disorders of social functioning with onset specific to childhood

471

2.03

9.35

3.1

1.9

21.34

22.65

e6/l

0.04

350

Hyperplasia of prostate

392

1577

1.43

9.34

1.3

1.4

19.01

31.39

e6/l

0.36

302

1221

Fracture of foot, except ankle

308

2114

1.47

9.34

1.5

57.49

22.59

e6/l

0.45

238

1619

Assault

188

1160

1.64

9.30

1.3

1.5

11.98

24.27

e6/l

1.15

130

894

Noninfectious colitis NAS

173

1047

1.67

9.23

1.4

1.6

10.39

24.78

e6/l

1.20

130

804

Insulin medication

714

4770

1.29

9.23

1.4

19.45

29.45

e6/l

0.99

580

3700

Scleritis and episcleritis

446

2.06

9.22

1.1

1.4

24.08

12.34

e6/l

0.31

340

Generalized epilepsy

321

2.26

9.22

1.5

1.9

5.09

13.97

e6/l

1.47

254

Other diseases of the respiratory system

205

1294

1.60

9.18

1.6

1.5

12.31

22.17

e6/l

0.72

157

983

Other respiratory disorders and diseases

205

1294

1.60

9.18

1.6

1.5

12.31

22.17

e6/l

0.72

157

983

Unspecified privation

139

796

1.77

9.10

1.1

1.5

16.02

27.84

e6/l

0.59

619

Diabetic retinopathy, excluding more controls

273

1016

1.53

9.08

1.4

16.91

18.30

e6/l

0.08

215

782

Mental and behavioural disorders due to use of other stimulants, including caffeine

224

2.53

9.07

1.6

37.17

13.81

e6/l

0.80

177

Disorders of vitreous body and globe

537

3959

1.33

9.06

1.4

27.81

31.94

e6/l

0.19

421

3043

Schizophrenia

215

1380

1.57

9.01

1.2

1.4

37.68

25.42

e6/l

0.16

158

1068

Abnormal findings on diagnostic imaging of other body structures

154

911

1.71

8.97

1.5

1.4

10.45

29.45

e6/l

1.43

110

700

Chronic viral hepatitis

424

2.07

8.96

2.0

1.5

35.08

13.59

e6/l

1.01

332

Superficial injury of hip and thigh

160

956

1.69

8.94

1.2

1.4

12.33

24.08

e6/l

0.62

127

731

Retinal detachments and breaks

362

2580

1.41

8.93

1.4

17.58

33.50

e6/l

0.97

270

2013

Hyperhidrosis

123

3.07

8.90

1.1

1.7

20.78

12.50

e6/l

0.18

Viral pneumonia (unknown virus, not influenza)

501

1.97

8.85

1.5

33.89

35.50

e6/l

0.02

385

Other/unspecified enthesopathies of lower limb, excluding foot

466

2.00

8.85

1.2

1.5

13.82

21.44

e6/l

0.32

355

Senile cataract

702

3393

1.29

8.84

1.4

13.56

37.13

e6/l

2.96

561

2588

Adhesive capsulitis of shoulder

186

1159

1.62

8.83

1.3

26.93

35.80

e6/l

0.18

149

881

Obesity due to excess calories

571

4375

1.31

8.80

1.3

1.4

63.33

24.37

e6/l

0.84

450

3385

Benign neoplasm: Brain, infratentorial

4.92

8.80

2.3

2.2

24.31

3.40

e6/l

0.61

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1239

7000

1.21

8.79

1.8

1.4

25.36

29.38

e6/l

0.20

961

5379

Malnutrition

114

3.18

8.79

2.0

2.3

111.86

5.85

e6/l

0.48

Secondary hypertension

469

1.99

8.78

1.5

1.4

13.84

17.61

e6/l

0.12

341

Unspecified haematuria

428

2685

1.37

8.78

1.5

1.4

13.58

32.54

e6/l

1.63

338

2092

Benign neoplasm: Cranial nerves

198

2.60

8.76

1.7

1.2

83.23

49.53

e6/l

0.19

158

Benign neoplasm: Cranial nerves

198

2.60

8.76

1.7

1.2

83.23

30.44

e6/l

0.35

152

Obsessive-compulsive disorder

483

1.98

8.70

1.2

1.5

3.21

18.54

e6/l

4.18

384

Direct fill therapy

184

1150

1.62

8.67

1.9

1.7

50.88

22.68

e6/l

0.38

146

883

Other specified/unspecified systemic involvement of connective tissue

409

2.07

8.66

1.3

1.4

8.48

22.41

e6/l

0.91

308

Other condition

179

1112

1.63

8.65

1.9

1.5

50.63

23.79

e6/l

0.42

146

859

Other arthrosis

613

3379

1.30

8.64

1.4

42.17

29.22

e6/l

0.26

474

2588

Streptococcal septicaemia

512

1.94

8.63

2.3

1.5

149.83

10.28

e6/l

1.19

401

Anankastic personality disorder

279

2.31

8.62

1.6

1.4

9.47

13.20

e6/l

0.34

218

False labour

426

1951

1.38

8.61

1.3

13.51

28.33

e6/l

1.20

339

1514

Other disorders starting during childhood or adolecense, excluding more controls

337

2.16

8.57

3.5

2.6

11.11

20.34

e6/l

0.68

250

Episcleritis

385

2.09

8.51

1.1

1.4

27.30

11.76

e6/l

0.36

289

Vertical strabismus

231

2.44

8.50

2.0

1.7

19.21

15.02

e6/l

0.18

174

Conductive and sensorineural hearing loss

910

5100

1.24

8.48

1.5

1.4

54.18

26.05

e6/l

0.85

725

3917

Disorders of tooth development and eruption

421

2.03

8.46

4.8

1.6

16.11

22.29

e6/l

0.26

314

Other postsurgical states

475

1.97

8.43

2.1

1.7

9.27

30.32

e6/l

0.92

362

Other diseases of the digestive system

322

2273

1.43

8.41

1.4

33.00

23.74

e6/l

0.17

240

1746

Vitamin deficiency, wide

334

2.17

8.39

1.2

1.6

22.29

26.25

e6/l

0.08

267

Vitamin deficiency

334

2.17

8.39

1.2

1.6

22.29

26.25

e6/l

0.08

267

Other specified and unspecified disorders of eye and adnexa

251

2.36

8.38

1.4

23.37

11.08

e6/l

0.40

200

Diseases of arteries, arterioles and capillaries (FINNGEN)

264

1244

1.49

8.32

1.5

1.2

39.97

24.31

e6/l

0.38

217

925

Disorders of vitreous body

519

3873

1.32

8.30

1.4

21.39

32.25

e6/l

0.92

406

2975

Anomalies of pupillary function

135

2.91

8.22

1.0

1.4

5.22

11.78

e6/l

0.43

105

Failure and rejection of transplanted organs and tissues

3.45

8.21

3.8

1.2

3.29

9.03

e6/l

0.79

Corneal ulcer

227

1508

1.52

8.18

1.3

1.4

61.73

16.47

e6/l

1.19

187

1148

Fracture at wrist and hand level

414

3062

1.36

8.16

1.3

1.4

26.21

33.48

e6/l

0.21

326

2361

Lateral epicondylitis

159

974

1.65

8.14

1.2

1.4

25.21

32.49

e6/l

0.29

126

739

Tubulo-interstitial nephritis, not specified as acute or chronic

439

1.99

8.13

1.4

169.73

24.27

e6/l

0.54

342

Other hearing loss

259

1737

1.47

8.11

1.3

1.4

33.80

21.39

e6/l

0.31

210

1350

Other female pelvic inflammatory diseases

204

1328

1.55

8.09

1.3

14.11

41.56

e6/l

1.47

165

1016

GI-bleeding

320

2273

1.42

8.09

1.5

1.4

32.50

23.40

e6/l

0.17

244

1749

Childhood asthma (age<16), excluding more controls

177

877

1.61

8.06

1.5

1.4

11.43

24.43

e6/l

1.09

140

637

Disorders of gallbladder, biliary tract and pancreas

1212

6531

1.20

8.06

1.4

41.43

27.71

e6/l

0.49

905

5077

Other maternal disorders predominantly related to pregnancy

740

3698

1.26

8.04

1.3

1.4

21.82

33.20

e6/l

0.87

589

2822

Other eating disorders

428

2.00

8.03

1.3

1.7

14.38

24.06

e6/l

0.40

326

Childhood asthma (age<16)

177

880

1.61

7.97

1.5

1.4

11.43

25.09

e6/l

1.17

140

640

Causalgia

105

3.16

7.96

1.2

1.5

4.15

3.62

e6/l

0.10

Behavioural disorders

172

2.64

7.95

1.3

1.7

30.43

10.89

e6/l

0.60

133

Other/unspecified soft tissue disorders related to use, overuse and pressure

166

2.65

7.93

1.3

1.2

8.88

12.92

e6/l

0.25

127

Misadventures to patients during surgical and medical care

164

1020

1.63

7.92

1.7

1.4

24.54

18.70

e6/l

0.18

126

795

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

673

1.78

7.91

1.7

1.4

7.44

27.58

e6/l

1.40

525

Transient global amnesia

514

1.89

7.89

1.2

1.4

13.29

33.30

e6/l

0.78

381

Menorrhagia

460

1898

1.35

7.87

1.3

1.4

24.52

26.00

e6/l

0.07

355

1498

Eating disorders

154

944

1.65

7.87

1.2

1.5

12.47

21.12

e6/l

0.69

120

729

Hernia

1168

6628

1.20

7.81

1.4

1.5

33.50

31.12

e6/l

0.07

899

5138

Acute and transient psychotic disorders

158

980

1.63

7.74

1.3

1.4

30.57

26.82

e6/l

0.06

118

764

Injuries to the elbow and forearm

839

6172

1.23

7.74

1.4

1.5

26.12

30.12

e6/l

0.25

650

4755

Complications of genitourinary prosthetic devices, implants and grafts

151

2.72

7.73

1.4

40.61

25.92

e6/l

0.17

120

Spondylopathies (FG)

179

1144

1.58

7.72

1.3

1.4

66.01

16.57

e6/l

0.94

146

876

Systemic lupus erythematosus

248

2.31

7.71

1.3

1.5

15.76

9.22

e6/l

0.37

189

Suppurative and unspecified otitis media

487

3295

1.32

7.68

1.9

1.4

24.92

19.16

e6/l

0.39

379

2518

Glaucoma

564

3852

1.29

7.67

1.4

23.04

29.88

e6/l

0.32

446

2975

Paroxysmal tachycardia

256

1486

1.47

7.65

1.3

1.4

36.01

25.85

e6/l

0.19

207

1107

Reimbursement for rheumatic diseases

683

5445

1.26

7.58

1.3

1.4

33.72

30.55

e6/l

0.12

529

4217

Abnormal reflex

5.22

7.56

1.3

1.2

1.50

2.14

e6/l

—

Rash and other nonspecific skin eruption

118

682

1.75

7.56

2.0

1.5

11.82

29.95

e6/l

0.94

516

Other disorders of the musculoskeletal system and connective tissue

167

1056

1.60

7.56

1.4

1.3

13.13

24.26

e6/l

0.63

133

812

Superficial injury of wrist and hand

256

1772

1.46

7.54

1.4

1.5

33.90

21.39

e6/l

0.26

200

1372

Hyperfunction of pituitary gland

369

2.04

7.54

1.3

1.6

205.53

20.40

e6/l

0.49

284

Varicella [chickenpox]

356

2.06

7.51

1.5

1.9

62.46

6.56

e6/l

1.32

277

Infections with a predominantly sexual mode of transmission

405

3026

1.35

7.51

1.5

1.3

25.57

28.05

e6/l

0.12

307

2346

Other and unspecified mononeuropathies, also in other diseases

189

2.49

7.49

1.4

1.5

8.22

7.88

e6/l

0.02

140

Other cataract

463

2720

1.32

7.48

1.4

16.30

35.27

e6/l

1.38

373

2080

Injuries to the hip and thigh

480

3361

1.31

7.46

1.4

26.27

28.56

e6/l

0.08

381

2598

Disorders of calcium metabolism

377

2.02

7.46

1.3

1.6

18.34

16.47

e6/l

0.04

299

Gonarthrosis [arthrosis of knee](FG)

900

4335

1.23

7.43

1.3

1.4

28.34

30.97

e6/l

0.12

696

3339

Tobacco use

392

2.00

7.42

1.3

1.4

70.45

34.69

e6/l

0.23

304

SLE, ICD10

241

2.30

7.32

1.4

16.39

10.46

e6/l

0.30

183

SLE, strict definition

241

2.30

7.32

1.4

16.39

10.46

e6/l

0.30

183

Haemorrhage, not elsewhere classified

132

2.77

7.32

2.8

1.4

3.77

8.04

e6/l

0.46

Heart failure, not strict

853

4807

1.23

7.31

1.4

1.5

42.52

30.28

e6/l

0.44

684

3687

Cholecystectomy

801

5773

1.23

7.30

1.3

1.4

39.51

28.84

e6/l

0.28

606

4484

Fracture of shoulder and upper arm

391

2920

1.35

7.28

1.6

1.4

32.31

27.16

e6/l

0.17

310

2258

Other and unspecified urticaria

249

1728

1.45

7.26

1.5

1.6

14.15

25.65

e6/l

0.81

199

1312

Other specified/unspecified hearing loss

536

1.83

7.26

1.2

1.5

40.40

29.73

e6/l

0.12

414

Reactive arthropathies, FINNGEN

508

1.86

7.23

1.2

1.5

105.60

12.72

e6/l

0.89

393

Dental pulpitis 3

197

931

1.54

7.21

1.8

1.9

14.45

20.66

e6/l

0.45

148

726

Myositis

151

2.65

7.19

1.3

3.43

60.19

e6/l

0.82

118

Renal failure

417

2876

1.33

7.18

1.4

1.5

15.00

29.25

e6/l

1.30

318

2235

Eating disorder

129

775

1.68

7.18

1.2

1.6

13.57

23.15

e6/l

0.64

101

601

Other arrhythmias

798

4980

1.23

7.16

1.3

1.4

38.07

27.93

e6/l

0.43

629

3827

Meniscus derangement

669

3656

1.26

7.12

1.3

1.4

17.13

30.78

e6/l

1.17

522

2786

Unspecified visual impairment (binocular)

3.25

7.08

1.2

2.0

3.52

3.36

e6/l

0.04

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

336

2466

1.37

7.07

1.5

1.4

12.16

28.98

e6/l

2.54

266

1887

Sequelae of other external causes

365

2.01

7.03

1.5

1.4

34.51

34.20

e6/l

0.00

292

Tonsillectomy and adenotomy

793

4504

1.23

7.02

1.4

1.5

16.60

30.34

e6/l

1.61

621

3455

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.25

6.99

1.1

11.05

2.58

e6/l

0.43

Osteoporosis with pathological fracture (FG)

338

2.04

6.99

1.8

1.4

8.86

21.81

e6/l

0.98

253

Mental retardation, excluding more controls

235

2.26

6.97

1.7

3.1

32.93

13.33

e6/l

0.44

172

Tinnitus

263

1858

1.43

6.97

1.3

1.4

61.65

22.84

e6/l

0.37

194

1425

Disorders of pituitary gland, other and/or unspecified

4.38

6.97

1.3

58.33

3.18

e6/l

0.46

Sensorineural hearing loss

827

4744

1.22

6.95

1.4

57.25

26.39

e6/l

0.84

658

3643

Endometriosis of pelvic peritoneum

208

1388

1.49

6.94

1.3

16.78

27.68

e6/l

0.67

157

1086

Heartburn

121

722

1.69

6.94

1.3

1.4

5.73

36.50

e6/l

2.56

558

Superficial injury of thorax

172

1118

1.55

6.94

1.2

1.4

40.18

22.64

e6/l

0.25

124

866

Dermatographic urticaria

516

1.83

6.91

1.3

1.4

2.89

21.99

e6/l

3.31

399

Sequelae of injuries of neck and trunk

197

2.39

6.88

1.5

31.27

29.53

e6/l

0.02

152

Other specified/unspecified inflammatory spondylopathies

320

2.07

6.88

1.3

1.5

16.45

27.83

e6/l

0.30

248

Crohn disease

171

1114

1.55

6.85

1.5

23.17

24.28

e6/l

0.03

128

855

Reactive arthropathies

112

658

1.72

6.82

1.2

1.5

91.27

15.86

e6/l

0.87

510

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

351

2610

1.35

6.81

1.3

1.4

22.60

25.79

e6/l

0.11

257

2019

Conduct disorder

180

2.46

6.79

1.3

1.8

31.32

13.65

e6/l

0.50

138

Intermittent heterotropia

512

1.83

6.78

1.4

2.4

17.75

13.89

e6/l

0.12

389

Cellulitis

247

1736

1.43

6.75

1.8

1.4

71.24

21.29

e6/l

0.55

193

1330

Drug-induced adrenocortical insufficiency

116

2.86

6.74

1.6

1.2

63.05

5.26

e6/l

1.03

Gonarthrosis

762

3553

1.23

6.74

1.3

1.4

27.57

28.67

e6/l

0.05

599

2719

Other neurotic disorders

296

2.09

6.71

1.3

1.4

6.83

24.23

e6/l

0.87

230

Obesity, other/unspecified

405

3084

1.32

6.68

1.3

1.4

44.40

22.71

e6/l

0.31

305

2406

Dental pulpitis 3, only avohilmo

180

862

1.54

6.68

1.4

1.9

15.65

18.91

e6/l

0.19

133

672

Sacroiliitis, not elsewhere classified

318

2.04

6.62

1.2

1.4

60.52

18.78

e6/l

0.56

244

Presbyopia

451

1.87

6.62

1.3

17.86

23.81

e6/l

0.18

336

Impingement syndrome of shoulder

261

1859

1.41

6.61

1.5

1.4

32.67

32.81

e6/l

0.00

224

1429

Other diseases of intestine

130

801

1.64

6.60

1.3

1.4

16.00

27.83

e6/l

0.37

102

616

Assault by bodily force

108

635

1.72

6.59

1.2

1.5

10.97

17.22

e6/l

0.49

491

Amblyopia ex anopsia

313

2.05

6.55

1.7

2.5

28.02

10.42

e6/l

0.49

233

Orchitis and epididymitis

563

1.76

6.47

1.5

1.6

76.02

24.05

e6/l

0.40

443

Other/unspecified synovitis and tenosynovitis

132

822

1.62

6.43

1.2

1.4

29.79

31.20

e6/l

0.02

631

Other retinal disorders

649

4212

1.24

6.43

1.5

1.4

28.97

32.15

e6/l

0.06

487

3283

Astigmatism

484

1.82

6.42

2.6

2.3

18.47

29.26

e6/l

0.27

375

Medical abortion

783

3486

1.23

6.41

1.3

1.4

16.33

35.04

e6/l

2.23

594

2705

Other abnormal immunological findings in serum

125

2.72

6.40

1.1

1.6

44.00

8.79

e6/l

0.40

101

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

131

2.69

6.40

4.7

2.6

1.28

10.14

e6/l

1.08

106

Elevated blood glucose level

573

1.75

6.39

1.7

130.56

29.75

e6/l

0.39

444

Other diseases of liver

203

1392

1.47

6.37

1.3

1.4

27.89

25.01

e6/l

0.11

149

1073

Other fall from one level to another

270

1948

1.40

6.36

2.0

1.6

58.06

20.42

e6/l

0.45

218

1488

Insulin, fast-acting

411

3160

1.31

6.31

1.4

1.5

18.22

25.81

e6/l

0.67

334

2437

Alcohol induced polyneuropathy

3.81

6.29

1.2

2.86

21.21

e6/l

0.75

Postzoster neuralgia

3.15

6.28

1.2

13.65

12.78

e6/l

0.02

Acute suppurative otitis media

358

2523

1.33

6.27

2.1

1.5

30.42

20.38

e6/l

0.57

279

1933

Poisoning by narcotics and psychodysleptics [hallucinogens]

115

2.78

6.27

3.1

1.4

57.67

20.28

e6/l

0.67

Dissection of cerebral arteries, nonruptured

4.15

6.27

1.6

1.1

38.67

9.73

e6/l

0.36

Vascular dementia (undefined)

3.03

6.24

1.5

1.3

3.20

56.88

e6/l

0.90

Cholecystitis

139

883

1.59

6.24

1.2

1.4

13.85

19.81

e6/l

0.30

106

694

Missing teeth due to accident, extraction or parodontitis

133

838

1.60

6.20

1.5

1.4

17.63

27.75

e6/l

0.46

107

636

Other peripheral vascular diseases

571

1.74

6.20

1.2

1.4

9.13

28.19

e6/l

0.86

437

Otalgia

105

624

1.71

6.19

1.7

1.8

61.12

32.96

e6/l

0.27

479

Other specified/unspecified dorsopathies

213

2.25

6.18

1.2

1.6

4.03

23.44

e6/l

0.68

160

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

673

5406

1.23

6.18

1.4

20.64

30.73

e6/l

0.73

501

4175

Impotence

306

2.02

6.17

1.4

5.88

24.52

e6/l

1.06

243

TMD related operations

205

1418

1.46

6.17

1.2

1.4

71.99

24.52

e6/l

0.39

170

1074

Malignant neoplasm of digestive organs

181

2601

0.68

6.15

1.4

19.38

27.97

e6/l

0.42

145

2019

Injury of eye and orbit

169

1126

1.51

6.14

1.3

1.5

24.00

22.33

e6/l

0.05

134

868

Abnormal serum enzyme levels

299

2179

1.36

6.12

1.3

1.4

35.32

21.58

e6/l

0.26

218

1703

Other acute viral hepatitis

3.04

6.10

1.0

1.3

33.05

9.17

e6/l

0.48

Toxic effect of other and unspecified substances

3.03

6.09

1.7

1.3

1.28

9.04

e6/l

1.22

Cholelithiasis, broad definition with cholecystitis

1018

5909

1.18

6.06

1.3

1.4

39.47

28.23

e6/l

0.34

775

4611

Persistent delusional disorders

531

1.76

6.03

1.1

1.4

13.46

31.04

e6/l

0.70

411

Drug-induced headache, not elsewhere classified

4.27

6.02

1.3

1.1

3.30

3.03

e6/l

—

Benign neoplasm of colon, rectum, anus and anal canal

590

3392

1.25

6.00

1.4

26.68

29.49

e6/l

0.11

451

2658

Melanocytic naevi

329

2474

1.34

5.99

1.4

1.3

16.63

25.86

e6/l

0.67

255

1942

Unspecified misadventure during surgical and medical care

373

1.91

5.98

1.8

1.5

34.36

33.74

e6/l

0.01

292

Other and unspecified injuries of head

410

1.86

5.90

1.3

1.6

9.40

38.17

e6/l

1.19

320

Calcific tendinitis of shoulder

396

1.87

5.89

1.6

1.3

30.55

44.14

e6/l

0.24

295

Iridocyclitis in diseases classified elsewhere

125

2.64

5.88

1.5

1.6

4.91

3.11

e6/l

0.52

Allergic conjunctivitis

702

5701

1.22

5.87

1.4

19.94

30.05

e6/l

0.77

523

4409

Toxic effects of substances chiefly nonmedicinal as to source

146

953

1.55

5.87

1.3

1.6

19.70

23.96

e6/l

0.18

117

739

Glaucoma suspect

350

2665

1.32

5.84

1.4

11.53

28.91

e6/l

1.80

287

2087

Ulcer of vagina/vulva

174

2.36

5.84

1.1

1.4

28.87

9.98

e6/l

0.38

136

Other embolism and thrombosis

141

914

1.56

5.84

1.3

1.4

46.92

21.15

e6/l

0.31

116

704

Vestibular neuronitis

104

627

1.68

5.83

1.2

1.3

10.06

25.40

e6/l

0.84

481

Gout

246

1615

1.40

5.82

1.5

1.4

75.90

23.23

e6/l

0.55

189

1258

Other diseases of jaws

507

1.76

5.82

1.5

18.06

37.69

e6/l

0.66

391

Other congenital malformations

122

766

1.61

5.81

1.5

2.2

25.46

21.56

e6/l

0.10

581

Thyroiditis, ILD-related definition

134

860

1.57

5.81

1.3

1.4

43.85

23.04

e6/l

0.40

112

644

Inflammatory diseases of prostate (prostatitis)

132

844

1.58

5.80

1.3

1.4

13.30

24.67

e6/l

0.79

102

666

Disorders of synovium and tendon in diseases classified elsewhere

114

2.70

5.79

1.3

1.2

14.80

4.37

e6/l

0.55

Mixed disorders of conduct and emotions, excluding more controls

162

2.40

5.79

1.3

2.1

40.00

10.78

e6/l

0.77

127

Lesion of radial nerve

240

2.12

5.74

1.3

1.5

8.46

10.11

e6/l

0.13

183

Pedestrian injured in transport accident

502

1.76

5.73

1.1

1.5

5.97

31.89

e6/l

1.39

390

Intentional self-harm by unspecified means

3.13

5.73

1.4

1.2

11.33

7.27

e6/l

0.17

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

251

2675

0.73

5.72

1.4

14.54

24.82

e6/l

0.92

194

2101

Injury of muscle and tendon at shoulder and upper arm level

372

2866

1.31

5.71

1.3

1.4

27.66

27.24

e6/l

0.01

295

2214

Diabetes mellitus

1312

6789

1.16

5.70

1.4

25.49

31.93

e6/l

0.40

1001

5250

Diabetes, varying definitions

1303

6751

1.16

5.66

1.4

25.56

32.08

e6/l

0.40

993

5221

Use of disulfiram, acamprosate or naltrexone

116

725

1.62

5.66

1.4

118.72

23.48

e6/l

0.41

560

Other congenital malformations of skin

317

1.96

5.64

1.8

2.0

47.00

8.67

e6/l

0.74

236

Otitis media, unspecified

158

972

1.51

5.64

1.9

1.7

21.88

19.56

e6/l

0.05

117

733

Benign neoplasm of other and ill-defined parts of digestive system

178

1221

1.47

5.63

1.3

35.13

28.12

e6/l

0.12

145

968

Osteonecrosis

388

1.86

5.62

2.0

1.4

20.57

36.25

e6/l

0.31

300

Cholelithiasis

973

5800

1.18

5.61

1.3

1.4

41.11

28.31

e6/l

0.39

746

4521

Insulin, fast-acting or short human

412

3223

1.28

5.59

1.4

1.5

18.22

26.06

e6/l

0.71

334

2491

Sicca syndrome [Sjögren]

102

619

1.67

5.59

1.4

1.3

3.75

28.21

e6/l

1.98

465

Vasomotor and allergic rhinitis

467

3659

1.26

5.56

1.3

1.5

23.17

33.87

e6/l

0.53

374

2800

Dental operations, only avohilmo

860

3693

1.20

5.54

1.4

1.5

20.81

27.37

e6/l

0.52

663

2867

Amyloidosis

111

2.68

5.54

1.3

1.2

15.90

31.69

e6/l

0.22

Viral pneumonia (known virus, not influenza)

147

2.44

5.54

2.0

2.2

19.41

31.23

e6/l

0.21

112

Benign neoplasm of colon, rectum, anus and anal canal

621

4593

1.22

5.53

1.4

25.46

30.93

e6/l

0.26

475

3568

Testicular dysfunction

237

2.11

5.53

1.2

1.4

5.23

31.44

e6/l

1.07

172

Urolithiasis

332

2532

1.32

5.51

1.4

52.85

27.47

e6/l

0.33

254

1955

Type 2 diabetes

1218

6254

1.16

5.50

1.4

27.04

33.46

e6/l

0.34

932

4843

Testicular hypofunction

198

2.22

5.49

1.3

1.4

5.06

32.28

e6/l

0.91

144

Correction of physiology of bite - demanding therapy visit

541

1.70

5.42

1.3

1.4

22.59

19.22

e6/l

0.07

415

Benign neoplasm: Colon

509

4016

1.25

5.40

1.4

19.39

29.25

e6/l

0.72

399

3117

Carrier of infectious disease

155

2.38

5.40

1.5

1.7

18.60

11.48

e6/l

0.32

125

Familial hypercholesterolemia

143

947

1.52

5.39

1.3

1.4

29.07

18.24

e6/l

0.38

118

755

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.54

5.39

1.2

1.5

12.92

9.12

e6/l

0.13

Acute lymphadenitis

467

1.76

5.39

2.1

1.6

12.61

22.98

e6/l

0.38

366

Collagenous colitis

104

641

1.64

5.38

1.4

1.5

22.96

29.45

e6/l

0.13

489

Nonsuppurative otitis media

297

1930

1.34

5.36

1.8

1.5

79.62

17.45

e6/l

0.86

242

1476

Event of undetermined intent

476

1.75

5.33

1.5

18.25

31.01

e6/l

0.37

374

Haemorrhage in early pregnancy

337

2526

1.31

5.32

1.2

1.3

10.96

37.55

e6/l

2.50

286

1932

Erosion of teeth

102

2.72

5.31

4.1

1.6

10.58

38.40

e6/l

0.42

Other maltreatment syndromes

255

2.04

5.29

1.5

1.4

20.07

13.78

e6/l

0.28

200

Fentanyl

536

1.69

5.28

1.3

1.4

22.86

20.59

e6/l

0.05

409

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

276

1.99

5.27

1.3

1.6

23.05

19.65

e6/l

0.07

216

Other diseases of oesophagus

598

1.65

5.26

1.3

1.4

61.19

27.97

e6/l

0.37

470

Other inflammation of eyelid

143

953

1.51

5.26

1.7

1.4

3.61

26.67

e6/l

2.79

100

729

Calculus of kidney and ureter

309

2351

1.32

5.24

1.4

55.82

26.35

e6/l

0.37

240

1815

Benign neoplasm: Colon

502

3095

1.25

5.24

1.4

19.52

27.29

e6/l

0.56

396

2424

Thyrotoxicosis, other and/or unspecified

213

1532

1.40

5.22

1.5

1.4

66.29

34.30

e6/l

0.49

161

1181

Systemic lupus erythematosus, unspecified

216

2.13

5.21

1.2

1.4

11.45

11.38

e6/l

0.00

162

Cerebral palsy

133

2.48

5.21

2.7

2.1

43.09

7.56

e6/l

0.45

Myopia

157

1069

1.48

5.21

1.4

1.6

31.84

24.97

e6/l

0.24

126

811

Other disorders of patella

208

1491

1.40

5.20

1.2

1.4

31.17

33.21

e6/l

0.04

170

1140

Vitreous haemorrhage

108

678

1.61

5.20

1.5

1.4

12.44

25.25

e6/l

0.56

526

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

190

2.20

5.18

1.4

1.7

15.15

7.41

e6/l

0.34

146

Glomerular diseases

195

1384

1.42

5.17

1.5

27.52

22.15

e6/l

0.14

147

1050

Overexertion and strenuous or repetitive movements

125

813

1.55

5.17

1.5

1.4

10.56

25.81

e6/l

1.06

632

Motor disorders, excluding more controls

127

2.48

5.17

2.5

4.4

9.25

7.25

e6/l

0.09

Divergent concomitant strabismus

602

1.65

5.16

1.7

1.6

11.40

31.06

e6/l

1.01

461

Ankylosing spondylitis

100

617

1.64

5.16

1.4

1.5

71.07

19.33

e6/l

0.53

466

Sequelae of inflammatory diseases of the central nervous system

5.20

5.13

3.5

1.0

454.73

2.88

e6/l

0.48

Glucagon-like peptide-1 (GLP-1) analogues

552

3705

1.23

5.12

1.4

1.3

25.10

30.77

e6/l

0.27

428

2853

Burns and corrosions

170

1180

1.45

5.11

1.7

1.6

19.25

21.29

e6/l

0.09

138

902

Rheumatoid arthritis

339

2379

1.30

5.11

1.2

1.4

27.65

30.95

e6/l

0.14

264

1818

Decubitus ulcer and pressure area

307

1.91

5.09

2.6

1.3

48.42

37.99

e6/l

0.13

242

Care involving dialysis

505

1.70

5.08

1.4

1.7

12.46

29.04

e6/l

0.58

381

Type 1 diabetes

307

2342

1.32

5.08

1.5

28.08

25.52

e6/l

0.08

252

1817

Hypoplasia of dental enamel, including avohilmo

2.82

5.06

11.6

4.2

6.05

6.41

e6/l

0.02

Congenital iodine-deficiency syndrome/hypothyroidism

179

2.22

5.05

1.6

1.8

3.15

17.60

e6/l

1.49

134

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

307

2616

0.76

5.03

1.4

1.3

20.28

36.34

e6/l

1.01

212

2048

Procreative management

410

2738

1.27

5.03

1.6

27.79

33.88

e6/l

0.15

303

2081

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

307

2615

0.76

5.02

1.4

1.3

20.28

36.35

e6/l

1.01

212

2047

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

414

2884

1.27

5.02

1.5

1.4

34.21

25.22

e6/l

0.25

324

2267

Previous suicide attempt

2.98

5.02

1.1

1.2

1.41

6.42

e6/l

0.74

Other and unspecified intracranial injuries

167

2.26

4.98

3.7

1.4

18.59

29.04

e6/l

0.19

135

Candidiasis

150

1022

1.48

4.98

1.6

1.4

82.67

28.44

e6/l

0.31

123

764

Meralgia paraesthetica

220

2.09

4.97

1.3

1.6

2.20

32.91

e6/l

0.67

163

Excessive attrition of teeth

494

2155

1.25

4.97

1.4

39.17

28.43

e6/l

0.17

382

1694

Other diseases of pleura

427

3016

1.26

4.96

1.5

16.77

27.46

e6/l

0.66

323

2339

Rosacea

130

861

1.52

4.96

1.3

4.70

28.58

e6/l

2.50

105

658

Open wound of lower leg

160

1105

1.46

4.95

1.4

1.5

18.37

23.43

e6/l

0.25

131

841

Early onset COPD, excluding more controls

195

1394

1.41

4.95

1.5

1.3

13.03

16.89

e6/l

0.29

152

1062

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

202

1455

1.40

4.95

1.3

1.4

14.24

24.06

e6/l

0.75

147

1121

Acute laryngitis and tracheitis

152

1023

1.47

4.94

2.2

1.5

23.93

27.68

e6/l

0.09

118

774

240

2.01

4.90

1.4

1.2

7.05

33.78

e6/l

0.71

200

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

201

2.13

4.90

2.2

1.2

11.81

45.40

e6/l

0.63

172

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.72

4.90

1.2

1.5

1.56

5.56

e6/l

0.77

Colorectal adenocarcinoma

1255

0.59

4.89

1.2

1.3

10.39

24.14

e6/l

0.98

965

Pyogenic arthritis

413

1.76

4.89

1.2

1.5

6.69

8.45

e6/l

0.22

321

Other erythematous conditions

222

2.06

4.86

1.4

1.6

4.31

12.80

e6/l

0.94

177

Atrial fibrillation and flutter

329

1653

1.30

4.85

1.4

1.3

53.49

24.48

e6/l

0.53

245

1235

Heart failure and coronary heart disease

148

1599

0.69

4.85

1.3

15.57

24.34

e6/l

0.49

128

1232

Other and unspecified erythematous conditions

196

2.13

4.81

1.4

1.6

3.91

14.41

e6/l

1.07

154

Superficial injury of shoulder and upper arm

127

843

1.52

4.81

1.3

1.5

118.83

26.47

e6/l

0.47

662

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.95

4.80

1.8

1.3

27.86

17.05

e6/l

0.25

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1148

6515

1.15

4.79

1.4

30.81

32.29

e6/l

0.06

896

5021

Neovascular glaucoma

251

1.98

4.77

1.8

1.3

20.35

40.83

e6/l

0.32

199

Melanocytic naevi

329

2562

1.29

4.75

1.4

16.63

27.49

e6/l

0.72

255

1985

Benign neoplasm of other and ill-defined parts of digestive system

178

1264

1.42

4.75

1.3

35.13

25.67

e6/l

0.17

145

975

Mental and behavioural disorders due to cannabinoids

252

1.98

4.74

1.7

1.4

38.63

14.41

e6/l

0.94

197

Viral conjunctivitis

152

2.29

4.72

1.4

1.8

2.96

13.01

e6/l

1.25

117

L02BA Anti-estrogens

1266

0.60

4.71

1.4

28.82

30.67

e6/l

0.04

975

Methotrexate

159

1109

1.44

4.69

1.2

1.4

41.83

20.31

e6/l

0.49

124

843

Disorder of lipoprotein metabolism, unspecified

121

799

1.53

4.69

1.2

1.4

35.07

18.82

e6/l

0.24

635

Striking against or struck by other objects

381

3026

1.26

4.67

1.3

1.6

25.58

26.44

e6/l

0.03

292

2328

Ganglion

226

1674

1.36

4.66

1.4

52.33

28.29

e6/l

0.60

181

1275

Medicines for HER+ breast cancer

217

2845

0.74

4.65

1.3

1.4

12.70

40.15

e6/l

2.71

149

2205

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

296

1.89

4.65

1.7

1.6

18.36

15.62

e6/l

0.09

222

Malignant neoplasm of breast

349

3193

0.79

4.65

1.4

17.86

39.53

e6/l

1.71

237

2493

Phlebitis and thrombophlebitis (not including DVT)

231

1719

1.35

4.63

1.4

42.55

30.45

e6/l

0.19

177

1315

Fibroblastic disorders

216

1591

1.36

4.62

1.4

45.84

30.49

e6/l

0.28

171

1232

Use of biperiden

384

1.77

4.61

1.4

26.02

35.90

e6/l

0.17

296

Diabetes medication

1283

6863

1.14

4.61

1.4

27.74

31.91

e6/l

0.22

987

5301

Car occupant injured in other and unspecified transport accidents

224

1662

1.36

4.59

1.3

1.4

13.83

22.27

e6/l

0.60

176

1285

Crushed, pushed or stepped on by crowd or human stampede

590

1.61

4.59

1.3

1.9

7.76

17.43

e6/l

0.99

452

Car occupant injured in noncollision transport accident

269

1.93

4.58

1.1

1.4

4.92

24.75

e6/l

1.02

218

Chondropathies

183

1315

1.40

4.58

1.5

1.4

30.54

22.86

e6/l

0.23

141

1012

Disease of hard tissues of teeth, NOS

3.15

4.57

1.3

6.40

7.91

e6/l

—

Glomerulonephritis

114

749

1.54

4.56

1.6

30.07

25.61

e6/l

0.07

583

Diseases of peritoneum

107

693

1.56

4.56

1.5

1.4

4.01

26.42

e6/l

1.83

536

Other specified/unspecified disorders of bone/cartilage

174

2.17

4.55

1.2

6.79

6.58

e6/l

0.02

132

Poisoning by medicine, drug-induced

2.61

4.53

1.3

1.2

1.43

6.71

e6/l

1.10

Medial epicondylitis

235

1.99

4.53

1.3

1.4

5.69

13.33

e6/l

0.83

173

Amyloidosis, other/unspecified

2.65

4.53

1.3

1.2

4.56

37.86

e6/l

0.49

Glaucoma secondary to other eye disorders

256

1.94

4.53

1.8

1.3

20.35

42.71

e6/l

0.35

200

Myocarditis

284

1.89

4.51

1.8

1.3

8.88

10.00

e6/l

0.08

213

Sulfasalazine

314

2448

1.29

4.51

1.3

50.15

30.66

e6/l

0.45

254

1872

Redundant prepuce, phimosis and paraphimosis

216

1591

1.36

4.50

1.4

1.6

16.37

34.03

e6/l

0.92

165

1239

Thyrotoxicosis

263

2004

1.32

4.50

1.5

1.3

53.29

30.49

e6/l

0.43

203

1549

Other Crohn's disease

555

1.62

4.47

1.6

1.5

8.78

25.26

e6/l

1.26

426

Vertigo of central origin

2.75

4.47

1.0

1.1

3.56

4.23

e6/l

0.12

Papulosquamous disorders

417

3366

1.24

4.47

1.3

1.4

21.55

31.04

e6/l

0.59

316

2589

Other and unspecified mononeuropathies of upper limb

189

2.10

4.44

1.7

1.2

25.55

8.65

e6/l

0.45

135

Continuous positive airway pressure

183

1136

1.40

4.44

1.6

37.82

13.41

e6/l

0.90

137

838

Chondrocostal junction syndrome [Tietze]

258

1.93

4.44

1.3

1.6

71.21

8.46

e6/l

0.72

201

Abnormal findings on diagnostic imaging of lung

447

3540

1.23

4.44

1.4

16.83

29.02

e6/l

0.85

342

2761

Other coagulation defects

534

1.63

4.40

1.6

1.5

25.54

30.44

e6/l

0.11

423

Specific development disorders of scholastic skills

400

1.73

4.40

2.0

2.5

6.48

14.28

e6/l

0.96

300

Unspecified nephritic syndrome

144

2.27

4.39

1.3

1.2

8.32

10.35

e6/l

0.12

115

Arthropathies in other diseases classified elsewhere

245

1.95

4.39

1.9

1.6

87.53

11.25

e6/l

0.61

196

Fissure and fistula of anal and rectal regions

261

1994

1.32

4.39

1.5

1.4

22.52

29.66

e6/l

0.34

202

1531

Exposure to other specified electric current

2.66

4.37

1.2

1.4

3.33

14.54

e6/l

1.00

Polymyalgia rheumatica

116

772

1.51

4.37

1.3

20.29

26.19

e6/l

0.18

592

Other epidermal thickening

288

1.87

4.36

1.8

1.6

8.38

40.10

e6/l

0.87

229

Abnormal findings on antenatal screening of mother

110

725

1.53

4.36

1.4

9.66

18.58

e6/l

1.33

561

TMD muscular pain linked with fibromyalgia

3.06

4.35

1.2

1.5

2.38

4.92

e6/l

0.66

Other specified/unspecified soft tissue disorders

281

1.87

4.34

1.4

1.3

2.63

45.36

e6/l

1.25

212

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1214

0.61

4.33

1.2

1.3

10.39

23.35

e6/l

0.87

958

Residual foreign body in soft tissue

325

1.81

4.32

1.3

12.63

32.54

e6/l

0.51

250

Budesonide

149

1045

1.44

4.31

1.6

1.3

102.54

22.17

e6/l

0.53

116

790

Fracture of lower leg, including ankle

612

5128

1.19

4.30

1.4

1.5

16.52

31.77

e6/l

2.11

480

3945

Other and unspecified vaccines and biological substances

3.29

4.29

1.1

1.0

1.40

2.45

e6/l

—

Respiratory disorders in diseases classified elsewhere

2.70

4.29

1.3

1.2

18.71

4.93

e6/l

0.80

Adenomyosis (Endometriosis of uterus)

149

1047

1.43

4.27

1.4

1.3

20.76

30.83

e6/l

0.45

114

833

Nail disorders

625

1.57

4.26

1.5

1.4

142.11

27.43

e6/l

0.43

469

Disorders of breast

546

4216

1.20

4.25

1.3

1.4

21.59

33.26

e6/l

0.71

430

3261

Malignant neoplasm of breast, HER-positive

203

2680

0.74

4.25

1.3

1.4

13.27

40.40

e6/l

2.40

138

2073

Artrosis, including avohilmo

1066

5111

1.15

4.24

1.3

1.4

27.77

31.46

e6/l

0.19

821

3932

Benign neoplasm: Spinal meninges

3.01

4.23

1.8

1.0

67.45

8.51

e6/l

0.52

Infectious mononucleosis

113

754

1.51

4.23

1.6

32.17

17.46

e6/l

0.56

582

Orthopaedic devices associated with adverse incidents

110

0.00

4.21

0.0

1.1

—

37.89

—

Pregnancy examination and test

217

1005

1.36

4.20

1.3

1.2

15.74

29.37

e6/l

0.50

175

773

Dermatitis due to substances taken internally

388

1.72

4.18

1.7

1.6

35.17

38.46

e6/l

0.05

307

Nummular dermatitis

557

1.60

4.18

1.3

1.4

40.88

30.22

e6/l

0.13

435

Other and unspecified coagulation defects

366

1.75

4.18

1.5

21.75

17.05

e6/l

0.13

286

Other and unspecified disorders of adult personality and behaviour

3.24

4.18

1.3

1.2

2.88

7.23

e6/l

—

Polyarthrosis

187

1313

1.37

4.17

1.5

1.4

29.80

24.90

e6/l

0.16

153

999

Malignant neoplasm of breast, HER2-negative

339

3125

0.79

4.17

1.4

18.46

38.57

e6/l

1.49

228

2441

Other inflammatory liver diseases

472

1.65

4.17

1.2

1.5

6.66

28.60

e6/l

1.03

373

Vitamin D deficiency

122

2.35

4.16

1.2

1.5

36.76

6.53

e6/l

0.74

Fracture of forearm

598

4716

1.19

4.15

1.4

1.5

21.47

32.76

e6/l

1.07

466

3632

Hypertrophic scar

397

1.71

4.14

1.4

1.5

1.96

20.60

e6/l

2.46

312

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.97

4.13

1.2

1.1

12.92

51.02

e6/l

0.37

Nonalcoholic fatty liver disease

106

702

1.53

4.13

1.3

1.5

42.95

26.45

e6/l

0.42

547

Inflammatory bowel disease

365

2932

1.25

4.13

1.4

45.38

31.10

e6/l

0.18

278

2263

Other diseases of anus and rectum

285

2220

1.29

4.13

1.3

1.4

15.71

25.51

e6/l

0.77

220

1720

Other and unspecified injuries of wrist and hand

273

1.86

4.08

1.2

1.8

9.58

15.44

e6/l

0.33

211

Hyperprolactinaemia

259

1.88

4.07

1.1

1.4

287.97

12.30

e6/l

0.48

204

Colorectal cancer

103

1534

0.67

4.06

1.2

1.3

18.51

24.60

e6/l

0.21

1182

Other diseases of blood and blood-forming organs

468

1.64

4.06

1.5

1.4

13.86

30.48

e6/l

0.60

360

Disorder of the sleep-wake schedule

130

2.29

4.05

1.6

1.9

12.22

8.10

e6/l

0.16

Later onset COPD

118

1347

0.68

4.03

1.2

1.3

50.98

24.62

e6/l

0.34

1061

Congenital malformations of the circulatory system

178

1263

1.38

4.02

1.8

2.0

11.59

22.34

e6/l

0.85

134

958

Retinal vascular occlusion

104

690

1.52

4.01

1.4

1.3

8.88

25.03

e6/l

0.99

533

Open wound of abdomen, lower back and pelvis

204

1.99

4.01

1.6

1.8

35.82

14.54

e6/l

0.45

164

Superficial injury of forearm

116

788

1.49

4.00

1.3

1.7

21.02

26.43

e6/l

0.18

606

Sequelae of injuries of upper limb

114

772

1.49

4.00

1.4

18.05

29.22

e6/l

0.50

594

Heart failure and antihypertensive medication

252

1273

1.31

4.00

1.4

15.46

23.43

e6/l

0.53

199

966

Other disorders of white blood cells

386

1.71

4.00

2.8

1.6

8.33

31.12

e6/l

0.81

303

Bulimia nervosa (incl. atypical)

283

1.83

3.97

1.1

1.6

17.21

18.46

e6/l

0.04

214

Effects of other external causes

212

1.97

3.96

1.2

1.4

20.50

17.59

e6/l

0.06

165

Cardiodefibrillation

201

2659

0.75

3.95

1.5

1.4

97.19

29.03

e6/l

0.53

149

2064

Endometriosis ASRM stages 1,2

213

1609

1.33

3.94

1.3

17.66

23.63

e6/l

0.41

162

1224

Viral haemorrhagic fevers, not elsewhere classified/unspecified

590

1.56

3.93

1.5

1.4

23.99

25.29

e6/l

0.03

462

Other and unspecified iridocyclitis

306

1.79

3.92

1.4

1.6

8.12

10.07

e6/l

0.16

233

Infections of genitourinary tract in pregnancy

117

801

1.47

3.90

1.4

1.3

30.43

27.18

e6/l

0.08

595

Use of interferon beta-1a

172

2.08

3.90

1.3

1.6

11.68

10.80

e6/l

0.05

136

Anogenital herpesviral [herpes simplex] infection

497

1.61

3.89

1.4

26.43

21.69

e6/l

0.15

380

Perforation of tympanic membrane

113

769

1.48

3.88

1.4

1.5

28.91

14.56

e6/l

0.32

593

Other keratitis

127

884

1.45

3.88

1.2

1.4

14.14

17.07

e6/l

0.17

677

Retinal vascular disorders

105

704

1.50

3.86

1.4

1.3

8.77

24.54

e6/l

0.99

545

Other disorders involving the immune mechanism, not elsewhere classified

207

1.97

3.86

9.1

1.6

20.77

24.13

e6/l

0.05

167

Pedestrian injured in collision with pedal cycle

214

1.95

3.86

1.1

1.4

9.66

12.42

e6/l

0.18

169

Other skin changes

157

1136

1.39

3.84

1.3

1.4

43.64

25.78

e6/l

0.21

120

877

Syphilis

180

2.04

3.83

2.0

1.3

23.70

39.53

e6/l

0.22

142

Melanocytic naevi of upper limb, including shoulder

160

2.11

3.81

2.1

1.6

7.32

9.55

e6/l

0.14

123

Intestinal malabsorption

324

1.75

3.80

1.3

1.5

18.85

8.79

e6/l

0.39

248

Follicular lymphoma, hilmo

258

1.85

3.79

1.7

1.3

6.30

43.28

e6/l

0.92

202

Benign neoplasm: Adrenal gland

508

1.59

3.79

1.3

6.91

27.85

e6/l

1.03

397

Hypertrophic disorders of skin

438

1.64

3.79

1.4

1.6

1.94

19.78

e6/l

2.65

343

Arthropod-borne viral fevers and viral haemorrhagic fevers

106

716

1.49

3.79

1.5

1.4

21.02

24.08

e6/l

0.08

558

Diseases of salivary glands

204

1541

1.33

3.79

1.2

1.4

6.15

28.86

e6/l

2.93

150

1188

Congenital malformations and deformations of the musculoskeletal system

119

819

1.46

3.77

1.9

2.2

13.47

18.78

e6/l

0.32

622

Parodontitis or operation codes

1038

6748

1.14

3.76

1.3

1.4

38.93

31.09

e6/l

0.18

765

5271

Hyperkalaemia

273

1.81

3.76

1.4

9.30

18.95

e6/l

0.38

220

Other and unspecified trigeminal disorders

2.50

3.76

1.3

1.2

78.71

4.07

e6/l

0.51

Gout, FINNGEN

246

1908

1.30

3.76

1.5

1.4

75.90

20.68

e6/l

0.59

189

1478

Secondary polycythaemia

141

2.17

3.75

1.3

1.2

9.64

12.58

e6/l

0.13

110

Other/unspecified reactive arthropathies

510

1.59

3.74

1.1

1.4

115.18

19.12

e6/l

0.75

397

Toxic effect of ethanol

296

1.78

3.73

1.2

1.6

20.05

10.56

e6/l

0.34

226

Bruxism

135

2.20

3.72

1.4

1.5

2.58

6.65

e6/l

0.93

110

Extracorporeal dialysis

410

1.65

3.70

1.4

1.5

3.35

31.42

e6/l

1.19

314

Noninflammatory disorders of female genital tract

541

2280

1.20

3.69

1.4

1.3

26.51

24.38

e6/l

0.11

398

1792

Pregnancy hypertension

493

3722

1.20

3.68

1.3

1.4

20.63

31.20

e6/l

0.41

395

2855

Fracture of neck

380

1.68

3.68

1.3

12.51

33.89

e6/l

0.67

294

Fitting and adjustment of other devices

298

2205

1.26

3.68

1.5

1.4

28.34

28.99

e6/l

0.02

255

1702

Retinal detachment with retinal break

122

852

1.44

3.67

1.5

1.3

4.65

23.79

e6/l

1.93

659

Generalized epilepsy, mode (most common among epilepsy diagnosis)

225

1.90

3.67

1.1

1.8

5.28

13.93

e6/l

0.98

180

Parodontitis and operation codes

976

6687

1.14

3.66

1.3

1.4

40.71

31.26

e6/l

0.21

723

5216

Use of amantadine

104

2.36

3.64

1.0

1.2

5.94

13.40

e6/l

0.49

Parodontitis

1035

6750

1.13

3.63

1.3

1.4

39.07

31.07

e6/l

0.19

762

5274

Acute mastoiditis

3.03

3.62

1.2

1.6

265.20

7.63

e6/l

—

Dislocation, sprain and strain of joints and ligaments of knee

732

5891

1.16

3.61

1.3

1.4

15.20

31.80

e6/l

2.79

563

4518

Injury of nerves at shoulder and upper arm level

2.65

3.60

1.1

19.71

9.86

e6/l

0.25

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

539

1.55

3.60

3.2

2.5

18.47

20.53

e6/l

0.07

410

Benign neoplasm of eye and adnexa

651

1.50

3.59

1.5

1.3

8.30

23.41

e6/l

0.90

510

Erosion of teeth, including avohilmo

232

1736

1.30

3.59

1.7

1.4

10.32

28.70

e6/l

1.49

180

1364

Autoimmune hyperthyroidism

391

1.65

3.56

1.6

1.5

48.04

33.76

e6/l

0.22

302

Rheumatoid arthritis, including avohilmo

383

3147

1.22

3.56

1.3

1.4

28.21

28.72

e6/l

0.02

297

2437

Other/unspecified enthesopathies, not elsewhere classified

564

1.54

3.55

1.3

1.4

9.52

35.29

e6/l

1.18

424

Chronic periodontitis

149

1085

1.38

3.55

1.5

1.4

18.97

29.82

e6/l

0.46

100

836

Ingrowing nail

392

1.65

3.54

1.5

202.71

13.86

e6/l

0.51

303

Malignant melanoma, excluding all cancers (controls excluding all cancers)

157

1153

1.37

3.54

1.2

1.3

9.71

24.42

e6/l

1.42

116

911

Mixed conductive and sensorineural hearing loss

118

826

1.44

3.53

1.3

1.4

121.55

25.85

e6/l

0.47

630

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

294

1.75

3.52

1.5

1.4

11.86

20.27

e6/l

0.24

221

Intentional self-harm by sharp object

186

1.97

3.52

1.3

1.6

8.77

7.35

e6/l

0.10

144

Other specified and unspecified strabismus

2.54

3.51

1.9

2.5

24.85

6.73

e6/l

0.49

Other symptoms and signs involving the digestive system and abdomen

156

1146

1.37

3.51

1.6

1.5

15.93

49.09

e6/l

1.30

116

869

Other and unspecified injuries of lower leg

566

1.53

3.51

1.3

1.5

46.36

32.24

e6/l

0.15

439

Gastric ulcer

154

1129

1.37

3.50

1.4

30.47

25.45

e6/l

0.17

120

873

Chronic periodontitis, including avohilmo

1029

6752

1.13

3.49

1.3

1.4

39.37

31.06

e6/l

0.19

756

5277

Other and unspecified disorders of vitreous body

393

3227

1.22

3.49

1.4

21.53

34.28

e6/l

0.92

306

2470

Stomatitis and related lesions

640

1.50

3.47

3.2

1.5

7.25

33.30

e6/l

1.77

490

Diseases of arteries, arterioles and capillaries

650

4173

1.17

3.45

1.4

33.02

29.92

e6/l

0.10

516

3246

Benign neoplasm: Spinal meninges

2.66

3.44

1.8

1.1

67.45

15.00

e6/l

0.44

Dipeptidyl peptidase 4 (DPP-4) inhibitors

109

756

1.45

3.44

1.4

1.3

22.15

23.15

e6/l

0.03

582

Early syphilis

2.51

3.43

2.0

1.4

28.43

19.08

e6/l

0.19

Atopic dermatitis

680

5020

1.16

3.41

1.4

1.5

19.97

30.32

e6/l

0.81

522

3840

Crohn disease (strict definition, require KELA)

514

1.55

3.41

1.8

1.5

18.54

35.20

e6/l

0.51

399

Ulcer of lower limb, not elsewhere classified

119

840

1.43

3.41

1.4

33.35

20.93

e6/l

0.35

660

Paralytic ileus

231

1.84

3.40

1.3

1.6

8.40

45.71

e6/l

0.81

181

Coxarthrosis

502

2870

1.19

3.39

1.4

31.08

28.77

e6/l

0.06

390

2194

Diabetic retinopathy

309

1566

1.25

3.39

1.4

15.41

28.50

e6/l

1.04

244

1213

Benign neoplasm: Adrenal gland

523

1.55

3.39

1.3

1.4

6.91

29.68

e6/l

1.19

403

Melanocytic naevi of upper limb, including shoulder

168

2.00

3.38

2.1

1.4

7.32

38.70

e6/l

0.52

136

Burn and corrosion of hip and lower limb, except ankle and foot

168

2.00

3.38

2.8

1.4

70.68

10.45

e6/l

1.01

128

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

196

1.92

3.38

9.7

1.6

23.00

25.39

e6/l

0.03

158

Crohn disease (strict definition, all UC cases excluded)

382

1.64

3.37

1.6

12.38

31.59

e6/l

0.58

294

Preterm labour and delivery

293

2356

1.25

3.37

1.2

1.4

8.86

36.86

e6/l

2.88

224

1818

Type 1 diabetes, wide definition, subgroup 1

246

1937

1.28

3.36

1.4

1.5

21.63

25.37

e6/l

0.20

200

1495

Burns and corrosions of external body surface, specified by site

127

910

1.41

3.36

1.7

22.13

22.84

e6/l

0.02

104

691

Perineal laceration during delivery

116

1450

0.71

3.36

1.3

19.62

19.26

e6/l

0.02

1133

Follicular lymphoma

269

1.77

3.35

1.7

1.2

6.30

38.94

e6/l

0.86

218

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1148

6266

1.12

3.35

1.4

23.88

33.30

e6/l

0.77

891

4847

Human immunodeficiency virus [HIV] disease

128

2.15

3.34

1.8

1.3

16.95

14.46

e6/l

0.08

Crohn's disease of small intestine

541

1.53

3.33

1.8

1.5

17.02

35.06

e6/l

0.62

422

Coeliac disease

138

1005

1.38

3.32

1.4

1.6

13.56

29.52

e6/l

1.20

108

760

Degenerative macular diseases

105

730

1.45

3.28

1.4

1.3

9.16

27.88

e6/l

1.35

564

Colon adenocarcinoma

702

0.57

3.28

1.4

1.3

14.62

24.28

e6/l

0.32

539

Diseases of tongue

416

1.60

3.28

1.2

1.4

2.82

41.80

e6/l

1.88

325

Abnormal findings in nipple discharge synovial fluid wound secretions

103

2.29

3.27

1.2

2.73

3.52

e6/l

0.27

Chronic iridocyclitis

370

1.64

3.27

1.4

1.5

8.29

10.32

e6/l

0.20

292

Gestational [pregnancy-induced] hypertension

301

2433

1.24

3.26

1.3

11.74

32.53

e6/l

1.90

236

1872

Use of rotigotine

2.58

3.26

1.6

1.3

3.50

8.96

e6/l

0.60

Other noninflammatory disorders of vulva and perineum

682

1.46

3.26

1.5

1.3

13.28

22.59

e6/l

0.50

539

Crohn disease (strict definition, require KELA, min 2 HDR)

504

1.54

3.26

1.8

1.5

19.20

35.79

e6/l

0.49

390

Personal history of other diseases and conditions

140

1021

1.38

3.25

1.8

1.7

27.30

23.34

e6/l

0.11

104

781

Mixed disorders of conduct and emotions

206

1.88

3.25

1.3

2.2

40.00

23.27

e6/l

0.32

155

Postmenopausal osteoporosis with pathological fracture

309

1.70

3.25

1.4

1.3

7.51

15.71

e6/l

0.89

238

Acute generalized exanthematous pustulosis

317

1.69

3.24

1.8

1.7

32.37

14.35

e6/l

0.41

249

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

536

4004

1.17

3.24

1.3

1.4

20.60

30.47

e6/l

0.42

430

3067

Specific developmental disorder of motor function

161

2.00

3.24

2.5

5.0

9.25

4.92

e6/l

0.24

108

Melanocytic naevi of trunk

124

891

1.40

3.24

1.2

1.3

6.54

21.38

e6/l

1.40

703

Acute peritonitis

410

1.60

3.22

1.7

1.5

5.19

31.22

e6/l

1.06

314

Coronary artery bypass grafting

148

1513

0.74

3.22

1.3

17.92

25.45

e6/l

0.29

117

1147

Postprocedural musculoskeletal disorders, not elsewhere classified

466

1.56

3.21

1.5

1.3

20.77

31.17

e6/l

0.22

357

Cardiac murmurs and other cardiac sounds

109

759

1.43

3.18

2.1

1.8

16.96

33.36

e6/l

0.65

569

Unspecified event, undetermined intent

165

1.97

3.17

1.7

1.5

19.00

14.59

e6/l

0.12

132

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

207

2149

0.78

3.16

1.3

1.4

13.04

37.73

e6/l

2.13

141

1684

Injury of muscle and tendon at wrist and hand level

145

1074

1.36

3.15

1.4

1.5

11.95

18.90

e6/l

0.39

114

837

Salpingitis and oophoritis

189

1455

1.31

3.14

1.3

1.4

12.53

40.92

e6/l

1.73

141

1111

Open wound of wrist and hand

489

4121

1.18

3.14

1.2

1.4

41.22

29.25

e6/l

0.20

370

3167

Type 2 diabetes, definitions combined

1107

5916

1.12

3.13

1.4

26.38

34.15

e6/l

0.41

833

4583

Gonococcal infection

253

1.77

3.12

1.7

1.3

17.71

21.11

e6/l

0.13

190

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

132

965

1.38

3.12

1.3

7.87

24.73

e6/l

1.51

754

Other abnormal findings of blood chemistry

298

1.70

3.12

1.6

1.3

2.73

34.06

e6/l

0.94

236

Benign neoplasm: Stomach

631

1.47

3.11

1.3

49.11

26.84

e6/l

0.23

484

Chronic kidney disease

243

1923

1.26

3.11

1.4

1.5

15.81

23.29

e6/l

0.58

191

1486

Thyrotoxicosis with diffuse goitre

146

1085

1.35

3.11

1.7

1.3

25.69

25.60

e6/l

0.00

117

826

Cardiomyopathy in other diseases

3.60

3.09

1.2

1.1

5.80

2.55

e6/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

330

1808

1.23

3.09

1.4

1.3

20.91

24.98

e6/l

0.21

250

1417

Anorexia (incl.atypical)

486

1.54

3.09

1.2

1.5

3.74

23.80

e6/l

3.00

374

Achilles tendinitis

100

698

1.44

3.09

1.1

1.4

17.92

17.53

e6/l

0.01

510

Benign neoplasm of other and unspecified sites

217

1.82

3.08

1.2

6.07

50.74

e6/l

0.94

168

Benign neoplasm: Skin of lower limb, including hip

181

1.91

3.08

1.1

1.4

2.62

33.01

e6/l

0.98

137

Disorders of multiple cranial nerves

11.49

3.08

1.4

1.40

4.00

e6/l

—

Infection of intervertebral disc (pyogenic)

2.56

3.08

2.1

1.2

2.50

55.00

e6/l

0.63

Hepatic failure, not elsewhere classified

232

1.79

3.07

1.4

2.97

47.89

e6/l

1.09

185

Pregnancy with abortive outcome

770

3528

1.14

3.06

1.4

21.21

34.74

e6/l

1.06

600

2737

Ménière disease

642

1.46

3.05

1.2

1.4

12.53

29.81

e6/l

0.94

489

Dementia due to Parkinson's disease

106

2.21

3.05

1.2

1.3

1.69

83.49

e6/l

0.87

Other (not insulin) diabetes medications

1120

6062

1.12

3.05

1.4

27.73

33.78

e6/l

0.30

859

4689

Coxarthrosis [arthrosis of hip](FG)

534

3309

1.17

3.04

1.4

29.49

28.88

e6/l

0.02

414

2553

Malignant neoplasm of prostate

233

1852

0.79

3.04

1.3

38.99

28.59

e6/l

0.14

167

1465

Other and unspecified epidermal thickening

182

1.90

3.04

1.8

1.7

11.57

25.66

e6/l

0.37

150

Presence of other functional implants

552

3358

1.17

3.03

1.5

1.4

36.91

30.88

e6/l

0.11

439

2601

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

684

0.58

3.01

1.4

1.3

14.62

29.06

e6/l

0.49

530

Biomechanical lesions, not elsewhere classified

324

1.66

3.01

1.3

1.4

6.84

37.02

e6/l

0.95

255

Hodgkin lymphoma, hilmo

197

1.86

3.01

1.6

1.3

4.75

25.11

e6/l

0.70

157

Other local infections of skin and subcutaneous tissue

104

736

1.42

3.00

2.8

1.6

35.59

23.51

e6/l

0.27

571

Dependent personality disorder

148

2.00

2.98

1.2

1.4

6.83

5.87

e6/l

0.07

111

Hydrocele

104

737

1.42

2.96

1.3

1.6

11.60

24.63

e6/l

0.74

581

Complications of internal orthopaedic prosthetic devices, implants and grafts

188

1459

1.29

2.96

1.5

1.3

87.46

33.09

e6/l

0.40

142

1129

Gastroduodenal ulcer

217

1710

1.27

2.95

1.3

1.4

56.25

22.28

e6/l

0.54

167

1331

Other disorders starting during childhood or adolescence

504

1.51

2.95

3.4

2.5

10.82

20.64

e6/l

0.76

382

Recurrent dislocation of patella

412

1.57

2.95

1.1

1.5

37.72

17.15

e6/l

0.42

322

Pruritus

109

781

1.41

2.93

1.5

1.4

15.16

31.58

e6/l

0.92

602

Dislocation, sprain and strain of joints and ligaments of thorax

206

1.82

2.93

1.2

1.4

4.25

24.25

e6/l

0.72

163

Benign neoplasm of eye and adnexa

681

1.44

2.93

1.5

1.4

8.30

25.23

e6/l

1.08

519

Other articular cartilage disorders

149

1.98

2.92

1.2

1.5

2.18

4.14

e6/l

1.00

114

Septal defects

554

1.48

2.92

1.4

2.9

5.94

25.22

e6/l

0.98

419

Atopic dermatitis, strict definition with reimbursement

366

2967

1.20

2.91

1.4

1.5

15.97

28.28

e6/l

1.05

289

2271

Other and unspecified mental retardation

164

1.94

2.90

1.8

4.8

43.00

6.41

e6/l

0.54

119

Type 2 diabetes, strict (exclude DM1)

1108

5953

1.11

2.90

1.4

26.45

34.18

e6/l

0.41

834

4606

Early complications of trauma

289

1.68

2.90

1.4

26.88

41.36

e6/l

0.23

228

!Aliquae complicationes praecoces traumatis

289

1.68

2.90

1.4

26.88

41.36

e6/l

0.23

228

Other disorders of kidney and ureter

121

885

1.38

2.88

1.3

1.4

38.44

23.99

e6/l

0.34

685

Perioral dermatitis

157

1.95

2.88

1.4

6.33

3.97

e6/l

0.25

116

118

860

1.38

2.88

1.1

1.3

17.79

18.37

e6/l

0.02

673

Impetigo

336

1.63

2.88

2.9

1.9

7.25

10.77

e6/l

0.30

259

Dermatophytosis

126

928

1.37

2.88

1.5

1.4

28.02

22.09

e6/l

0.09

102

714

Malignant melanoma

130

962

1.36

2.88

1.3

10.92

21.98

e6/l

0.91

742

Recurring oral aphthae, including avohilmo

144

1083

1.34

2.87

2.7

1.4

31.04

25.46

e6/l

0.18

120

820

Vulvovaginal ulceration/inflammation in other diseases

455

1.53

2.87

1.2

1.4

22.96

23.37

e6/l

0.01

351

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

553

1.48

2.85

1.8

1.5

18.24

34.42

e6/l

0.52

430

Myocardial infarction, strict

327

2873

0.83

2.85

1.3

1.4

19.37

33.40

e6/l

0.83

265

2197

Outcome of delivery

211

1027

1.28

2.84

1.3

1.2

38.07

29.05

e6/l

0.21

150

791

Acidosis

130

2.04

2.84

1.2

1.6

1.00

29.93

e6/l

0.64

101

Diabetic nephropathy, excluding more controls

123

752

1.37

2.83

1.6

1.4

55.19

13.29

e6/l

0.87

103

583

Asthma mixed form (mode)

337

1.62

2.83

1.2

1.5

31.31

20.27

e6/l

0.24

259

Asthma mixed form (mode), excluding more controls

337

1.62

2.83

1.2

1.5

31.31

20.19

e6/l

0.24

260

Female genital prolapse

327

1556

1.22

2.82

1.3

1.4

45.36

28.10

e6/l

0.18

247

1226

Other and unspecified vascular occlusions

529

1.48

2.82

1.5

1.3

9.93

28.08

e6/l

0.83

412

L02BG Aromatase inhibitors

177

2267

0.78

2.82

1.3

1.4

8.21

34.99

e6/l

2.88

122

1755

Benign neoplasm: Stomach

645

1.44

2.81

1.3

49.11

27.91

e6/l

0.22

491

Sequelae of injuries of lower limb

103

737

1.41

2.81

1.3

1.4

134.20

28.67

e6/l

0.46

574

Other and unspecified rosacea

629

1.44

2.81

1.3

4.49

30.65

e6/l

1.81

477

Other peripheral vertigo

604

1.45

2.80

1.4

1.3

11.99

28.87

e6/l

0.84

464

Open wound of ankle and foot

109

788

1.39

2.80

1.4

1.6

27.60

24.61

e6/l

0.08

609

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

246

1.72

2.80

1.2

32.03

39.06

e6/l

0.09

208

Respiratory insufficiency

401

1.55

2.77

1.7

1.5

6.04

10.77

e6/l

0.56

308

Crohn's disease NAS

516

1.49

2.76

1.5

1.6

36.42

30.66

e6/l

0.08

403

Melanocytic naevi of trunk

124

918

1.36

2.76

1.2

1.4

6.54

28.03

e6/l

2.34

717

Other and unspecified local infections of skin and subcutaneous tissue

698

1.41

2.76

2.9

1.6

37.11

24.60

e6/l

0.26

538

Complications predominantly related to the puerperium

293

2415

1.22

2.75

1.2

1.3

17.88

35.90

e6/l

1.14

217

1867

Other and unspecified disorders of skin and subcutaneous tissue

435

0.50

2.75

1.1

1.4

90.13

33.26

e6/l

0.29

335

Sub-endpoint used in defining T1D endpoints

310

2526

1.21

2.75

1.5

28.11

23.36

e6/l

0.17

255

1939

Female infertility, associated with anovulation

665

1.42

2.75

1.4

1.3

14.62

21.67

e6/l

0.35

539

Presbycusis

628

1.43

2.74

1.2

1.3

41.48

28.68

e6/l

0.14

497

Colorectal cancer, excluding all cancers (controls excluding all cancers)

147

1857

0.76

2.74

1.3

1.4

14.20

24.09

e6/l

0.52

117

1457

Benign neoplasm of other and unspecified sites

226

1.75

2.73

1.2

1.3

6.07

43.14

e6/l

0.82

183

Other bursopathies

118

869

1.37

2.71

1.3

1.4

26.33

28.06

e6/l

0.05

663

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

249

1.71

2.71

1.3

1.4

10.36

7.86

e6/l

0.20

191

Allergic urticaria

667

1.42

2.71

1.9

1.7

10.10

33.24

e6/l

1.46

506

Ischemic heart diseases

838

4673

1.13

2.71

1.3

1.4

13.91

33.08

e6/l

3.35

681

3557

Motor disorders

175

1.87

2.71

2.5

4.8

9.25

5.37

e6/l

0.21

120

Biguanides

1095

6097

1.11

2.71

1.4

27.21

33.30

e6/l

0.29

832

4721

Contact with heat and hot substances

406

1.54

2.68

1.4

1.8

3.78

19.19

e6/l

1.17

310

Tuberculosis, wide

422

1.53

2.67

1.5

1.3

21.04

31.45

e6/l

0.25

334

Psoriatic and enteropathic arthropathies

120

889

1.36

2.67

1.3

1.4

22.16

16.15

e6/l

0.25

679

Post-traumatic wound infection, not elsewhere classified

169

1.86

2.65

1.2

1.3

36.81

10.73

e6/l

0.45

133

Abnormal results of function studies

620

1.43

2.65

1.2

1.6

4.99

25.71

e6/l

1.41

487

Tuberculosis, IBD comorbidity

407

1.53

2.64

1.5

1.3

21.04

32.40

e6/l

0.27

324

Disorders of orbit

297

1.63

2.64

1.5

50.50

14.79

e6/l

0.90

229

Hypertrophy of breast in women and men

206

1644

1.26

2.64

1.5

1.3

12.55

35.94

e6/l

1.68

161

1254

Other diseases of pancreas

505

1.48

2.63

1.2

1.5

94.59

25.37

e6/l

0.36

398

Malignant neoplasm of other connective and soft tissue

141

1.95

2.63

1.0

1.2

34.14

47.87

e6/l

0.11

108

Anaemia in chronic diseases classified elsewhere

141

1.95

2.63

1.2

1.4

16.00

72.39

e6/l

0.74

114

Injuries involving multiple body regions

259

1.68

2.63

1.4

1.5

2.42

13.14

e6/l

1.93

204

Localized swelling, mass and lump of skin and subcutaneous tissue

299

2482

1.21

2.63

1.8

1.4

19.96

30.18

e6/l

0.54

231

1904

Lichen simplex chronicus

229

1.73

2.62

1.5

1.3

24.07

46.36

e6/l

0.34

182

Alcoholic liver disease

680

1.41

2.62

1.2

1.4

16.75

22.40

e6/l

0.18

524

Diseases of spleen

100

2.14

2.61

1.3

1.64

14.55

e6/l

1.06

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

252

1.69

2.61

1.2

1.9

32.42

22.31

e6/l

0.19

190

Abscess of anal and rectal regions

655

1.41

2.61

1.4

1.5

20.32

24.10

e6/l

0.12

499

Disorders of parathyroid gland

172

1327

1.29

2.61

1.3

1.4

29.72

35.99

e6/l

0.15

130

1027

Insulin, fast-acting (human)

159

1231

1.30

2.61

1.4

26.51

24.89

e6/l

0.06

126

959

Acute pancreatitis

186

1469

1.27

2.60

2.0

1.4

9.72

22.67

e6/l

1.49

132

1135

Ovarian dysfunction

631

1.42

2.59

1.2

1.4

2.22

20.50

e6/l

4.12

482

Haemorrhoids and perianal venous thrombosis

263

2157

1.22

2.59

1.3

1.4

11.28

26.08

e6/l

1.64

207

1670

Colonic or urogenital fistula

273

2251

1.22

2.58

1.5

1.4

26.12

29.30

e6/l

0.11

210

1721

Diabetes, insulin treatment (Kela reimbursement)

1184

6589

1.10

2.57

1.4

23.25

33.97

e6/l

0.97

918

5082

Acne

123

921

1.34

2.56

1.5

11.99

21.05

e6/l

1.02

100

706

Seropositive rheumatoid arthritis

236

1914

1.23

2.56

1.2

1.4

28.82

28.80

e6/l

0.00

185

1484

Exposure to other and unspecified inanimate mechanical forces

550

1.45

2.55

1.4

1.7

9.81

30.97

e6/l

1.00

423

Acute gastritis

501

1.47

2.53

1.5

17.60

29.71

e6/l

0.35

390

Acute bronchiolitis

509

1.44

2.53

2.4

2.7

3.51

17.59

e6/l

2.33

381

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

613

0.60

2.53

1.1

1.4

4.33

25.16

e6/l

1.36

473

Benign lipomatous neoplasm

282

2338

1.21

2.53

1.4

1.3

45.24

22.43

e6/l

0.53

223

1837

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

131

993

1.33

2.52

1.3

1.4

18.86

21.38

e6/l

0.10

100

765

Injury of unspecified body region

535

1.45

2.51

1.3

1.6

32.18

30.44

e6/l

0.03

413

Malignant neoplasm of colon

892

0.67

2.51

1.4

26.49

23.66

e6/l

0.06

694

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

807

0.65

2.50

1.1

1.3

5.33

25.04

e6/l

1.55

636

Chronic pancreatitis

118

882

1.35

2.50

1.1

1.4

20.01

20.18

e6/l

0.00

683

Other diseases of arteries and capillaries

602

1.42

2.50

1.4

20.13

26.81

e6/l

0.17

467

Vascular diseases of the intestine

217

1.72

2.49

1.3

1.2

156.50

54.05

e6/l

0.44

171

Benign neoplasm: Skin of lower limb, including hip

195

1.77

2.49

1.1

1.4

2.62

24.64

e6/l

0.75

154

Hodgkin lymphoma

210

1.74

2.49

1.6

1.2

4.75

43.45

e6/l

0.79

170

Charcot foot

109

2.06

2.49

1.9

1.2

198.62

59.46

e6/l

0.41

Type 2 diabetes, definitions combined, including avohilmo

1109

5964

1.10

2.48

1.4

25.72

34.19

e6/l

0.46

834

4621

Acute pancreatitis (for exclusion)

186

1479

1.26

2.48

2.0

1.4

9.72

20.24

e6/l

1.33

132

1132

Other noninflammatory disorders of vagina

570

1.43

2.47

1.7

1.4

56.69

27.28

e6/l

0.49

453

Mental retardation

342

1.57

2.47

1.7

3.4

32.93

7.76

e6/l

0.63

259

Adenocarcinoma and papilloma adenocarcinoma of rectum

584

0.60

2.47

1.1

1.4

4.64

26.32

e6/l

1.34

451

Personal history of malignant neoplasm

264

1.65

2.46

4.0

1.6

2.10

17.07

e6/l

2.94

207

Pilonidal cyst

722

1.38

2.46

1.6

1.5

26.29

26.52

e6/l

0.01

571

Preparation and fitting of bite rail to mouth

149

1154

1.30

2.46

1.2

1.4

96.12

27.87

e6/l

0.42

124

887

Hernia of abdominal wall

447

3863

1.16

2.46

1.4

18.55

29.79

e6/l

0.73

344

2999

malignant neoplasm of male genital organs

250

1932

0.82

2.46

1.3

1.4

36.70

28.68

e6/l

0.11

181

1523

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1204

0.72

2.45

1.1

1.4

6.27

25.83

e6/l

2.06

942

Other disorders of penis

672

1.39

2.45

1.4

1.9

3.70

23.03

e6/l

2.04

520

Type 1 diabetes, wide definition

249

2045

1.22

2.44

1.4

1.6

21.35

24.47

e6/l

0.16

203

1574

Muscle strain

174

1.80

2.43

1.2

18.38

25.58

e6/l

0.13

130

Thyroiditis

523

1.45

2.42

1.4

52.70

25.19

e6/l

0.30

407

Superficial injuries involving multiple body regions

175

1.80

2.40

1.4

1.3

2.81

16.18

e6/l

1.53

140

Benign mammary dysplasia

134

1027

1.31

2.40

1.5

1.4

57.63

35.53

e6/l

0.34

108

783

Dislocation, sprain and strain of joint and ligaments of hip

220

1.70

2.40

1.6

1.3

2.07

49.73

e6/l

1.07

172

Atopic dermatitis, strict definition

355

2961

1.18

2.39

1.4

1.6

13.61

22.88

e6/l

1.17

279

2263

Other specified and unspecified retinal disorders

228

1.69

2.38

2.6

1.4

7.29

27.01

e6/l

0.73

176

Dialysis

298

1.60

2.38

1.5

1.8

17.29

18.99

e6/l

0.03

229

Disorders of globe

132

1.92

2.38

1.7

1.3

152.35

17.47

e6/l

0.56

104

Bitten or struck by other mammals

119

899

1.33

2.37

1.2

1.5

14.66

26.75

e6/l

0.48

692

Other dialysis

221

1.70

2.37

1.6

1.7

21.43

23.91

e6/l

0.04

170

Unspecified abortion

378

1.52

2.37

1.2

1.3

18.35

28.15

e6/l

0.30

293

Injury of nerves at forearm level

2.30

2.37

1.1

1.3

106.22

3.51

e6/l

—

Diabetic retinopathy, strict definition

154

1056

1.29

2.36

1.3

1.4

18.08

29.53

e6/l

0.50

124

810

Delayed milestone in childhood

200

1.71

2.36

2.7

5.2

33.37

8.86

e6/l

0.35

137

Acute nasopharyngitis (common cold)

129

980

1.32

2.36

1.7

1.4

16.52

35.83

e6/l

0.65

103

745

Systemic sclerosis (FG)

154

1.85

2.36

1.2

1.6

2.43

10.79

e6/l

1.04

118

Oligomenorrhoea

283

1.61

2.36

1.7

1.4

15.31

21.62

e6/l

0.21

222

L04AC Interleukin inhibitors

379

1.52

2.34

1.2

1.4

25.22

16.94

e6/l

0.15

293

Kidney transplant status

412

1.50

2.33

1.6

1.9

16.35

32.04

e6/l

0.38

314

Deviated nasal septum

336

2853

1.18

2.32

1.2

1.4

16.12

29.54

e6/l

1.16

274

2155

Recurring oral aphthae

340

1.55

2.31

4.8

1.5

7.58

35.91

e6/l

0.87

258

Alcohol-induced chronic pancreatitis

470

1.46

2.31

1.1

1.4

16.06

26.10

e6/l

0.24

365

Ehlers-Danlos syndrome

2.28

2.31

1.3

1.5

1.18

4.80

e6/l

1.46

Blood alcohol or alcohol intoxication level

170

1.79

2.31

1.3

1.5

6.82

10.58

e6/l

0.46

132

Other leukaemias of specified cell type

4.13

2.30

8.4

1.1

55.00

2.31

e6/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

156

1.82

2.28

1.3

1.4

22.68

6.57

e6/l

0.41

128

Problems related to social environment

156

1.81

2.27

1.3

1.4

11.64

10.68

e6/l

0.04

128

Spontaneous abortion

508

3024

1.15

2.27

1.2

1.4

26.15

35.39

e6/l

0.40

392

2336

Cysts of oral region, not elsewhere classified

302

1.57

2.26

1.4

80.69

38.72

e6/l

0.30

238

Volvulus

149

1.83

2.26

1.1

1.3

3.21

44.87

e6/l

0.63

116

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

2.13

2.25

1.2

14.11

92.63

e6/l

0.65

Malignant neoplasm of bronchus and lung

1002

0.72

2.25

1.2

1.3

44.12

25.88

e6/l

0.20

768

Tibial collateral bursitis [Pellegrini-Stieda]

2.24

1.6

1.7

87.60

4.31

e6/l

—

Other and unspecified injuries of ankle and foot

303

1.57

2.23

1.6

1.7

2.70

15.66

e6/l

2.58

233

Gonarthrosis,primary

938

5352

1.10

2.23

1.3

1.4

29.01

32.16

e6/l

0.15

732

4141

Injury of other and unspecified intrathoracic organs

425

1.47

2.21

1.4

10.91

31.96

e6/l

0.79

336

Ankylosing spondylitis, ICD10

729

1.35

2.19

1.4

72.78

21.11

e6/l

0.51

557

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

652

1.37

2.19

1.2

1.5

27.24

11.83

e6/l

0.56

503

COPD, hospital admissions 1, only main diagnosis

201

2094

0.82

2.19

1.4

1.3

31.59

30.56

e6/l

0.02

161

1624

Mental retardation, wide definition

369

1.51

2.19

1.7

3.3

31.52

7.99

e6/l

0.62

279

Generalized skin eruption due to drugs and medicaments

281

1.58

2.19

1.7

1.6

37.43

14.46

e6/l

0.45

220

Myocardial infarction, unclassifiable

1135

0.74

2.18

1.3

5.49

21.68

e6/l

1.85

879

Other menopausal disorders

300

1455

1.19

2.18

1.4

18.64

29.14

e6/l

0.63

215

1138

Plantar fascial fibromatosis

662

1.37

2.16

1.3

9.13

34.41

e6/l

1.56

499

Lichen planus

121

930

1.31

2.16

1.3

25.84

29.86

e6/l

0.09

700

Other follicular disorders

561

1.40

2.16

1.2

1.3

45.76

33.36

e6/l

0.19

428

Blepharochalasis

245

2041

1.20

2.15

1.2

1.4

26.13

31.56

e6/l

0.13

184

1573

Endocrine disorders, other/unspecified

130

1.87

2.14

1.3

1.2

16.20

6.13

e6/l

0.34

103

Adalimumab

725

1.35

2.12

1.4

1.6

60.15

20.72

e6/l

0.55

558

Chronic conjunctivitis

213

1.66

2.12

2.1

1.7

14.65

14.09

e6/l

0.02

171

Effects of foreign body entering through natural orifice

258

2164

1.20

2.11

1.6

1.5

36.23

25.94

e6/l

0.28

200

1649

Congenital malformations of cardiac septa

594

1.38

2.11

1.4

2.7

5.87

26.58

e6/l

1.17

446

Other leukaemias of specified cell type

3.71

2.10

8.4

1.1

55.00

4.20

e6/l

—

Foreign body in alimentary tract

406

1.47

2.09

1.3

1.6

43.29

32.44

e6/l

0.16

308

Correction of physiology of bite - very demanding therapy visit

214

1.66

2.09

1.1

1.5

3.71

8.90

e6/l

0.99

164

Hypertrichosis

161

1.76

2.08

1.1

1.3

24.86

12.89

e6/l

0.34

127

Habit and impulse disorders

110

1.94

2.08

2.1

1.7

2.50

10.19

e6/l

1.42

Other contact dermatitis

608

1.37

2.07

1.3

1.4

7.21

34.98

e6/l

1.90

479

Iron deficiency

154

1.78

2.06

1.3

1.9

15.53

25.28

e6/l

0.23

119

Malignant neoplasm of rectum

592

0.64

2.06

1.1

1.4

6.10

25.83

e6/l

1.16

454

Other and unspecified disorders of white blood cells

270

1.57

2.05

3.8

1.4

11.03

22.59

e6/l

0.40

210

Systemic sclerosis

162

1.75

2.04

1.2

1.5

2.43

11.69

e6/l

1.27

123

Pre-eclampsia or eclampsia

235

1963

1.20

2.03

1.2

1.3

26.50

37.72

e6/l

0.19

191

1505

Benign lipomatous neoplasm

282

2394

1.18

2.02

1.4

1.3

45.24

28.31

e6/l

0.35

223

1849

Vascular disorders of the intestines

359

1.49

2.02

1.2

1.3

109.86

35.35

e6/l

0.46

277

Otitis externa, unspecified

114

879

1.30

2.02

1.4

1.5

10.10

26.25

e6/l

1.17

681

Other obstructive and reflux uropathy

311

1.52

2.02

1.2

1.6

6.21

35.11

e6/l

0.92

240

Caught, crushed, jammed or pinched in or between objects

360

1.49

2.01

1.2

1.7

61.73

21.32

e6/l

0.71

277

Trigger finger

128

1002

1.28

2.01

1.4

23.19

30.59

e6/l

0.33

103

770

Chronic hepatitis, not elsewhere classified

224

1.63

2.01

1.4

47.41

13.58

e6/l

0.72

179

Atrophic disorders of skin

138

1091

1.27

2.01

1.4

22.47

40.49

e6/l

0.59

101

846

Other specified/unspecified bacterial intestinal infections

451

1.43

2.01

1.8

1.5

13.28

32.30

e6/l

0.69

349

Campylobacter enteritis

178

1.71

2.00

1.2

1.3

1.74

10.96

e6/l

1.53

140

Ventral hernia

212

1756

1.21

2.00

1.5

1.4

16.05

23.29

e6/l

0.39

170

1353

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

108

1169

0.77

2.00

1.2

1.3

32.46

22.95

e6/l

0.14

923

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

312

1.52

2.00

2.6

2.4

3.26

16.13

e6/l

1.12

242

Female infertility

353

1877

1.16

2.00

1.4

1.3

16.36

26.79

e6/l

0.79

267

1472

Hydronephrosis

741

1.33

1.99

1.3

1.4

4.77

21.31

e6/l

1.44

577

Wide developmental disorders, excluding more controls

199

1.66

1.99

1.3

2.8

8.00

12.39

e6/l

0.32

148

Benign neoplasm: Rectum, anus and anal canal

164

1324

1.24

1.99

1.3

1.4

45.80

22.72

e6/l

0.41

111

1047

Habitual aborter

171

1.72

1.99

1.2

1.5

26.67

23.34

e6/l

0.07

139

Ischaemic heart disease, wide definition

809

4591

1.10

1.99

1.3

1.4

13.63

33.34

e6/l

3.42

652

3496

Benign neoplasm: Sigmoid colon

151

1208

1.26

1.99

1.4

1.3

28.99

23.55

e6/l

0.11

114

950

Injuries to unspecified part of trunk, limb or body region

716

1.33

1.98

1.3

1.5

28.25

26.48

e6/l

0.03

548

Nonspecific lymphadenitis

461

1.42

1.97

1.9

1.4

28.31

14.22

e6/l

0.42

362

Benign neoplasm: Other/unspecified site

1.97

1.4

1.1

11.21

12.80

e6/l

0.07

Follow-up care involving plastic surgery

243

0.45

1.97

1.5

1.4

0.40

48.62

e6/l

—

183

Hypertrophy of breast

176

1435

1.23

1.96

1.4

1.3

6.13

33.29

e6/l

2.38

138

1089

Ulcer of oesophagus

445

1.43

1.96

1.3

6.02

29.68

e6/l

1.08

352

Examination and encounter for administrative purposes

203

1.64

1.93

1.3

1.4

13.23

31.76

e6/l

0.48

148

Additional codes for the location of defect, injury or illness

405

1.44

1.93

1.3

1.4

64.26

30.48

e6/l

0.24

318

Dysplasia of cervi uteri

263

1721

1.19

1.92

1.2

1.3

85.96

25.66

e6/l

0.65

202

1355

Other puerperal infections

694

1.33

1.92

1.2

1.3

23.49

20.24

e6/l

0.08

536

Hyperkinetic disorders (excl. ADHD)

164

1.72

1.91

1.4

3.2

67.67

12.94

e6/l

0.73

120

Ulcerative colitis

258

2187

1.18

1.91

1.3

1.4

60.68

25.03

e6/l

0.36

197

1671

Myocardial infarction

374

3077

0.87

1.90

1.3

1.4

17.20

33.04

e6/l

1.16

308

2365

Systemic sclerosis, icd10

166

1.71

1.89

1.2

2.43

16.90

e6/l

1.35

126

Dermatitis herpetiformis

114

1.87

1.89

1.5

1.4

47.63

12.02

e6/l

0.38

DVT of lower extremities

164

1333

1.23

1.89

1.3

1.4

43.17

22.44

e6/l

0.33

133

1028

Congenital malformations of spine and bony thorax

2.47

1.88

1.2

3.6

1.18

3.20

e6/l

1.30

Burns and corrosions confined to eye and internal organs

197

1.64

1.88

1.7

1.6

13.52

9.46

e6/l

0.20

153

Malignant neoplasm of mesothelium and soft tissue

276

1.54

1.88

1.1

1.3

34.16

40.70

e6/l

0.08

214

Evidence of alcohol involvement determined by level of intoxication

2.07

1.88

1.4

1.3

8.55

9.03

e6/l

0.03

Hereditary retinal dystrophy

100

1.93

1.87

1.3

1.7

3.00

6.89

e6/l

0.65

Hyperparathyroidism

143

1132

1.25

1.87

1.3

1.4

32.69

38.25

e6/l

0.11

106

877

Personal history of certain other diseases

144

1.76

1.87

1.6

1.5

9.41

25.70

e6/l

0.51

115

Fracture of femur

193

1456

1.21

1.87

1.5

1.4

22.13

21.81

e6/l

0.01

161

1128

Other lesions of median nerve

159

1.72

1.86

1.0

1.2

42.19

7.61

e6/l

0.40

121

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

625

0.67

1.86

1.0

1.3

4.23

26.64

e6/l

1.32

487

Other diseases of pericardium

301

1.51

1.86

1.6

5.15

20.00

e6/l

0.79

241

Allergic rhinitis

361

3117

1.15

1.86

1.3

1.6

21.83

27.53

e6/l

0.21

284

2388

Nasal polyp

181

1490

1.22

1.85

1.2

1.4

26.25

27.29

e6/l

0.02

145

1141

Superficial injury of neck

137

1.78

1.85

1.2

1.5

3.63

9.08

e6/l

1.11

110

ILD, hospital admissions 3, with pneumonia sepsis

442

1.41

1.84

1.1

1.4

24.87

23.95

e6/l

0.02

344

Psoriatic arthropathies

751

1.31

1.84

1.3

1.5

26.27

17.73

e6/l

0.29

576

Retinal breaks without detachment

144

1158

1.25

1.84

1.3

1.4

32.81

36.79

e6/l

0.07

106

886

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

611

0.67

1.84

1.0

1.3

4.33

27.22

e6/l

1.31

476

Primary open-angle glaucoma, strict

196

1624

1.21

1.83

1.5

1.3

17.08

33.24

e6/l

0.76

155

1262

Benign neoplasm: Other and unspecified parts of mouth

230

1.58

1.83

1.3

1.2

18.80

26.48

e6/l

0.20

180

Benign neoplasm: Other and unspecified parts of mouth

230

1.58

1.83

1.3

1.2

18.80

43.46

e6/l

0.46

188

Other disorders of male genital organs

246

1.56

1.82

1.3

1.5

8.48

28.48

e6/l

0.79

192

Radial styloid tenosynovitis [de Quervain]

360

1.45

1.82

1.4

10.88

16.52

e6/l

0.33

270

Atrial fibrillation and flutter with reimbursement

232

1249

1.19

1.81

1.4

1.3

41.72

23.85

e6/l

0.30

163

925

Prepatellar bursitis

295

1.50

1.81

1.2

1.4

90.31

33.71

e6/l

0.32

230

Other disorders of breast

126

1001

1.27

1.80

1.3

6.50

22.34

e6/l

3.54

749

Malignant melanoma of skin

754

1.31

1.80

1.3

1.4

9.32

23.90

e6/l

1.01

581

Recurrent dislocation and subluxation of joint

555

1.36

1.79

1.3

1.6

16.85

12.49

e6/l

0.23

430

Inflammatory disorders of breast

496

1.38

1.79

1.2

1.4

4.88

19.67

e6/l

1.89

378

Systemic sclerosis,strict definition

2.14

1.78

1.2

1.1

3.00

4.20

e6/l

—

Polypectomy (DHB20)

488

1.38

1.78

1.3

1.4

3.37

25.06

e6/l

1.11

384

Seborrhoeic keratosis

186

1543

1.21

1.77

1.5

1.4

51.49

33.01

e6/l

0.31

142

1205

Open wound of forearm

686

1.32

1.77

1.3

1.5

63.91

30.11

e6/l

0.35

529

Pneumonia due to Streptococcus pneumoniae

264

1.53

1.77

1.6

1.4

42.12

14.07

e6/l

0.50

209

Endometriosis of rectovaginal septum and vagina

591

1.34

1.77

1.2

1.4

11.37

31.37

e6/l

1.05

467

IBD patients in KELA-register

250

2130

1.18

1.77

1.5

63.70

25.58

e6/l

0.38

191

1632

L02BX Other hormone antagonists and related agents

298

0.53

1.77

1.1

1.4

11.82

39.56

e6/l

0.70

235

Glucosamine medication

435

3072

1.13

1.76

1.4

24.27

32.26

e6/l

0.35

341

2368

Peripheral arterial reconstruction

931

0.74

1.75

1.3

7.34

23.67

e6/l

1.29

710

Polyarthritis, unspecified

257

1.53

1.74

1.3

1.7

13.18

9.02

e6/l

0.23

199

Follicular cysts of skin and subcutaneous tissue

180

1492

1.21

1.74

1.6

1.4

18.73

24.20

e6/l

0.22

154

1138

Biological medication for rheuma

168

1384

1.22

1.73

1.3

1.5

46.48

25.79

e6/l

0.44

127

1050

Achalasia of cardia

103

1.87

1.73

1.2

1.3

2.92

63.94

e6/l

0.67

AV-block

141

1034

1.24

1.73

1.2

1.5

15.41

15.65

e6/l

0.01

115

819

Acne vulgaris

733

1.30

1.72

1.4

1.5

12.81

22.57

e6/l

0.86

569

Other disorders of the genitourinary system

111

874

1.28

1.72

1.4

1.3

126.21

32.99

e6/l

0.39

667

Disorders of oesophagus in diseases classified elsewhere

118

1.80

1.72

2.0

1.2

3.87

56.79

e6/l

0.64

Melanocytic naevi, other sites/unspecified

577

1.34

1.72

1.2

1.3

20.44

27.90

e6/l

0.15

457

Unspecified kidney failure

551

1.35

1.71

1.6

1.3

5.31

25.71

e6/l

1.17

436

Benign neoplasm: Transverse colon

638

1.32

1.71

1.7

1.3

6.45

26.61

e6/l

1.15

501

5-aminosalicylic acid

218

1843

1.19

1.70

1.4

78.18

22.18

e6/l

0.52

166

1398

Embolic stroke

218

1.57

1.70

1.7

1.3

7.07

48.89

e6/l

0.87

171

Diabetes mellitus in pregnancy

379

2158

1.14

1.70

1.3

19.18

28.27

e6/l

0.49

297

1669

Hirsutism in women

141

1.73

1.70

1.2

1.3

28.28

4.65

e6/l

0.71

110

Benign neoplasm: Other/unspecified site

104

1.86

1.69

1.4

1.2

11.21

85.03

e6/l

0.76

Bicipital tendinitis

308

1.47

1.69

1.4

1.3

7.18

34.38

e6/l

0.74

237

Vitamin B12 deficiency anaemia

665

1.31

1.69

1.4

13.49

26.22

e6/l

0.57

521

Primary angle-closure glaucoma

251

1.53

1.69

1.4

1.3

5.12

46.25

e6/l

1.03

194

Sleepwalking [somnambulism]

3.29

1.69

1.3

1.2

0.33

2.21

e6/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

180

1449

1.21

1.68

1.4

2.0

4.72

23.24

e6/l

3.35

136

1103

Mixed specific developmental disorders

219

1.55

1.68

1.8

4.3

8.30

6.96

e6/l

0.07

154

Benign neoplasm: Rectum, anus and anal canal

164

1353

1.22

1.67

1.3

45.80

23.06

e6/l

0.41

111

1034

Pedal cyclist injured in other and unspecified transport accidents

111

878

1.27

1.67

1.4

10.00

26.08

e6/l

1.17

679

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

197

1408

0.84

1.66

1.3

46.92

18.73

e6/l

0.38

142

1098

Parodontitis, under 40 years

110

870

1.27

1.66

1.1

1.5

10.51

24.89

e6/l

1.32

680

Polycystic ovarian syndrome

452

1.38

1.66

1.1

1.3

2.63

22.37

e6/l

2.94

353

Parodontitis, under 40 years, or operation codes

110

871

1.27

1.64

1.1

1.5

10.51

24.85

e6/l

1.32

681

Seronegative rheumatoid arthritis

102

800

1.28

1.64

1.2

1.4

38.83

18.26

e6/l

0.85

615

Combinations of oral blood glucose lowering drugs

259

2229

1.17

1.64

1.4

1.3

33.70

32.55

e6/l

0.03

199

1716

Postprocedural disorders of digestive system, not elsewhere classified

229

1.54

1.63

1.5

1.6

113.21

42.47

e6/l

0.29

178

Cerebral atherosclerosis

2.27

1.63

1.4

1.1

10.33

15.65

e6/l

—

Benign neoplasm: Choroid

394

1.41

1.63

1.7

1.3

8.38

28.19

e6/l

0.70

314

Single delivery by forceps and vacuum extractor

126

952

0.80

1.63

1.2

1.3

25.20

29.16

e6/l

0.10

726

Vasculitis limited to skin, not elsewhere classified

143

1.70

1.62

1.1

1.4

7.43

31.29

e6/l

0.52

112

Angina pectoris

580

3539

1.11

1.62

1.3

1.4

11.69

35.18

e6/l

3.61

463

2695

Psoriasis

277

2399

1.16

1.62

1.2

1.4

18.31

32.77

e6/l

0.93

205

1833

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

2.57

1.62

1.6

1.2

68.00

5.92

e6/l

—

Melanocytic naevi, other sites/unspecified

584

1.33

1.60

1.2

1.4

20.44

30.31

e6/l

0.20

452

Premature rupture of membranes

180

1579

0.84

1.60

1.3

20.76

26.63

e6/l

0.22

141

1230

Presence of cardiac and vascular implants and grafts

310

2684

0.87

1.60

1.3

1.4

34.15

32.74

e6/l

0.02

256

2088

Benign neoplasm: Sigmoid colon

151

1243

1.22

1.59

1.4

1.3

28.99

27.75

e6/l

0.02

114

950

Multiple myeloma, excluding all cancers (controls excluding all cancers)

263

1.49

1.59

1.5

1.3

10.29

39.76

e6/l

0.71

212

Umbilical hernia

256

2208

1.16

1.59

1.4

16.64

25.79

e6/l

0.39

194

1696

Pneumonia derived septicemia

231

1.53

1.58

1.5

1.8

409.29

43.18

e6/l

1.02

186

Bronchitis, not specified as acute or chronic

629

1.31

1.58

1.2

1.5

6.19

24.79

e6/l

1.13

481

Otitis externa

218

1858

1.18

1.58

1.3

1.5

15.49

23.62

e6/l

0.62

172

1426

Other sexually transmitted chlamydial diseases

586

1.32

1.57

1.6

1.5

33.08

20.68

e6/l

0.39

453

Other acquired deformities of musculoskeletal system and connective tissue

330

1.44

1.57

1.3

1.4

5.68

21.03

e6/l

0.87

255

Pedestrian injured in collision with car, pick-up truck or van

160

1.64

1.57

1.2

1.70

11.97

e6/l

1.59

132

Tumor necrosis factor alpha inhibitors

152

1255

1.22

1.57

1.3

1.5

50.89

26.40

e6/l

0.49

115

959

Myocardial infarction, with ST-elevation

1071

0.77

1.56

1.3

32.59

21.88

e6/l

0.21

827

Diabetic nephropathy

124

989

1.24

1.56

1.6

1.4

54.66

20.38

e6/l

0.65

104

753

Lichen ruber planus, wide definition including periferal and oral lichen planus

190

1602

1.19

1.56

1.3

1.4

22.81

33.38

e6/l

0.35

140

1244

Granulomatous disorders of skin and subcutaneous tissue

168

1.62

1.56

1.4

1.3

21.57

7.97

e6/l

0.29

132

Pre-eclampsia

216

1842

1.18

1.56

1.2

1.3

28.61

37.68

e6/l

0.14

176

1415

Burns and corrosions of multiple and unspecified body regions

145

1.67

1.55

3.1

1.2

20.06

10.64

e6/l

0.20

114

Gluteal tendinitis

224

1.53

1.55

1.5

26.07

11.99

e6/l

0.43

169

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

570

1.32

1.55

1.1

1.3

118.72

16.97

e6/l

0.68

446

Tongue abnormality

424

1.38

1.54

1.2

1.5

2.69

33.58

e6/l

1.43

327

Lichen sclerosus et atrophicus

693

1.29

1.54

1.4

1.3

34.13

25.43

e6/l

0.25

525

Entropion and trichiasis of eyelid

458

1.36

1.54

1.2

1.3

61.33

23.28

e6/l

0.33

359

Maternal care for known or suspected abnormality of pelvic organs

284

1702

1.15

1.54

1.3

25.43

27.31

e6/l

0.06

225

1322

Erythema multiforme

161

1.63

1.54

1.7

1.4

2.20

10.48

e6/l

1.15

126

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1213

0.79

1.54

1.4

1.3

18.56

22.91

e6/l

0.13

960

Sulfonylureas

216

2017

0.85

1.53

1.4

1.3

25.10

29.42

e6/l

0.12

167

1573

Osteomyelitis

416

1.38

1.53

1.3

1.4

24.45

32.41

e6/l

0.16

333

ILD, hospital admission 2, with pulmonary infections

519

1.34

1.53

1.1

1.4

23.06

14.52

e6/l

0.26

412

Other abnormal products of conception

360

2118

1.14

1.52

1.2

1.4

27.27

30.77

e6/l

0.14

274

1641

Amiodarone users

621

0.71

1.52

1.4

1.3

46.54

23.87

e6/l

0.33

486

Inflammatory bowel disease, strict (require KELA)

250

2161

1.16

1.52

1.5

1.4

63.70

25.37

e6/l

0.38

191

1657

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

607

1.31

1.52

1.5

1.3

37.98

27.49

e6/l

0.23

473

Haemangioma, any site

607

1.31

1.52

1.4

1.3

8.49

25.59

e6/l

0.97

473

Intestinal adhesions without obstruction

546

1.33

1.51

1.4

1.5

16.39

29.74

e6/l

0.45

422

Pre-eclampsia or poor fetal growth

334

2939

1.14

1.51

1.2

1.3

30.02

29.67

e6/l

0.01

269

2266

Parodontitis, under 40 years and operation codes

104

828

1.26

1.51

1.2

1.5

11.02

20.09

e6/l

1.07

647

Melanoma in situ

250

1.49

1.51

1.1

1.3

10.62

44.30

e6/l

0.76

196

Pedal cyclist injured in transport accident

226

1940

1.17

1.51

1.4

1.5

17.22

23.27

e6/l

0.31

171

1500

Palmar fascial fibromatosis [Dupuytren]

116

935

1.24

1.51

1.4

1.3

77.24

21.29

e6/l

0.71

724

Injury of nerves at lower leg level

2.04

1.50

1.0

1.1

2.86

7.64

e6/l

—

Dissocial personality disorder

101

1.81

1.50

2.9

1.2

6.50

18.77

e6/l

0.66

Parodontitis, operation under 40 years and operation codes

104

829

1.26

1.50

1.2

1.5

11.02

20.06

e6/l

1.07

648

Nontoxic goitre/thyroid nodule

267

2322

1.15

1.50

1.3

1.4

28.00

29.66

e6/l

0.03

204

1804

Benign neoplasm: Choroid

401

1.38

1.50

1.7

1.4

8.38

34.52

e6/l

1.01

311

Conductive hearing loss, unspecified

626

1.30

1.49

1.9

1.6

53.55

32.04

e6/l

0.31

479

Other endocrine disorders

460

1.35

1.49

2.6

2.9

10.55

12.47

e6/l

0.13

339

Melanoma in situ

251

1.49

1.1

1.3

10.62

39.47

e6/l

0.64

202

LSIL lesion of the cervix uteri, vagina or vulva

150

1245

1.21

1.48

1.5

1.3

60.07

24.02

e6/l

0.71

112

962

Benign neoplasm: Rectum

143

1181

1.22

1.48

1.3

54.16

21.19

e6/l

0.53

928

Prolonged pregnancy

119

1334

0.81

1.48

1.5

1.3

6.21

27.75

e6/l

1.57

1049

Endometriosis diagnosis and infertility diagnosis occurring together

116

938

1.24

1.48

1.4

1.3

20.97

22.52

e6/l

0.05

733

Intercostal neuropathy

2.27

1.48

1.1

1.3

4.40

4.21

e6/l

—

Glomerular disorders in diseases classified elsewhere

104

831

1.26

1.47

1.5

1.4

20.27

23.73

e6/l

0.11

648

Melanocytic naevi of lower limb, including hip

318

1.43

1.47

1.4

1.3

20.62

35.86

e6/l

0.28

256

Congenital deformities of feet

187

1.57

1.47

1.7

1.9

2.95

10.24

e6/l

0.90

140

Hordeolum and other deep inflammation of eyelid

394

1.38

1.47

2.3

1.5

18.90

30.21

e6/l

0.24

305

Lichen planus, including avohilmo

162

1356

1.20

1.47

1.3

1.4

23.80

34.01

e6/l

0.28

122

1049

Injury of nerves at wrist and hand level

260

1.47

1.5

1.3

41.04

26.10

e6/l

0.24

204

Diseases of external ear

322

2842

1.14

1.46

1.5

14.89

26.99

e6/l

1.06

244

2198

Urethral stricture

319

1.42

1.44

1.2

1.4

1.96

37.70

e6/l

1.23

251

Suggestive for eosinophilic asthma

665

1.28

1.44

1.2

1.3

48.06

24.03

e6/l

0.27

512

Scoliosis

586

1.30

1.43

1.9

1.7

19.73

24.84

e6/l

0.12

449

Primary open-angle glaucoma

236

1990

1.16

1.42

1.5

1.3

14.61

31.44

e6/l

1.06

190

1561

Spontaneous rupture of synovium and tendon

517

1.32

1.42

1.4

1.3

14.35

31.36

e6/l

0.61

391

Valvular operations

999

0.78

1.42

1.2

1.6

300.59

16.28

e6/l

0.96

771

Injury of urinary and pelvic organs

126

1.69

1.41

1.8

1.4

1.75

5.66

e6/l

1.06

104

Haemolytic anaemias

246

1.48

1.41

1.4

1.7

2.92

41.19

e6/l

0.95

196

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

120

980

1.23

1.41

1.4

1.3

8.68

25.05

e6/l

1.34

759

Anxious personality disorder

134

1.66

1.40

1.3

1.2

1.69

8.66

e6/l

1.74

104

Other and unspecified vasculitis limited to skin

134

1.66

1.40

1.1

1.4

7.85

33.24

e6/l

0.51

104

Lesion of sciatic nerve

238

1.48

1.40

1.2

8.17

32.40

e6/l

0.56

188

Bacterial, viral and other infectious agents

722

1.27

1.39

1.3

1.6

6.20

28.23

e6/l

1.61

550

Hereditary spherocytosis

2.71

1.39

1.5

1.1

0.50

3.00

e6/l

—

Alopecia areata

198

1.53

1.39

1.1

1.7

14.65

3.82

e6/l

0.48

148

Nontoxic diffuse goitre

198

1.53

1.38

1.5

6.80

14.04

e6/l

0.55

151

Postmenopausal bleeding

261

1247

1.15

1.38

1.4

18.35

29.69

e6/l

0.73

189

981

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.06

1.38

2.0

1.0

4.20

4.64

e6/l

—

Chromosomal abnormalities, not elsewhere classified

190

1.54

1.37

1.4

3.7

4.15

10.87

e6/l

0.70

135

Peritonsillar abscess

222

1920

1.16

1.37

1.4

32.18

23.80

e6/l

0.23

173

1475

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

627

4692

1.09

1.37

1.3

55.45

27.32

e6/l

0.64

471

3631

Chronic ulcer of skin, not elsewhere classified

425

1.35

1.37

1.3

1.4

2.95

32.59

e6/l

1.41

336

Assault by unspecified means

151

1.61

1.36

1.4

10.00

15.48

e6/l

0.25

119

All dysplastic lesions of the vulva

315

1.41

1.36

2.0

1.4

23.56

12.57

e6/l

0.28

237

Unspecified human immunodeficiency virus [HIV] disease

1.95

1.35

2.5

1.4

31.13

7.53

e6/l

—

Melanocytic naevi of lower limb, including hip

324

1.40

1.35

1.4

1.6

20.62

12.30

e6/l

0.22

250

Sequelae of infectious and parasitic diseases

531

1.31

1.34

1.7

1.4

25.13

28.74

e6/l

0.08

409

Persons encountering health services in circumstances related to reproduction

685

4276

1.09

1.33

1.5

21.03

36.88

e6/l

1.32

526

3230

Other and unspecified follicular disorders

283

1.43

1.32

1.2

1.3

21.63

40.85

e6/l

0.33

223

Other orthopaedic follow-up care

359

1.37

1.32

1.2

1.5

9.63

38.88

e6/l

0.93

272

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

283

1.42

1.32

1.1

1.3

29.61

38.18

e6/l

0.11

224

Haemangioma and lymphangioma, any site

656

1.27

1.32

1.4

1.3

8.67

25.65

e6/l

1.06

511

Pneumococcal septicemia

225

1.48

1.32

1.5

1.8

424.37

44.47

e6/l

1.02

177

Lichen simplex chronicus and prurigo

428

1.34

1.32

1.5

1.3

76.29

32.94

e6/l

0.32

332

Abnormal findings on examination of urine, without diagnosis

300

1.41

1.32

1.5

1.6

102.26

38.13

e6/l

0.44

235

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

213

1504

0.86

1.31

1.3

43.27

18.83

e6/l

0.36

157

1173

Congenital malformations of the respiratory system

153

1.59

1.30

1.3

3.5

65.83

5.80

e6/l

0.61

111

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

513

3190

1.10

1.30

1.3

1.4

70.28

25.89

e6/l

0.70

384

2504

Marasmic kwashiorkor

2.89

1.30

1.6

1.9

602.80

1.54

e6/l

—

Macular pucker

113

927

1.22

1.29

1.3

1.4

17.52

31.58

e6/l

0.70

704

Superficial injury of ankle and foot

126

1046

1.21

1.29

1.7

1.6

110.95

25.63

e6/l

0.45

103

795

Other factor of the environment

1.81

1.28

1.7

1.2

115.13

10.38

e6/l

—

Mantle cell lymphoma

2.08

1.28

1.2

1.4

12.22

17.68

e6/l

—

Nontoxic multinodular goitre

167

1423

1.18

1.27

1.3

1.4

37.92

34.22

e6/l

0.04

127

1100

Retinal haemorrhage

146

1.59

1.27

2.8

1.2

2.11

34.12

e6/l

0.87

117

Carbimazole or st.post thyroidectomy, condition for graves disease

196

1693

1.16

1.26

1.5

1.3

57.62

30.18

e6/l

0.42

140

1302

Ankyloglossia

162

1.56

1.26

2.4

3.6

6.26

5.98

e6/l

0.03

119

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

458

1.32

1.26

1.6

1.3

17.26

26.95

e6/l

0.24

361

Gout, idiopatic and unspecified

187

1610

1.16

1.25

1.3

93.31

22.35

e6/l

0.56

141

1250

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

590

1.28

1.25

1.1

1.4

118.72

20.06

e6/l

0.66

454

Spermatocele

423

1.33

1.25

1.6

1.3

21.69

26.56

e6/l

0.11

333

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

432

1.33

1.25

1.1

1.3

49.37

28.44

e6/l

0.33

341

Dislocation, sprain and strain of joints and ligaments of elbow

511

1.30

1.25

1.8

1.9

13.33

21.01

e6/l

0.41

384

Endometriosis of ovary

172

1469

1.17

1.24

1.4

1.3

43.79

27.49

e6/l

0.30

135

1159

Spondylopathies in diseases classified elsewhere

1.93

1.24

1.2

27.50

17.59

e6/l

—

Intentional self-harm by smoke, fire and flames

2.76

1.24

1.4

0.20

1.69

e6/l

—

Benign neoplasm: Rectum

143

1207

1.19

1.23

1.3

54.16

24.74

e6/l

0.45

923

Convalescence

347

1.36

1.23

1.4

65.61

38.46

e6/l

0.22

259

Postpartum haemorrhage due to anatomy

933

0.79

1.23

1.2

1.3

17.59

21.59

e6/l

0.14

728

Fibrosis of liver

2.20

1.22

2.3

1.1

28.63

5.50

e6/l

—

Carcinoma in situ of breast, intraductal

606

0.74

1.22

1.4

1.3

49.41

23.05

e6/l

0.31

454

Other bullous disorders

180

1.51

1.22

1.4

1.6

36.81

10.84

e6/l

0.36

141

Other diseases of stomach and duodenum

417

1.33

1.21

1.6

1.5

20.07

34.05

e6/l

0.27

319

Benign neoplasm of mouth and pharynx

763

1.24

1.21

1.3

22.62

24.97

e6/l

0.07

588

Multiple myeloma and malignant plasma cell neoplasms

263

1.42

1.21

1.5

1.3

10.90

39.75

e6/l

0.68

212

Female infertility, tubal origin

374

1.34

1.21

1.2

1.4

22.45

28.84

e6/l

0.12

297

Other diseases of peritoneum

297

1.39

1.21

1.2

1.5

1.65

35.90

e6/l

1.23

231

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

541

1.28

1.20

1.4

1.3

41.82

29.39

e6/l

0.25

422

Hyperaldosteronism

189

1.50

1.20

2.1

1.5

11.24

26.82

e6/l

0.42

145

Molar incisor enamel hypoplasia

292

1.39

1.19

8.4

2.8

4.37

15.65

e6/l

0.77

220

Need for immunization against single bacterial diseases

0.00

1.19

0.0

4.3

—

4.21

—

Malignant neoplasm of heart, mediastinum and pleura

1.90

1.19

2.4

1.2

47.71

14.22

e6/l

—

Adjustment and management of implanted device

127

1065

1.20

1.18

1.2

1.4

6.89

20.85

e6/l

1.46

827

Other disorders of gingiva or/and edentulous alveolar ridge

324

1.37

1.18

1.4

1.6

4.64

46.88

e6/l

1.48

256

Certain conditions originating in the perinatal period

103

750

1.22

1.18

3.0

2.1

18.63

16.62

e6/l

0.07

570

Benign neoplasm: Transverse colon

676

1.25

1.18

1.7

1.4

6.45

23.87

e6/l

1.18

523

Benign neoplasm of major salivary glands

658

1.25

1.18

1.3

21.85

22.94

e6/l

0.03

514

Graves disease, strict definition

775

1.23

1.18

1.7

1.4

17.80

21.00

e6/l

0.15

593

Atrioventricular septal defect

0.00

1.18

0.0

4.3

—

3.35

—

Fall on and from ladder

516

1.29

1.17

1.2

1.3

6.20

25.95

e6/l

0.99

402

Other and unspecified abdominal hernia

248

1.42

1.17

1.3

1.4

26.79

23.40

e6/l

0.05

198

Abnormal spermatozoa

737

0.77

1.17

1.2

1.3

7.85

25.20

e6/l

0.96

566

Haemangioma, any site

632

1.26

1.17

1.4

1.6

8.49

27.60

e6/l

1.18

486

Iron deficiency anaemia secondary to blood loss (chronic)

127

1067

1.19

1.16

1.5

1.4

13.63

25.88

e6/l

0.68

821

Oesophagitis

342

1.35

1.16

1.3

1.4

2.41

36.72

e6/l

1.29

270

Emphysema

420

1.32

1.16

1.6

1.4

4.63

28.26

e6/l

0.99

332

Other (seronegative) rheumatoid arthritis, wide

165

1418

1.17

1.16

1.2

1.4

31.43

24.57

e6/l

0.27

123

1108

Gestational diabetes (for exclusion)

418

2687

1.10

1.16

1.3

15.37

26.97

e6/l

1.10

324

2094

Acute epiglottitis

1.74

1.16

1.3

1.2

26.75

5.63

e6/l

—

Ulcerative colitis, NAS

138

1169

1.18

1.16

1.3

1.5

24.05

23.77

e6/l

0.01

108

906

Complications following myocardial infarction

0.00

1.16

0.0

1.2

—

2.33

—

Ankylosing spondylitis, strict definition

334

1.36

1.16

1.5

1.4

31.63

13.01

e6/l

0.39

262

Sequelae of other and unspecified infectious and parasitic diseases

412

1.32

1.15

1.7

1.4

32.59

23.14

e6/l

0.22

316

Artificial opening status

360

1.34

1.15

1.9

1.7

34.38

34.84

e6/l

0.01

270

Complications associated with artificial fertilization

142

1.57

1.15

1.3

1.6

14.47

26.30

e6/l

0.48

119

Other and unspecified psoriasis

465

1.30

1.15

1.3

1.5

9.79

28.83

e6/l

0.76

355

Supervision of high-risk pregnancy

239

1271

1.14

1.2

1.3

26.34

30.14

e6/l

0.11

186

967

Viral warts

787

1.22

1.14

1.3

1.6

23.70

27.82

e6/l

0.10

607

Dental caries 2

911

6716

1.07

1.14

1.8

1.4

48.85

26.66

e6/l

0.67

675

5206

Skin changes due to chronic exposure to nonionizing radiation

283

2388

1.12

1.14

1.3

30.18

33.05

e6/l

0.07

210

1888

Other and/or unspecified nontoxic goitre

554

1.27

1.14

1.3

1.4

9.76

29.09

e6/l

1.27

417

Bronchiectasis

492

1.29

1.14

1.3

1.5

10.02

25.05

e6/l

0.62

386

Other and unspecified disorders of orbit

2.39

1.13

1.7

1.0

125.00

3.40

e6/l

—

Injury of intra-abdominal organs

175

1.50

1.13

1.7

1.4

1.95

15.88

e6/l

1.68

142

Oral leukoplakia

113

0.44

1.13

1.2

18.80

21.68

e6/l

—

Obstructed labour due to maternal pelvic abnormality

144

1227

1.18

1.13

1.3

17.15

50.72

e6/l

1.34

104

940

Other bursitis of hip

103

1.67

1.13

1.2

1.3

3.64

47.82

e6/l

0.74

Corneal scars and opacities

167

1.51

1.13

2.1

1.5

42.70

7.83

e6/l

0.58

129

LSIL lesion of the vulva

225

1.44

1.13

2.4

1.4

8.62

13.72

e6/l

0.37

169

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

246

0.61

1.13

1.3

0.80

44.11

e6/l

—

196

Multiple myeloma and malignant plasma cell neoplasms

267

1.39

1.13

1.5

1.3

10.90

42.71

e6/l

0.77

211

Atopic conjunctivitis

327

1.35

1.13

1.1

1.8

46.69

20.32

e6/l

0.26

250

Other interventions on the root canals of the tooth

127

1.59

1.12

1.4

1.5

1.09

11.83

e6/l

1.28

104

Contact with sharp object, undetermined intent

143

1.55

1.12

1.4

1.3

7.81

11.82

e6/l

0.24

113

Deep endometriosis

753

1.23

1.12

1.2

1.3

10.19

23.68

e6/l

0.93

565

Other diseases of lip and oral mucosa

142

1210

1.18

1.12

1.7

1.4

38.20

32.03

e6/l

0.11

109

935

Bursitis of shoulder

143

1.55

1.12

2.3

1.2

2.94

29.49

e6/l

0.58

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

467

1.29

1.12

1.6

1.4

17.26

28.90

e6/l

0.30

362

Dental caries 2 and operation codes

894

6666

1.07

1.12

1.7

1.4

49.56

26.49

e6/l

0.70

669

5163

Simple and mucopurulent chronic bronchitis

259

1.40

1.12

1.8

1.9

2.93

36.54

e6/l

0.87

209

Atrial septal defect

343

1.34

1.11

1.5

3.1

2.06

7.48

e6/l

1.68

260

Chronic nephritic syndrome

268

1.39

1.11

1.7

1.4

11.42

42.97

e6/l

0.71

207

Polycystic ovarian syndrome, broad definition

120

1009

1.19

1.11

1.2

1.3

5.89

19.92

e6/l

2.84

789

Hallux rigidus

115

963

1.20

1.11

1.3

1.4

46.05

22.03

e6/l

0.40

737

Degeneration of macula and posterior pole

361

2694

1.11

1.3

1.4

43.39

34.29

e6/l

0.10

262

2123

Congenital deformities of hip

168

1.50

1.11

3.0

2.7

51.87

3.82

e6/l

0.68

128

Endometriosis ASRM stages 3,4

228

2014

1.14

1.10

1.3

32.98

29.99

e6/l

0.06

184

1551

Disorders resulting from impaired renal tubular function

243

1.41

1.10

1.4

1.5

5.53

22.00

e6/l

0.65

188

Benign neoplasm of ovary

152

1305

1.17

1.10

1.3

1.4

8.27

27.30

e6/l

1.89

110

1022

Other or ill-defined heart diseases

363

1.33

1.10

2.4

1.4

11.16

21.26

e6/l

0.48

292

Hair colour and hair shaft abnormalities

2.43

1.10

1.2

1.00

2.86

e6/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

638

1.24

1.09

1.4

1.3

21.12

21.63

e6/l

0.02

500

Other disorders of conjunctiva

117

983

1.19

1.09

1.2

1.4

7.89

21.58

e6/l

1.46

762

Other endophthalmitis

2.24

1.09

1.1

1.7

3.29

23.52

e6/l

—

Malignant neoplasm of skin

525

3641

1.09

1.3

1.4

69.56

25.41

e6/l

0.71

391

2851

Carcinoma in situ of skin of other and unspecified parts of face

381

1.32

1.09

1.2

1.3

27.00

33.53

e6/l

0.12

313

Opening and dilatation of root channel of tooth

487

1.28

1.08

1.2

1.4

22.10

24.25

e6/l

0.05

380

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

152

1693

0.86

1.07

1.5

1.4

26.44

32.68

e6/l

0.18

104

1327

COPD, early/later onset

312

2920

0.90

1.07

1.4

27.05

29.60

e6/l

0.06

239

2278

Exposure to other and unspecified animate mechanical forces

211

1.43

1.07

1.2

1.6

45.82

6.79

e6/l

0.46

163

LSIL lesion of the cervix uteri

117

986

1.19

1.07

1.2

1.3

74.03

21.56

e6/l

0.84

767

Crohn's disease of large intestine

409

1.30

1.07

1.1

1.6

3.51

25.03

e6/l

1.80

320

Lactose intolerance, other/unspecified

186

1.46

1.06

1.2

1.7

1.73

6.59

e6/l

2.14

143

Benign neoplasm of ovary

152

1309

1.16

1.06

1.3

1.4

8.27

39.23

e6/l

1.95

110

1013

Other superficial mycoses

137

1.55

1.06

1.1

1.5

2.93

11.56

e6/l

0.99

110

Presence of other devices

178

1550

1.15

1.06

1.5

1.4

13.03

25.34

e6/l

1.15

145

1217

Other osteochondropathies

569

1.25

1.06

1.6

1.5

27.78

27.83

e6/l

0.00

436

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

229

2030

1.13

1.06

1.4

1.3

11.03

32.98

e6/l

1.84

180

1558

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.73

1.06

1.4

1.3

1.88

3.06

e6/l

—

Burn and corrosion confined to eye and adnexa

170

1.48

1.05

1.2

1.6

7.20

5.10

e6/l

0.28

132

Single delivery by caesarean section

169

1126

0.87

1.05

1.6

1.3

41.48

29.57

e6/l

0.26

136

850

Chondrosarcoma

2.34

1.04

1.8

1.1

353.80

3.35

e6/l

—

Other aneurysm

323

1.34

1.04

2.2

1.4

20.71

38.47

e6/l

0.39

254

Bullous disorders

367

1.32

1.04

1.4

1.5

22.95

32.46

e6/l

0.16

288

Family history of certain disabilities and chronic diseases leading to disablement

341

1.33

1.03

1.2

1.5

121.70

21.94

e6/l

0.41

264

Anoxic brain damage

1.85

1.03

1.3

1.73

9.17

e6/l

0.88

Benign neoplasm: Descending colon

420

1.29

1.03

1.2

1.4

5.37

27.41

e6/l

0.89

327

Subacute thyroiditis

238

1.40

1.03

1.5

1.4

97.44

13.09

e6/l

0.43

175

Unspecified parasitic disease

1.94

1.03

1.2

1.3

1.56

24.65

e6/l

—

Seropositive rheumatoid arthritis, wide

235

2092

1.13

1.02

1.3

1.4

28.82

31.88

e6/l

0.10

185

1630

Benign neoplasm of mouth and pharynx

780

1.21

1.02

1.3

1.4

22.63

23.96

e6/l

0.04

598

Puerperal sepsis

123

1046

1.18

1.02

1.3

13.87

37.45

e6/l

0.97

790

Cyst of kidney

430

1.29

1.01

1.3

44.12

33.16

e6/l

0.13

335

Gout, unspecified

148

1278

1.16

1.01

1.4

1.3

37.96

17.32

e6/l

0.44

112

997

Family history of malignant neoplasm

864

0.81

1.01

1.3

7.16

28.06

e6/l

2.69

660

Gout due to impairment of renal function

1.90

1.01

1.0

1.2

0.56

4.13

e6/l

—

Other and unspecified papulosquamous disorders

2.03

1.01

1.4

1.3

1.00

3.67

e6/l

—

Early onset COPD

195

1718

1.14

1.01

1.5

1.4

13.03

25.04

e6/l

1.01

152

1309

Dental caries 3 and operation codes, only avohilmo

391

1790

1.10

1.00

1.5

1.7

25.76

41.19

e6/l

0.57

302

1430

Benign neoplasm: Colon, unspecified

189

1654

1.14

1.00

1.4

18.10

26.35

e6/l

0.46

153

1296

Congenital malformations of heart and great arteries

136

1131

1.17

1.00

1.5

2.1

5.62

23.40

e6/l

2.16

104

858

Ectropion of eyelid

172

1.46

1.00

1.3

145.71

35.70

e6/l

0.34

137

Lung transplant status

1.87

0.99

2.2

2.0

6.44

10.08

e6/l

—

Lung transplantation

1.87

0.99

2.2

2.0

6.44

10.08

e6/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

184

1617

1.14

0.99

1.4

1.3

20.40

23.66

e6/l

0.18

139

1245

Flat foot [pes planus] (acquired)

665

1.22

0.99

1.4

1.5

159.22

20.64

e6/l

0.46

508

Neuroendocrine tumor and carcinoma of stomach

0.00

0.99

0.0

1.1

—

1.90

—

Dislocation, sprain and strain of joints and ligaments of head

318

1.33

0.98

2.0

30.29

19.56

e6/l

0.25

249

Infective bursitis

173

1.46

0.98

1.4

1.3

10.21

53.98

e6/l

0.67

134

Type 1 diabetes, strict definition, subgroup 2

0.00

0.98

0.0

4.0

—

3.19

—

Hypothermia

100

1.62

0.97

1.1

1.4

0.80

14.60

e6/l

—

Gingival hyperplasia

224

1.39

0.97

1.6

1.7

4.96

49.70

e6/l

1.01

176

Chronic periodontitis, complicated

676

1.22

0.97

1.6

1.4

10.82

24.02

e6/l

0.66

528

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

469

1.26

0.96

1.5

1.3

52.59

30.25

e6/l

0.39

367

Carcinoma in situ of breast, intraductal

581

0.77

0.96

1.4

1.3

49.41

22.54

e6/l

0.32

446

Lifestyle-related condition

1.71

0.96

1.8

1.2

131.57

2.27

e6/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

120

1025

1.17

0.96

1.4

8.68

23.82

e6/l

1.37

780

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

550

1.24

0.96

1.9

1.4

18.73

28.46

e6/l

0.35

436

Disorders of eyelid in diseases classified elsewhere

216

1.40

0.96

1.4

5.95

12.57

e6/l

0.53

176

Hallux valgus (acquired)

313

2054

1.10

0.95

1.4

68.39

30.52

e6/l

0.47

258

1569

Unspecified jaundice

276

1.35

0.95

1.1

1.6

13.89

42.74

e6/l

0.70

219

COPD, hospital admissions

311

2895

0.91

0.95

1.4

27.16

29.72

e6/l

0.07

238

2263

Benign neoplasm: Ill-defined sites within the digestive system

1.92

0.95

1.1

0.57

2.39

e6/l

—

Other and unspecified nail disorders

125

1.53

0.94

1.3

7.77

9.03

e6/l

0.07

100

Use of ropinirole

251

1.36

0.94

1.4

1.3

2.61

45.96

e6/l

1.11

194

Laparoscopic right hemicolectomy

340

0.70

0.94

2.2

1.3

8.13

39.16

e6/l

1.01

265

Seborrhoeic dermatitis

669

1.22

0.94

1.5

1.4

9.62

24.39

e6/l

0.87

521

Carcinoma in situ of skin of other and unspecified parts of face

391

1.28

0.93

1.2

1.3

27.00

33.00

e6/l

0.11

314

Chalazion

103

871

1.19

0.93

1.3

1.4

23.67

24.23

e6/l

0.02

667

Other and unspecified glaucoma

391

1.28

0.93

1.6

1.3

68.05

32.08

e6/l

0.23

306

Contraceptive management

474

3084

1.08

0.92

1.3

1.4

29.49

37.55

e6/l

0.32

387

2329

Rhinophyma

2.18

0.92

1.8

1.3

1.17

6.00

e6/l

—

Lactose intolerance

218

1.39

0.92

1.4

1.7

4.88

7.51

e6/l

0.38

172

Total colectomy operation

287

1.33

0.92

1.1

1.6

52.90

22.50

e6/l

0.29

224

Total colectomy

287

1.33

0.92

1.1

1.6

52.90

22.50

e6/l

0.29

224

Maternal care for known or suspected malpresentation of fetus

159

1352

0.87

0.91

1.3

26.27

27.87

e6/l

0.04

123

1061

Actinic keratosis

269

2308

1.11

0.91

1.3

30.88

33.65

e6/l

0.06

200

1822

Other pleural conditions

599

1.22

0.91

1.5

1.4

41.07

26.02

e6/l

0.19

466

Foreign body entering into or through eye or natural orifice

654

1.21

0.91

1.7

1.8

65.27

24.61

e6/l

0.40

500

302

2584

1.10

0.90

1.4

28.70

31.74

e6/l

0.08

225

2040

Benign neoplasm: salivary glands, exclude unknown (D119)

609

1.22

0.90

1.3

1.4

15.22

26.63

e6/l

0.47

472

Maternal care for cervical incompetence

288

1.33

0.90

1.4

1.3

4.23

21.40

e6/l

1.34

220

L02BB Anti-androgens

440

0.75

0.90

1.1

1.3

6.26

36.69

e6/l

1.25

352

Pedal cyclist injured in noncollision transport accidents

108

921

1.18

0.90

1.3

1.6

26.34

25.74

e6/l

0.01

712

All dysplastic lesions of the cervix uteri, vagina or vulva

304

2752

1.10

0.89

1.3

77.06

20.65

e6/l

0.71

230

2129

Other benign neoplasms of connective and other soft tissue

719

1.20

0.89

1.4

1.3

31.81

27.66

e6/l

0.06

565

In situ neoplasms

305

2780

1.10

0.89

1.3

59.24

29.63

e6/l

0.31

227

2172

Melanocytic naevi of other and unspecified parts of face

421

1.26

0.89

1.5

1.3

24.44

31.37

e6/l

0.15

334

Tuberculosis

350

1.29

0.89

1.5

1.3

29.41

36.30

e6/l

0.12

279

Varicose veins of other sites

475

1.25

0.88

1.3

1.6

11.98

29.45

e6/l

0.63

367

Benign neoplasm: Parotid gland

529

1.23

0.88

1.3

16.83

27.13

e6/l

0.34

409

Anorexia

111

1.55

0.88

4.6

1.5

1.53

3.93

e6/l

1.47

Disorders of continuity of bone

711

1.20

0.88

1.7

1.4

5.87

27.28

e6/l

1.67

549

Haemangioma and lymphangioma, any site

693

1.20

0.88

1.4

1.6

8.67

27.04

e6/l

1.25

532

Periodontal disease, other/unspecified

2.05

0.88

1.0

1.7

16.33

2.63

e6/l

—

Chronic tubulo-interstitial nephritis

237

1.36

0.88

1.4

4.08

14.05

e6/l

1.35

188

Myeloproliferative diseases

557

1.23

0.87

1.5

1.4

27.96

28.03

e6/l

0.00

425

Benign neoplasm: Small intestine

255

1.34

0.87

1.5

1.3

18.68

39.53

e6/l

0.38

204

Respiratory tuberculosis

316

1.30

0.87

1.6

1.3

32.19

37.35

e6/l

0.08

249

Respiratory tuberculosis, confirmed and not-confirmed

316

1.30

0.87

1.6

1.3

32.19

37.35

e6/l

0.08

249

Acquired haemolytic anaemia

145

1.46

0.85

1.3

4.92

5.49

e6/l

0.07

122

COPD (mode)

244

1748

1.11

0.85

1.4

33.08

19.93

e6/l

0.32

184

1351

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

104

1.55

0.85

2.1

1.3

37.67

74.44

e6/l

—

Papillary adenocarcinoma of thyroid gland

362

1.28

0.84

1.4

33.04

13.94

e6/l

0.59

276

Other disorders of prostate

179

1.40

0.84

1.4

4.85

29.23

e6/l

0.79

144

Contact with other hot fluids

222

1.36

0.84

1.5

1.9

5.32

11.07

e6/l

0.67

161

Other chronic obstructive pulmonary disease, including avohilmo

396

3559

0.92

0.84

1.4

25.32

31.81

e6/l

0.23

304

2780

Major coronary heart disease event excluding revascularizations

531

3921

0.93

0.84

1.3

1.4

14.50

33.44

e6/l

2.01

439

3008

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

154

1.44

0.84

1.2

1.3

6.13

60.45

e6/l

0.84

127

Chronic lymphocytic leukaemia, helper endpoint

154

1.44

0.84

1.2

1.3

6.12

60.45

e6/l

0.84

127

Benign neoplasm: Descending colon

434

1.25

0.83

1.2

1.4

5.37

32.41

e6/l

1.20

332

Childhood allergy (age < 16)

178

1303

1.13

0.83

1.8

1.9

16.05

20.34

e6/l

0.29

144

993

Other specified disorders of kidney and ureter

214

1.36

0.83

1.2

1.5

109.42

38.53

e6/l

0.51

164

Hidradenitis suppurativa

275

1.32

0.82

1.2

1.4

78.37

12.43

e6/l

0.67

215

Benign neoplasm: Colon, unspecified

189

1689

1.12

0.82

1.4

1.3

18.10

23.27

e6/l

0.30

153

1307

Other blood glucose lowering drugs, excl. Insulins

132

1153

1.15

0.82

1.6

1.3

17.48

26.92

e6/l

0.44

100

876

Postpartum care and examination

159

894

1.14

0.82

1.3

1.2

29.32

31.85

e6/l

0.05

131

687

Follow-up examination after treatment for malignant neoplasms

507

1.23

0.82

1.6

1.4

17.58

27.73

e6/l

0.30

370

Abnormal findings in secretions and smears from cervix uteri vagina vulva

525

3857

1.07

0.82

1.3

52.97

27.60

e6/l

0.49

401

2990

Maternal care related to the fetus and amniotic cavity and possible delivery problems

507

2784

1.07

0.81

1.4

1.3

19.29

31.80

e6/l

0.88

395

2132

Gout, strict definition

123

1070

1.15

0.81

1.3

133.07

18.80

e6/l

0.62

846

Postpartum haemorrhage due to retained placenta

1078

0.85

0.81

1.5

1.3

24.57

23.35

e6/l

0.04

850

Ectopic pregnancy

170

1512

1.13

0.81

1.3

12.07

47.13

e6/l

2.02

128

1163

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.5

—

4.56

—

Other disorders of veins

364

3361

1.08

0.80

1.3

1.4

23.28

32.50

e6/l

0.47

261

2589

Adrenomedullary hyperfunction

0.00

0.80

0.0

1.1

—

2.65

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.80

0.0

1.0

—

2.95

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

1.85

0.80

1.7

1.2

294.83

3.38

e6/l

—

Sickle-cell disorders

0.00

0.80

0.0

1.7

—

3.39

—

Benign neoplasm: Ascending colon

840

1.17

0.79

1.3

16.82

29.07

e6/l

0.51

658

Crushing injury of wrist and hand

1.55

0.79

1.0

1.3

34.33

44.67

e6/l

0.10

Accidental poisoning by and exposure to alcohol

131

1.46

0.79

1.3

1.2

37.07

10.94

e6/l

0.34

Separation of retinal layers (serosa)

286

1.30

0.79

1.2

306.10

41.40

e6/l

0.41

219

Use of selegiline

286

1.30

0.79

1.4

1.3

1.46

40.84

e6/l

1.19

223

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

225

2037

1.11

0.79

1.3

1.4

30.04

32.65

e6/l

0.08

177

1582

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.78

0.0

4.7

—

11.16

—

Interstitial cystitis (chronic), drug-induced

0.00

0.78

0.0

1.0

—

1.30

—

Desensitization to allergens

451

0.77

0.78

1.4

1.9

1.77

18.83

e6/l

2.64

356

Contact with nonpowered hand tool

322

1.28

0.78

1.0

1.4

26.18

35.67

e6/l

0.15

251

Benign neoplasm: Ascending colon

842

1.17

0.77

1.3

16.82

25.81

e6/l

0.38

646

Idiopathic urticaria

157

1.41

0.77

1.2

1.8

37.18

8.63

e6/l

0.36

124

Benign neoplasm of major salivary glands

695

1.18

0.77

1.3

1.4

21.85

26.73

e6/l

0.15

536

Other/unspecified seropositive rheumatoid arthritis

228

2069

1.10

0.77

1.3

1.4

29.55

32.12

e6/l

0.08

180

1612

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.77

0.0

1.2

—

2.45

—

Paget disease

0.00

0.77

0.0

1.1

—

11.82

—

Infective dermatitis

853

1.16

0.76

1.4

47.85

29.07

e6/l

0.26

662

Coxarthrosis, primary

506

4116

1.07

0.76

1.4

29.67

29.06

e6/l

0.02

392

3190

Benign neoplasm: Pancreas

166

1.40

0.76

1.2

8.25

46.64

e6/l

0.62

129

Benign neoplasm: Parotid gland

540

1.21

0.76

1.3

1.4

16.83

28.11

e6/l

0.39

415

Other benign neoplasms of connective and other soft tissue

733

1.18

0.76

1.4

31.81

29.31

e6/l

0.03

564

Other congenital malformations of the digestive system

384

1.25

0.75

2.8

15.11

17.67

e6/l

0.06

290

Benign neoplasm: Caecum

632

1.19

0.75

1.4

1.3

6.37

31.91

e6/l

1.54

489

Toxic effect of other noxious substances eaten as food

2.12

0.75

1.2

1.0

1.60

3.44

e6/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

265

2314

0.91

0.75

1.3

22.24

23.70

e6/l

0.07

213

1800

Wet age-related macular degeneration

828

0.84

0.75

1.5

1.3

162.16

23.85

e6/l

0.42

646

Chronic lymphocytic leukaemia

158

1.40

0.75

1.2

6.13

60.39

e6/l

0.85

128

Use of antiglaucoma preparations and miotics

450

1.23

0.74

1.2

1.3

72.51

29.05

e6/l

0.26

354

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.87

0.74

3.3

2.1

28.29

10.77

e6/l

—

Psoriatic arthropathies, ICD10

837

1.16

0.74

1.3

1.4

26.59

24.67

e6/l

0.05

642

Squamous cell neoplasms and carcinomas of the skin

615

1.19

0.73

1.4

1.3

2.95

26.36

e6/l

1.70

485

Short stature, not elsewhere classified

230

1.31

0.73

4.0

4.6

9.42

15.14

e6/l

0.35

168

Mumps

176

1.37

0.73

1.3

1.4

14.40

11.07

e6/l

0.16

137

Artificial joint re-operation

425

1.23

0.72

1.3

286.92

33.54

e6/l

0.55

320

Foreign body in respiratory tract

380

1.24

0.72

2.4

1.8

24.82

33.21

e6/l

0.12

287

Acute nephritic syndrome

134

1.43

0.72

1.5

1.3

3.86

11.96

e6/l

0.80

107

Other psoriatic arthropathies

812

1.16

0.71

1.3

1.4

27.00

25.27

e6/l

0.04

625

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.96

0.71

1.4

1.1

13.00

2.79

e6/l

—

Antenatal screening

220

1363

0.91

0.71

1.3

11.59

27.14

e6/l

0.77

167

1036

Torsion of testis

143

1.41

0.70

1.4

2.3

87.62

18.74

e6/l

0.37

110

Arthropathic psoriasis

102

888

1.15

0.70

1.3

1.4

26.81

24.36

e6/l

0.07

680

Idiopathic pulmonary fibrosis

410

0.78

0.70

1.1

1.3

10.83

33.36

e6/l

0.79

327

Congenital malformations of the musculoskeletal system, not elsewhere classified

118

1.46

0.70

1.3

2.2

1.33

6.81

e6/l

1.35

Melanocytic naevi of other and unspecified parts of face

436

1.22

0.70

1.5

1.4

24.44

32.65

e6/l

0.20

339

Contact with sharp glass

292

1.27

0.70

1.6

1.4

2.58

15.05

e6/l

2.53

230

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

152

1.39

0.69

1.1

2.4

1.69

6.06

e6/l

1.74

115

Disorders of iron metabolism

1.54

0.69

1.1

1.3

2.50

7.12

e6/l

—

Vasomotor rhinitis (mode)

546

1.19

0.69

1.5

1.4

28.45

27.74

e6/l

0.01

416

Malignant neoplasm of endocrine gland

537

1.20

0.69

1.5

28.64

28.75

e6/l

0.00

415

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.88

0.69

1.4

13.00

2.63

e6/l

—

Benign neoplasm: Ill-defined sites within the digestive system

1.69

0.69

1.1

0.57

3.11

e6/l

—

Drowning and submersion while in natural water

1.88

0.69

1.0

1.4

4.20

2.76

e6/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.69

0.69

1.4

1.3

77.00

3.55

e6/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

222

1.31

0.68

1.4

1.5

13.50

20.16

e6/l

0.32

177

Benign neoplasm: Tonsil

0.54

0.67

1.0

1.1

1.20

38.51

e6/l

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

0.53

0.67

1.6

1.2

11.20

5.01

e6/l

—

Effects of heat and light

1.64

0.67

1.4

1.0

5.29

3.06

e6/l

—

Burn and corrosion of wrist and hand

276

1.27

0.67

1.3

1.5

13.73

11.84

e6/l

0.08

212

Disorders of sphingolipid metabolism and other lipid storage disorders

1.82

0.67

1.2

1.0

1.40

4.04

e6/l

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

906

0.86

0.67

1.2

1.3

6.32

24.36

e6/l

1.56

708

Other and unspecified diseases of spleen

1.81

0.67

1.2

1.4

2.00

12.86

e6/l

—

Benign neoplasm: Connective and other soft tissue of thorax

1.81

0.66

2.0

1.1

2.20

3.42

e6/l

—

Aortic valve malfunction, age under 60 years

756

0.84

0.66

1.7

19.38

23.77

e6/l

0.12

577

Major anomalies of jaw size

206

1.32

0.66

1.3

1.9

4.00

6.51

e6/l

0.43

162

Injury of muscle and tendon at lower leg level

130

1157

1.13

0.66

1.3

1.4

18.09

22.76

e6/l

0.20

887

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

624

1.17

0.64

1.4

1.3

2.95

28.43

e6/l

1.64

500

Benign neoplasm: Connective and other soft tissue of thorax

1.75

0.64

2.0

1.1

2.20

14.16

e6/l

—

Polyp of the female genital tract

319

1723

1.08

0.64

1.4

25.31

26.32

e6/l

0.04

233

1364

Contusion of toe(s) without damage to nail

172

1.35

0.64

2.1

1.5

19.94

12.28

e6/l

0.21

134

In situ neoplasms

305

2702

1.08

0.64

1.3

59.24

28.23

e6/l

0.33

227

2135

Abscess of Bartholin gland

216

1.30

0.64

1.1

1.5

4.73

12.01

e6/l

0.98

167

Inguinal hernia

609

3895

1.06

0.64

1.4

1.5

32.57

30.25

e6/l

0.07

476

3011

Mucosal proctocolitis

121

1075

1.13

0.63

1.3

1.5

25.87

24.83

e6/l

0.02

830

Viral agents as the cause of diseases classified to other chapters

155

1.36

0.63

1.2

1.7

14.63

10.40

e6/l

0.15

124

Hypoparathyroidism

234

1.29

0.63

1.3

1.4

11.50

17.81

e6/l

0.24

178

Dependence on enabling machines and devices, not elsewhere classified

1.50

0.63

3.0

2.9

1.25

3.62

e6/l

—

Other inflammation of vagina/vulva

288

1.26

0.62

1.2

1.5

3.41

19.10

e6/l

1.31

227

Hypoplasia of dental enamel , including avohilmo

276

1.26

0.62

9.6

2.8

4.90

15.72

e6/l

0.67

211

Basal cell carcinoma, including avohilmo

459

3406

1.06

0.62

1.4

75.84

26.63

e6/l

0.70

345

2663

Hypertensive Heart Disease

163

1205

1.11

0.62

1.4

1.3

41.20

22.49

e6/l

0.27

138

936

Motorcycle rider injured in noncollision transport accidents

217

1.30

0.62

1.1

1.6

8.39

18.38

e6/l

0.81

169

Mandibular hypoplasia

1.62

0.62

1.1

2.2

1.88

2.82

e6/l

—

Dental caries 2 and operation codes, only avohilmo

775

5032

0.95

0.62

1.4

1.5

48.05

28.80

e6/l

0.49

572

3935

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

130

1.39

0.61

1.0

1.2

13.15

36.20

e6/l

0.42

100

Multiple myeloma

130

1.39

0.61

1.0

1.2

13.15

36.20

e6/l

0.42

100

Operations 1 for CAVS

0.00

0.61

0.0

4.7

—

3.47

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

598

0.83

0.61

1.4

6.61

20.48

e6/l

1.31

466

Generalized pustular psoriasis

0.00

0.61

0.0

1.5

—

2.93

—

Normotensive glaucoma

499

1.19

0.60

1.4

1.3

25.30

33.01

e6/l

0.15

386

Malignant neoplasm of respiratory system and intrathoracic organs

114

1179

0.89

0.60

1.4

1.3

43.72

24.68

e6/l

0.34

908

Labour and delivery complicated by fetal stress [distress]

235

1701

0.92

0.60

1.2

1.3

16.06

26.91

e6/l

0.66

186

1337

Other and unspecified injuries of thorax

105

1.44

0.60

1.1

1.2

1.10

5.89

e6/l

—

Thyroid crisis or storm

0.00

0.60

0.0

1.2

—

1.87

—

Type1 diabetes, definitions combined, early onset

659

0.84

0.60

2.0

2.2

43.00

16.39

e6/l

0.84

516

Other and unspecified nonscarring hair loss

1.56

0.60

1.3

1.1

4.75

2.33

e6/l

—

Benign neoplasm: Small intestine

272

1.26

0.60

1.5

1.3

18.68

45.86

e6/l

0.55

212

Abnormalities of forces of labour

897

0.87

0.59

1.1

1.3

9.06

40.85

e6/l

1.43

689

Tooth eruption problems

147

1314

1.11

0.59

2.4

1.6

23.79

18.66

e6/l

0.18

113

1016

Other/unspecified rheumatoid arthritis

845

1.14

0.59

1.2

1.3

10.07

31.10

e6/l

1.66

652

Pregnancy, childbirth and the puerperium

291

1413

1.08

0.59

1.4

13.17

34.02

e6/l

1.20

223

1092

Basal cell carcinoma

446

3353

1.06

0.59

1.4

77.38

26.42

e6/l

0.71

338

2618

Special screening examination for neoplasms

201

1.30

0.59

1.5

4.94

22.58

e6/l

0.52

143

Benign neoplasm: Scrotum

0.00

0.59

0.0

1.2

—

6.44

—

Malignant neoplasm of breast, HER-negative

136

1507

0.90

0.58

1.5

1.4

26.43

31.49

e6/l

0.11

1182

Alcohol-induced acute pancreatitis

246

1.27

0.58

1.2

1.3

13.33

42.51

e6/l

0.60

192

Monoarthritis, not elsewhere classified

300

1.24

0.58

1.2

1.5

3.88

8.33

e6/l

0.77

236

Haemorrhagic and haematological disorders of fetus and newborn

218

1.28

0.58

5.7

4.4

40.05

6.21

e6/l

0.42

155

Other disorders of amniotic fluid and membranes

139

1242

1.11

0.58

1.2

1.3

12.81

29.41

e6/l

0.85

108

973

Antepartum haemorrhage, not elsewhere classified

753

1.15

0.58

1.2

1.3

35.37

15.50

e6/l

0.85

580

Malignant neoplasm of small intestine

123

1.39

0.58

1.6

1.2

14.75

38.03

e6/l

0.41

Mild mental retardation

193

1.30

0.58

1.2

2.2

69.63

7.05

e6/l

0.74

150

Sudden idiopathic hearing loss

707

1.15

0.57

1.6

1.3

54.05

26.56

e6/l

0.30

540

Allergic contact dermatitis

124

1113

1.12

0.57

1.2

1.4

12.30

29.58

e6/l

1.24

104

850

Juvenile arthritis (FINNGEN)

397

0.80

0.57

1.4

2.3

28.71

14.29

e6/l

0.33

303

Impacted teeth

165

1683

0.91

0.56

1.4

1.5

16.20

21.08

e6/l

0.28

134

1300

Other respiratory diseases principally affecting the interstitium

123

1104

1.12

0.56

1.2

1.3

84.91

22.94

e6/l

0.54

859

Benign neoplasm: Bronchus and lung

0.56

1.2

2.40

59.42

e6/l

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

218

0.73

0.56

1.1

1.3

21.40

46.59

e6/l

—

175

Malignant neoplasm of thyroid gland

494

1.18

0.56

1.4

29.29

20.30

e6/l

0.27

380

Carcinoma in situ, bladder

195

0.71

0.56

1.8

1.3

18.89

49.46

e6/l

—

157

Colorectal neuroendocrine tumor and carcinoma

0.56

1.6

1.2

11.20

13.34

e6/l

—

D07AA Corticosteroids, weak (group I)

155

1408

1.10

0.56

1.5

1.9

22.38

22.93

e6/l

0.02

125

1079

Disorder of external ear, unspecified

212

1.28

0.56

1.2

1.4

2.91

48.40

e6/l

0.96

166

Seropositive rheumatoid arthritis, strict definition

128

1153

1.11

0.56

1.2

1.3

23.61

24.27

e6/l

0.02

883

Anisometropia and aniseikonia

230

1.27

0.55

1.9

1.8

13.05

13.47

e6/l

0.02

170

Inguinal or femoral hernia, bilateral

681

1.15

0.55

1.3

1.4

18.41

13.67

e6/l

0.20

530

Inguinal hernia, bilateral

672

1.15

0.55

1.3

1.4

18.71

13.83

e6/l

0.20

523

Rheumatic valve diseases

122

0.65

0.55

2.9

1.3

6.38

10.95

e6/l

—

Acne conglobata

1.60

0.55

1.0

1.8

3.17

8.40

e6/l

—

Postpartum haemorrhage

233

2186

0.93

0.54

1.3

25.71

28.04

e6/l

0.07

184

1694

Dental caries 1 and operation codes, only avohilmo

321

1509

1.07

0.54

1.5

1.8

25.96

36.15

e6/l

0.33

246

1220

Calculus of lower urinary tract

312

1.22

0.54

1.4

48.52

35.06

e6/l

0.14

244

Other disorders of Eustachian tube

204

1.28

0.54

1.3

1.4

4.24

15.43

e6/l

1.10

155

Traction detachment of retina

1.47

0.53

1.4

1.1

12.56

13.57

e6/l

—

Benign neoplasm: Pancreas

178

1.30

0.53

1.2

8.25

52.29

e6/l

0.76

150

Other corneal oedema

1.55

0.53

1.2

1.1

2.00

2.06

e6/l

—

Cardiomyopathy (excluding other)

898

0.88

0.53

1.5

93.47

18.37

e6/l

0.48

689

Other disorders of pigmentation

295

1.23

0.53

1.1

1.3

9.43

16.56

e6/l

0.44

229

Other diseases of gallbladder

268

1.24

0.52

1.5

1.3

21.33

38.63

e6/l

0.26

214

Corns and callosities

470

1.17

0.52

1.8

1.4

12.77

30.77

e6/l

0.63

368

Synovial cyst of popliteal space [Baker]

461

1.17

0.52

1.2

1.3

44.98

41.15

e6/l

0.06

345

Mental and behavioural disorders due to tobacco

629

1.15

0.52

1.4

36.47

25.75

e6/l

0.16

489

Chronic laryngitis and laryngotracheitis

1023

0.89

0.52

1.4

22.21

23.19

e6/l

0.03

779

Otosclerosis

536

1.16

0.51

1.5

1.4

23.44

31.22

e6/l

0.20

405

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

188

1.28

0.51

1.5

1.2

11.19

51.06

e6/l

0.69

153

Smoking dependency

630

1.15

0.51

1.4

36.47

26.18

e6/l

0.15

488

Congenital malformations of aortic and mitral valves

314

0.79

0.51

1.6

2.3

3.84

39.82

e6/l

1.13

237

Later onset COPD, excluding more controls

110

953

0.90

0.50

1.2

1.3

54.51

9.01

e6/l

0.65

761

Asthma and opportunity respiratory infection

297

1.22

0.50

1.3

1.4

8.11

37.65

e6/l

0.82

234

Impacted maxillary molar

477

0.84

0.50

1.3

1.6

10.03

25.96

e6/l

1.09

370

Carcinoma in situ of other and unspecified sites

213

0.75

0.50

1.7

1.3

17.30

45.91

e6/l

—

171

Ankylosing hyperostosis [Forestier]

1.50

0.50

1.0

1.2

2.00

58.19

e6/l

—

Other chronic obstructive pulmonary disease

311

2747

0.94

0.50

1.4

27.16

30.61

e6/l

0.09

238

2154

Medical treatment for female infertility

190

2048

0.92

0.50

1.4

1.3

25.21

25.85

e6/l

0.02

149

1606

Other congenital malformations of tongue, mouth and pharynx

144

1.32

0.49

3.9

3.8

3.07

6.58

e6/l

0.96

106

Other disorders of choroid

1.44

0.49

1.1

1.6

3.43

14.78

e6/l

—

Left ventricular outflow tract obstruction, narrow definition

400

0.82

0.49

1.5

2.4

3.16

33.17

e6/l

1.22

298

Acute alcohol intoxication ICD-9

216

1.26

0.49

1.2

1.3

14.71

46.65

e6/l

0.55

169

Non-small cell lung cancer

934

0.89

0.49

1.2

1.3

6.32

26.17

e6/l

1.86

721

Malignant neoplasm of ovary

312

0.80

0.49

1.1

1.3

3.13

15.81

e6/l

1.92

236

Other diseases of biliary tract

540

0.85

0.49

1.2

1.6

13.17

26.80

e6/l

0.54

425

Moderate mental retardation

1.54

0.48

2.3

2.9

4.43

3.27

e6/l

—

Use of rasagiline

163

1.30

0.48

1.5

1.2

1.81

61.80

e6/l

0.96

126

Vitiligo

1.46

0.48

1.4

1.5

5.73

6.47

e6/l

0.06

Non-ischemic cardiomyopathy

233

1783

1.07

0.48

1.5

1.4

11.96

30.28

e6/l

1.99

187

1348

Carcinoma in situ, bladder

189

0.74

0.48

1.8

1.3

18.89

47.25

e6/l

—

156

Open wound of hip and thigh

226

1.24

0.48

1.3

1.6

168.09

16.95

e6/l

0.62

177

Contact with lifting and transmission devices, not elsewhere classified

128

1.34

0.48

1.6

1.3

33.33

36.11

e6/l

0.03

101

All-cause Heart Failure

430

3258

0.95

0.48

1.4

11.78

34.61

e6/l

2.64

352

2522

Perichondritis of external ear

102

1.38

0.47

1.4

1.3

2.11

13.04

e6/l

—

Other nonscarring hair loss

1.49

0.47

1.2

1.1

3.80

2.35

e6/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

263

1.22

0.47

1.5

1.4

32.12

38.08

e6/l

0.08

211

Other juvenile arthritis

343

0.81

0.47

1.5

2.5

31.05

15.01

e6/l

0.34

265

Benign neoplasm: Caecum

664

1.13

0.46

1.4

6.37

25.99

e6/l

1.33

504

Placenta praevia

375

0.82

0.46

1.6

1.3

8.88

24.10

e6/l

0.91

285

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

414

2707

1.05

0.46

1.4

83.38

26.70

e6/l

0.73

309

2127

Benign neoplasm: Tonsil

0.59

0.46

1.0

1.2

1.20

14.69

e6/l

—

Extreme obesity with alveolar hypoventilation

298

0.80

0.46

1.2

1.4

8.38

28.24

e6/l

0.56

233

Valvular heart disease excluding rheumatic fever

403

3096

0.95

0.46

1.4

1.5

63.24

27.10

e6/l

0.58

330

2401

Cardiomyopathies, Primary/intrinsic

876

0.89

0.46

1.5

94.96

17.37

e6/l

0.49

673

Essential (haemorrhagic) thrombocythaemia

237

1.23

0.45

1.2

1.4

57.50

41.26

e6/l

0.15

192

Benign leiomyoma with endometriosis

127

1162

1.09

0.44

1.3

1.4

51.17

27.26

e6/l

0.36

104

915

Delayed puberty

1.38

0.44

1.4

2.8

3.43

8.73

e6/l

—

Heart failure, strict

439

3311

0.95

0.44

1.4

12.21

34.12

e6/l

2.53

359

2565

Anomalies of dental arch relationship, including avohilmo

198

1657

1.07

0.44

2.4

1.6

13.10

23.90

e6/l

0.79

157

1250

Type 1 diabetes, strict (exclude DM2)

107

969

1.10

0.44

1.8

1.9

23.72

21.43

e6/l

0.08

751

therapeutic use

193

1.25

0.43

1.4

1.2

4.46

26.50

e6/l

0.74

150

Non-rheumatic valve diseases

398

3049

0.95

0.43

1.5

56.73

27.19

e6/l

0.45

326

2364

Idiopathic gout

555

1.14

0.43

1.2

1.3

195.41

20.83

e6/l

0.47

446

Nonischemic cardiomyopathy

393

0.84

0.43

1.6

1.5

170.27

29.50

e6/l

0.40

301

Complications of labour and delivery

686

3684

1.04

0.43

1.3

1.4

16.42

34.37

e6/l

2.08

509

2849

conjunctival haemorrhage

499

1.15

0.43

1.2

1.5

3.65

25.12

e6/l

1.31

388

Congenital malformations of ovaries, fallopian tubes and broad ligaments

471

1.15

0.42

1.3

1.4

12.30

21.27

e6/l

0.43

365

Occupational exposure to risk-factors

230

1.22

0.42

1.1

1.3

1.91

44.73

e6/l

1.02

183

ILD, hospital admissions

101

916

1.10

0.42

1.2

1.4

18.67

21.41

e6/l

0.09

716

Venous complications and haemorrhoids in the puerperium

1.39

0.42

1.3

1.1

21.57

3.18

e6/l

—

Other specified/unspecified spondylopathies

131

1.30

0.42

1.2

1.3

13.30

33.45

e6/l

—

100

Psoriasis vulgaris

166

1541

1.08

0.42

1.2

1.4

14.28

22.95

e6/l

0.52

120

1184

Toxic effect of alcohol

140

1.29

0.42

1.4

1.3

8.06

10.56

e6/l

0.12

108

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.42

0.0

1.2

—

4.22

—

Other obstructed labour

616

0.87

0.42

1.3

7.60

25.05

e6/l

1.75

474

Juvenile osteochondrosis

249

1.21

0.42

2.0

1.5

5.50

9.78

e6/l

0.62

189

Folliculitis decalvans

0.00

0.42

0.0

1.1

—

1.89

—

Uterine polyps

711

0.88

0.41

1.2

1.4

40.42

34.83

e6/l

0.09

565

Changes in corneal membranes

0.00

0.41

0.0

1.0

—

2.17

—

Pediculosis, acariasis and other infestations

426

1.15

0.41

1.3

1.5

19.47

29.13

e6/l

0.24

333

Congenital malformations of genital organs

847

1.11

0.41

1.4

2.0

46.51

18.43

e6/l

0.33

637

Rheumatic fever incl heart disease

172

0.75

0.41

2.2

1.2

4.62

27.08

e6/l

0.66

137

Type 1 diabetes, definitions combined

107

974

1.10

0.40

1.8

1.9

23.72

21.36

e6/l

0.08

757

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

168

0.75

0.40

3.5

5.1

0.88

7.70

e6/l

—

122

Abnormality of red blood cells

1.48

0.40

1.2

1.8

1.00

2.69

e6/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

846

0.90

0.40

1.6

1.9

16.61

22.14

e6/l

0.18

633

Complications of the puerperium, not elsewhere classified

324

1.18

0.40

1.2

1.4

11.68

22.33

e6/l

0.39

254

UC patients in KELA-register (code 208), prior to 1994

324

1.18

0.40

1.2

1.4

1.38

22.30

e6/l

1.35

248

Unspecified chronic bronchitis

205

0.78

0.40

1.3

11.73

47.65

e6/l

0.63

164

Oral lichen ruber planus wide, hypothyreosis or thyroxin

352

1.17

0.40

1.3

6.94

17.83

e6/l

0.94

265

Other noninfective disorders of lymphatic vessels and lymph nodes

241

1.21

0.40

1.2

1.5

208.95

10.25

e6/l

0.65

193

Benign neoplasm of bone and articular cartilage

625

1.12

0.40

1.2

1.3

7.11

26.36

e6/l

1.21

493

Allergic colitis

241

1.21

0.40

1.8

3.6

0.77

12.44

e6/l

1.90

176

All dysplastic lesions of the cervix uteri

258

2433

1.06

0.40

1.2

1.3

87.64

20.64

e6/l

0.73

198

1878

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

172

1604

1.07

0.40

1.4

82.90

21.68

e6/l

0.45

134

1236

Mandibular retrognathia

569

0.87

0.40

2.1

1.7

2.10

18.66

e6/l

2.99

441

Cholera

269

1.19

0.39

1.5

1.2

26.23

27.89

e6/l

0.02

205

Amputation

559

1.13

0.39

1.4

15.72

26.86

e6/l

0.31

443

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

153

1381

0.93

0.39

1.4

1.3

37.22

23.78

e6/l

0.30

106

1084

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.39

0.0

1.2

—

3.17

—

Benign leiomyoma with endometriosis

127

1171

1.09

0.39

1.3

1.4

51.17

31.37

e6/l

0.27

104

899

Drug-induced gout

0.00

0.39

0.0

1.2

—

1.79

—

Benign neoplasm: Rectosigmoid junction

251

1.20

0.39

1.3

3.81

41.26

e6/l

0.95

202

Interstitial lung disease

101

922

1.10

0.39

1.2

1.4

18.67

21.28

e6/l

0.08

721

Interstitial lung disease endpoints

101

922

1.10

0.39

1.2

1.4

18.67

21.28

e6/l

0.08

721

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

391

1.15

0.38

1.6

1.3

17.97

31.11

e6/l

0.42

303

Other interstitial pulmonary diseases

101

923

1.10

0.38

1.2

1.4

18.67

21.30

e6/l

0.08

720

Pulmonary eosinophilia, not elsewhere classified

1.35

0.38

1.0

1.2

141.67

5.23

e6/l

—

Deep bite that required surgery

1.36

0.38

1.1

1.3

2.33

5.77

e6/l

0.52

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.33

0.38

1.0

1.2

1.89

3.48

e6/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

628

1.12

0.37

1.3

1.2

52.42

25.74

e6/l

0.27

499

Pustular psoriasis

344

0.84

0.37

1.2

1.4

3.36

22.47

e6/l

1.26

266

Bicuspidal aortic valve syndrome

257

0.81

0.37

1.7

3.87

48.38

e6/l

1.14

192

Hypertensive heart and/or renal disease

180

1306

1.07

0.37

1.3

1.4

36.93

23.41

e6/l

0.21

155

1012

Other diseases of appendix

1.40

0.37

1.1

102.20

3.11

e6/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

115

1247

0.92

0.37

1.3

1.4

104.10

23.98

e6/l

0.39

960

Herpesviral keratitis and keratoconjunctivitis

290

1.18

0.37

1.4

1.6

5.89

7.71

e6/l

0.25

227

Etanercept

487

1.13

0.37

1.2

1.6

24.83

15.37

e6/l

0.20

370

Unspecified lump in breast

131

1214

1.08

0.37

1.3

1.4

17.59

31.07

e6/l

0.40

104

925

Toxic effect of contact with venomous animals

281

1.18

0.36

1.2

1.7

49.36

11.83

e6/l

0.85

217

Embedded and impacted teeth

253

2268

0.95

0.36

1.5

16.30

22.69

e6/l

0.44

206

1743

Lung cancer and mesothelioma

111

1030

0.92

0.36

1.2

1.4

35.92

10.53

e6/l

0.48

806

Benign neoplasm: Short bones of lower limb

0.64

0.36

1.2

1.1

2.80

3.70

e6/l

—

Benign neoplasm: Bronchus and lung

0.65

0.36

1.2

2.40

12.74

e6/l

—

Postpartum hemorraghe, parous women as controls

233

2155

0.95

0.36

1.3

25.71

23.27

e6/l

0.08

184

1680

Macular cyst

168

0.77

0.36

1.2

1.3

10.88

70.44

e6/l

—

133

Respiratory tuberculosis, not confirmed

226

1.20

0.36

1.6

1.2

27.21

48.83

e6/l

0.25

178

Carcinoma in situ of other and unspecified sites

201

0.79

0.35

1.7

1.3

17.30

44.77

e6/l

—

166

156

1478

0.93

0.35

1.4

1.3

83.12

24.80

e6/l

0.36

117

1150

Disorders of parathyroid gland, other and/or unspecified

1.41

0.35

1.0

1.1

39.00

5.44

e6/l

—

Conduction disorders

245

1930

1.06

0.35

1.2

1.5

14.49

23.87

e6/l

0.47

195

1479

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

403

2666

1.04

0.35

1.4

84.73

27.02

e6/l

0.73

304

2098

Contact with other sharp object(s)

527

1.12

0.35

1.1

1.4

13.59

32.65

e6/l

0.77

406

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

273

1.18

0.35

1.5

1.4

32.12

41.78

e6/l

0.13

211

Benign neoplasm of breast

931

0.91

0.35

1.3

15.25

24.59

e6/l

0.60

711

Peripheral artery operations in Hilmo

717

1.10

0.35

1.3

13.15

27.98

e6/l

0.57

564

Preparatory care for dialysis

292

1.17

0.34

1.3

1.5

6.88

39.82

e6/l

0.91

225

Artificial joint operation, meniscal resection

926

5996

1.03

0.34

1.3

1.4

36.49

32.88

e6/l

0.10

708

4638

Other malignant neoplasms of skin (=non-melanoma skin cancer)

427

3239

1.04

0.34

1.3

1.4

83.85

26.15

e6/l

0.77

316

2536

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

362

0.85

0.34

1.3

5.00

31.70

e6/l

0.96

287

Parodontitis or/and operation codes

715

4122

1.03

0.34

1.3

1.4

35.39

31.49

e6/l

0.08

542

3236

Other congenital malformations of face and neck

209

1.20

0.34

1.2

1.8

3.39

6.65

e6/l

0.61

164

Pyothorax

254

0.82

0.34

1.8

1.3

45.60

39.40

e6/l

0.07

204

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

340

0.85

0.34

1.2

1.3

1.94

31.39

e6/l

1.06

275

Benign lipomatous neoplasm of other sites/unspecified

594

0.89

0.33

1.8

1.4

41.87

25.51

e6/l

0.29

459

Non-small cell lung cancer, adenocarcinoma

361

0.86

0.33

1.3

5.00

36.44

e6/l

1.21

289

Non-small cell lung cancer, adenocarcinoma, helper endpoint

361

0.86

0.33

1.3

5.00

36.44

e6/l

1.21

289

Pneumothorax

472

1.13

0.33

1.3

5.22

28.16

e6/l

1.11

373

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

293

1.16

0.33

1.4

32.81

36.21

e6/l

0.04

232

Postpartum hemorraghe, all women as controls

233

2443

0.95

0.33

1.3

25.71

25.15

e6/l

0.02

184

1896

Maternal care for known or suspected fetal abnormality and damage

158

1318

1.07

0.33

1.3

18.19

29.76

e6/l

0.43

111

1034

Inflammation of lacrimal passages (chronic)

0.69

0.33

1.5

1.2

33.17

17.23

e6/l

—

Coxarthrosis, primary, with hip surgery

329

3255

0.96

0.33

1.4

1.3

40.66

28.16

e6/l

0.27

251

2535

Foreign body on external eye

133

1241

1.07

0.33

1.4

1.5

35.50

21.97

e6/l

0.21

104

955

Other acute skin changes due to ultraviolet radiation

231

0.82

0.32

2.5

1.4

8.36

25.69

e6/l

0.60

183

Other complications of labour and delivery, not elsewhere classified

101

1053

0.92

0.32

1.2

1.3

47.10

18.32

e6/l

0.82

825

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

685

0.90

0.32

1.4

1.3

18.00

23.21

e6/l

0.18

545

Other nonthrombocytopenic purpura

1.28

0.32

1.3

1.7

2.00

3.22

e6/l

—

Congenital malformations of the urinary system

464

1.12

0.32

1.2

2.2

3.92

29.82

e6/l

1.23

352

Maternal care for other known or suspected fetal problems

258

1575

1.05

0.32

1.2

1.3

19.54

26.99

e6/l

0.33

205

1234

Macular hole

332

1.15

0.32

1.4

1.3

4.64

41.75

e6/l

1.28

253

Other otitis externa (chronic)

465

1.12

0.31

1.4

1.6

8.95

29.89

e6/l

0.86

362

Endometriosis of fallopian tube

1.35

0.31

2.9

1.6

36.00

7.86

e6/l

—

Type 1 diabetes, strict definition

787

0.91

0.31

1.5

2.0

33.03

17.80

e6/l

0.54

617

Aortic aneurysm

142

1487

0.94

0.31

1.6

1.3

10.56

24.12

e6/l

1.04

111

1163

Multiple delivery

726

0.91

0.31

1.7

1.3

102.47

38.66

e6/l

0.36

539

Other assisted single delivery

147

1.23

0.31

1.1

1.4

2.00

18.56

e6/l

—

113

Congenital malformations of great arteries

225

0.83

0.31

1.3

4.2

9.85

7.17

e6/l

0.14

162

Benign neoplasm: Conjunctiva

221

1.18

0.30

1.1

1.4

1.89

9.23

e6/l

1.48

176

Other nutritional anaemias

1.30

0.30

3.1

1.2

1.57

7.88

e6/l

—

Calcific aortic valvular stenosis, operated

166

1721

0.94

0.30

1.3

1.4

12.74

21.60

e6/l

0.62

137

1352

Calcific aortic valvular stenosis

166

1721

0.94

0.30

1.3

1.4

12.74

21.60

e6/l

0.62

137

1352

Embolic stroke with flimmer

120

1.25

0.30

1.4

1.3

2.30

38.62

e6/l

—

100

Transitory endocrine and metabolic disorders specific to fetus and newborn

170

0.80

0.30

3.3

5.0

1.56

7.57

e6/l

—

124

Cardiomyopathy

138

1297

1.07

0.29

1.4

1.5

54.57

17.41

e6/l

0.44

104

980

Wide developmental disorders

288

1.15

0.29

1.3

3.0

8.00

15.20

e6/l

0.55

213

Other specified disorders of external ear

238

0.84

0.29

1.8

1.3

8.23

40.65

e6/l

0.70

193

Retained placenta and membranes, without haemorrhage

1033

0.93

0.28

1.3

6.29

37.79

e6/l

1.77

787

Coronary revascularization (ANGIO or CABG)

368

2662

0.96

0.28

1.4

14.14

35.35

e6/l

1.92

298

2036

Thyrotoxicosis with toxic multinodular goitre

386

0.88

0.28

1.4

1.3

162.40

24.53

e6/l

0.40

290

Ulcerative colitis (strict definition, require KELA)

156

1475

1.06

0.28

1.2

1.4

91.67

21.71

e6/l

0.46

121

1134

Secondary right heart disease

237

0.84

0.27

1.4

1.3

61.20

48.53

e6/l

0.08

188

Dental caries 2, only avohilmo

864

6657

1.02

0.27

1.4

1.5

44.26

27.39

e6/l

0.48

638

5164

Operations 2 for CAVS

166

1714

0.95

0.27

1.3

12.74

21.67

e6/l

0.63

137

1347

Calcific aortic valvular stenosis, diagnosis (helper)

166

1714

0.95

0.27

1.3

12.74

21.67

e6/l

0.63

137

1347

116

1028

1.07

0.27

1.4

1.3

108.43

26.78

e6/l

0.38

800

Malignant neoplasm of corpus uteri

501

0.90

0.27

1.4

7.22

24.86

e6/l

1.97

381

Injury of muscle and tendon at hip and thigh level

739

1.08

0.27

1.4

20.52

26.72

e6/l

0.22

572

Eustachian salpingitis and obstruction

662

1.09

0.27

1.5

13.59

25.23

e6/l

0.67

512

Other hammer toe(s) (acquired)

126

1110

1.07

0.27

1.4

133.83

25.14

e6/l

0.54

853

Benign neoplasm: Bones of skull and face

1.24

0.27

1.1

2.63

2.73

e6/l

—

Calcific aortic valvular stenosis, including rheumatic fever

167

1721

0.95

0.27

1.4

1.3

12.90

21.68

e6/l

0.62

138

1350

Myeloproliferative diseases (CML excluded)

509

1.10

0.27

1.2

1.4

34.86

30.24

e6/l

0.07

389

Olecranon bursitis

366

1.12

0.27

1.2

1.3

7.27

31.17

e6/l

0.79

284

Distal bite

326

1.13

0.26

3.5

2.5

5.65

13.29

e6/l

0.75

252

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

0.68

0.26

1.2

81.60

70.63

e6/l

—

Benign neoplasm: Conjunctiva

225

1.16

0.26

1.1

1.4

1.89

44.86

e6/l

1.01

182

Barrett oesophagus

310

1.13

0.26

1.2

1.4

2.68

35.65

e6/l

1.00

235

Poor fetal growth

121

1139

1.06

0.26

1.2

1.3

31.94

18.40

e6/l

0.53

891

Acquired absence of organs, not elsewhere classified

1.22

0.25

1.7

1.5

10.56

48.53

e6/l

—

Mixed hyperlipidaemia

254

1.14

0.25

1.5

1.3

17.29

19.83

e6/l

0.06

203

Infections of breast associated with childbirth

292

1.13

0.25

1.2

1.4

11.63

19.64

e6/l

0.36

230

Stenosis and insufficiency of lacrimal passages

627

1.09

0.25

1.7

1.4

24.16

21.80

e6/l

0.06

476

Other pulmonary heart/vessel disease

266

0.86

0.25

1.5

1.4

52.67

45.95

e6/l

0.05

212

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

995

1.07

0.25

1.2

1.4

21.24

22.25

e6/l

0.02

779

Benign neoplasm: Rectosigmoid junction

264

1.14

0.24

1.3

3.81

42.25

e6/l

1.02

207

Carcinoma in situ of cervix uteri

744

1.08

0.24

1.2

1.3

158.95

15.79

e6/l

0.47

586

161

1.18

0.24

1.3

1.8

16.40

10.69

e6/l

—

117

Primary coxarthrosis, bilateral

204

1954

1.04

0.24

1.4

1.3

39.41

29.91

e6/l

0.14

158

1539

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

284

1.13

0.23

1.5

1.3

98.67

36.98

e6/l

0.29

227

L01XE Protein kinase inhibitors

389

1.11

0.23

3.6

1.4

7.82

36.36

e6/l

1.08

296

Erectile dysfunction

464

0.90

0.23

1.4

1.5

4.77

27.15

e6/l

1.04

365

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

415

2762

1.03

0.23

1.3

1.4

84.76

26.49

e6/l

0.76

310

2164

Male infertility

351

1.11

0.23

1.3

1.6

32.55

26.81

e6/l

0.08

271

Other abnormal uterine and vaginal bleeding

187

1394

0.96

0.23

1.3

1.4

101.23

30.47

e6/l

0.51

141

1104

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

150

1428

1.05

0.23

1.2

1.4

94.76

22.32

e6/l

0.46

117

1098

Arterial embolism and thrombosis of lower extremity artery

200

0.85

0.23

1.4

1.3

17.76

49.69

e6/l

0.49

157

Whooping cough

1.26

0.22

1.4

1.0

20.00

2.94

e6/l

—

Pemphigus

1.26

0.22

1.6

1.1

19.40

22.19

e6/l

—

Pollen allergy

198

1879

1.04

0.22

1.3

1.8

15.63

24.34

e6/l

0.59

151

1444

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

231

0.86

0.22

1.0

1.3

4.14

12.06

e6/l

0.87

178

Ascorbic acid deficiency

0.00

0.22

0.0

2.9

—

2.80

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.21

0.0

1.0

—

1.09

—

Disorders of copper metabolism

0.00

0.21

0.0

3.8

—

4.10

—

Benign neoplasm: Larynx

199

0.85

0.21

1.6

1.2

12.00

44.39

e6/l

0.56

163

Alport

0.00

0.21

0.0

4.6

—

4.55

—

Obstetric embolism

0.00

0.21

0.0

1.0

—

2.17

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

1.10

—

Calcium deposit in bursa

0.00

0.21

0.0

1.8

—

4.91

—

Hirsprung

0.00

0.21

0.0

4.8

—

4.17

—

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.0

—

3.58

—

Abdominal aortic aneurysm (AAA)

487

0.92

0.20

1.4

1.3

5.66

27.72

e6/l

1.09

389

Prurigo nodularis

145

1.18

0.20

1.8

1.1

207.08

29.08

e6/l

0.39

116

COPD related to multimorbidity

270

2349

0.97

0.20

1.4

11.72

29.77

e6/l

1.71

206

1828

Delivery

408

2100

1.03

0.20

1.3

1.4

21.99

30.57

e6/l

0.41

304

1607

Heart failure and bmi 25plus

233

1664

0.96

0.20

1.3

1.4

15.61

46.33

e6/l

1.68

182

1293

Filling of root of tooth

221

1.13

0.20

1.2

1.5

19.05

9.40

e6/l

0.24

166

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.23

0.20

1.0

1.1

3.67

3.09

e6/l

—

Benign neoplasm of bone and articular cartilage

655

1.07

0.19

1.2

1.4

7.11

19.97

e6/l

1.35

501

Other deformity of hallux (acquired)

1.18

0.19

2.0

1.3

1.33

2.69

e6/l

—

Leiomyoma of uterus

603

3502

0.98

0.19

1.3

1.4

24.11

34.24

e6/l

0.66

470

2710

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

636

1.07

0.19

1.4

1.3

25.91

25.55

e6/l

0.01

501

Delivery, wide proxy

331

1711

1.03

0.19

1.4

23.62

32.69

e6/l

0.35

252

1332

COPD

336

2847

0.97

0.18

1.4

26.00

30.13

e6/l

0.12

254

2231

Cholangitis (primary sclerosing, PSC), with reimbursement 202

128

1.18

0.18

1.3

2.0

4.00

7.21

e6/l

—

Pleural plaque

539

0.93

0.18

1.2

1.3

10.19

30.85

e6/l

0.85

426

Oesophageal varices

269

0.89

0.18

1.2

1.7

13.88

38.70

e6/l

0.51

211

Peripheral retinal degeneration

223

1.12

0.18

2.6

1.4

8.13

12.54

e6/l

0.28

180

Scar conditions and fibrosis of skin

290

1.11

0.18

1.6

3.04

11.97

e6/l

1.52

229

Carcinoma in situ of skin, other sites/unspecified

1.19

0.18

1.6

1.3

2.43

14.48

e6/l

—

Hypertensive Renal Disease

166

1.15

0.18

1.2

1.4

2.16

12.28

e6/l

1.14

122

Pacemaker

204

2051

0.97

0.18

1.3

1.4

8.17

21.98

e6/l

1.90

166

1606

Left bundle-branch block

476

0.92

0.17

1.4

14.28

16.65

e6/l

0.08

368

Psoriasis (vulgaris), strict definition

216

0.88

0.17

1.6

1.4

60.93

24.50

e6/l

0.27

168

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

168

1618

1.04

0.17

1.4

30.66

22.08

e6/l

0.19

128

1274

Cardiomyopathy, other and unspecified

571

1.07

0.17

1.4

103.30

15.84

e6/l

0.48

447

Colectomy operation

121

1157

1.05

0.17

1.4

35.43

26.69

e6/l

0.19

899

Oral lichen ruber planus, including avohilmo

426

1.08

0.17

1.2

1.3

55.37

23.23

e6/l

0.31

327

Other obstetric trauma

434

0.92

0.17

1.2

1.3

52.11

19.94

e6/l

0.33

332

Benign neoplasm: Short bones of lower limb

0.73

0.17

1.2

1.1

2.80

4.11

e6/l

—

Obstructed labour due to malposition and malpresentation of fetus

216

2100

0.97

0.17

1.5

1.3

21.79

27.50

e6/l

0.28

164

1628

Emergency coronary revascularization (for ACS)

409

3006

0.98

0.17

1.3

1.4

14.50

32.52

e6/l

1.60

335

2339

Secondary malignant neoplasm of respiratory and digestive organs

0.72

0.17

1.4

1.2

1.20

18.23

e6/l

—

Acute appendicitis, with complications

153

1589

0.96

0.17

1.3

1.4

18.51

28.89

e6/l

0.46

114

1215

Benign neoplasm: Skin of eyelid, including canthus

103

1079

0.95

0.16

1.3

21.32

26.69

e6/l

0.21

825

Other congenital malformations of female genitalia

1.13

0.16

1.4

2.25

5.45

e6/l

—

Primary gonarthrosis, bilateral

416

3561

1.02

0.16

1.3

1.4

24.03

30.81

e6/l

0.30

318

2769

Crossbite

586

1.06

0.16

3.2

2.4

3.65

15.65

e6/l

2.68

444

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

151

0.86

0.16

1.3

0.50

55.60

e6/l

—

126

Injury of muscle and tendon at ankle and foot level

168

1.13

0.15

1.2

1.4

3.29

10.75

e6/l

0.95

127

Nontoxic single thyroid nodule

506

1.07

0.15

1.3

1.4

8.51

31.67

e6/l

1.48

377

Pustulosis palmaris et plantaris

307

0.91

0.15

1.2

1.4

3.36

25.14

e6/l

1.28

235

Use of cabergoline

1.13

0.15

2.9

1.3

69.44

5.89

e6/l

—

Deficiency of other B group vitamins

121

1.16

0.15

1.4

1.5

13.89

11.82

e6/l

—

Ascites

441

0.93

0.15

1.7

1.4

3.17

36.09

e6/l

1.68

341

Right bundle-branch block

234

0.90

0.15

1.1

1.4

1.93

23.95

e6/l

0.98

186

L01XX Other antineoplastic agents

342

1.08

0.15

1.2

1.3

18.39

37.72

e6/l

0.42

263

Benign neoplasm: Skin of lip

0.79

0.14

1.3

1.2

3.43

5.16

e6/l

—

Benign neoplasm: Skin of ear and external auricular canal

246

1.10

0.14

1.6

1.4

25.86

40.30

e6/l

0.20

202

Intrahepatic Cholestasis of Pregnancy (ICP)

596

1.06

0.14

1.2

1.3

3.14

18.32

e6/l

2.94

458

Benign lipomatous neoplasm of other sites/unspecified

563

0.94

0.14

1.8

1.3

41.87

24.43

e6/l

0.31

445

Dermatitis due to ingested food

349

1.08

0.14

1.7

3.1

34.14

10.10

e6/l

0.46

260

Benign neoplasm: Larynx

191

0.89

0.14

1.6

1.4

12.00

52.03

e6/l

0.68

152

Granuloma annulare

103

1.17

0.14

1.3

1.1

0.86

2.46

e6/l

—

Glaucoma-related operations

305

1.08

0.13

1.3

1.2

3.27

40.84

e6/l

1.25

244

Cardiac arrest

296

1.08

0.13

1.1

1.3

6.31

20.02

e6/l

0.51

220

Inflammatory disease of cervix uteri

451

1.07

0.13

1.2

1.4

3.89

19.38

e6/l

2.91

344

Gonarthrosis, primary, with knee surgery

446

3708

0.98

0.13

1.4

28.87

29.66

e6/l

0.02

334

2887

Cirrhosis of liver, NAS

315

1.08

0.13

1.6

1.3

9.85

38.55

e6/l

0.75

242

Benign neoplasm: Skin of other and unspecified parts of face

725

1.05

0.13

1.4

1.3

9.79

27.27

e6/l

0.97

566

Contact with machinery

837

0.95

0.13

1.3

1.4

4.50

20.35

e6/l

1.40

642

Pedal cyclist injured in collision with motor vehicle

228

1.10

0.13

1.3

1.2

19.00

10.81

e6/l

0.19

178

Duodenal ulcer

637

1.05

0.13

1.2

1.4

113.96

23.31

e6/l

0.42

502

Coronary atherosclerosis

609

3985

0.98

0.13

1.3

1.4

13.35

34.53

e6/l

2.93

476

3027

Pericarditis

242

0.91

0.13

1.1

1.6

5.76

20.49

e6/l

0.57

189

Non-allergic asthma

706

1.05

0.13

1.3

2.1

8.05

25.28

e6/l

1.17

552

Struck by thrown, projected or falling objec

355

1.07

0.12

1.2

1.6

1.34

37.08

e6/l

1.39

273

Ulcerative rectosigmoiditis

658

1.05

0.12

1.2

1.4

167.02

29.60

e6/l

0.42

507

Carcinoma in situ of skin of lower limb, including hip

104

1.16

0.12

1.1

1.2

3.67

4.25

e6/l

—

Chondromalacia

200

1.10

0.12

1.2

1.5

4.12

12.41

e6/l

1.02

158

Clear cell adenocarcinoma of kidney

297

1.08

0.12

1.5

1.3

98.67

41.46

e6/l

0.26

231

Carcinoma in situ of other and unspecified digestive organs

152

1.12

0.12

1.5

1.2

2.09

61.74

e6/l

0.93

124

Unspecified urinary incontinence

590

1.05

0.12

1.5

1.4

11.81

22.65

e6/l

0.71

448

Noise effects on inner ear

272

0.92

0.12

1.4

1.3

36.47

39.61

e6/l

0.04

210

Benign neoplasm of breast

885

0.96

0.12

1.3

15.25

22.47

e6/l

0.41

689

Carcinoma in situ of cervix uteri

767

1.04

0.12

1.2

1.3

158.95

18.53

e6/l

0.46

591

Coronary angioplasty

299

2249

1.02

0.12

1.4

11.36

33.10

e6/l

2.01

252

1716

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

722

0.95

0.12

1.3

1.4

22.60

29.51

e6/l

0.22

541

Pleural effusion

954

1.04

0.12

1.4

1.3

9.15

25.02

e6/l

1.14

737

Serous carcinoma of ovary

220

0.91

0.12

1.0

1.4

4.14

11.71

e6/l

0.89

164

Peripheral artery disease

310

2544

0.98

0.12

1.4

25.19

23.03

e6/l

0.11

248

1982

Other infective otitis externa

444

1.06

0.11

1.2

1.5

18.83

31.64

e6/l

0.32

348

Other secondary gonarthrosis

366

1.07

0.11

1.3

1.4

6.10

18.54

e6/l

0.73

280

Other noninflammatory disorders of cervix uteri

333

0.93

0.11

1.1

1.3

138.48

25.19

e6/l

0.55

262

Familial hypercholesterolemia, with ischemic heart disease

562

1.05

0.11

1.3

15.63

33.39

e6/l

0.68

425

Other benign neoplasms of skin

303

2916

1.02

0.11

1.3

15.49

27.05

e6/l

1.37

227

2301

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

739

1.04

0.11

1.3

48.71

22.92

e6/l

0.28

585

Nephrotic syndrome

240

1.09

0.11

1.8

2.0

112.72

28.36

e6/l

0.36

184

HSIL lesion of the cervix uteri

165

1693

0.97

0.11

1.2

1.3

86.34

23.99

e6/l

0.39

128

1326

Other disorders of cornea

679

0.96

0.11

1.7

1.4

22.11

14.90

e6/l

0.17

513

Supervision of normal pregnancy

235

1315

1.02

0.10

1.5

1.3

20.33

27.08

e6/l

0.23

171

1001

Major coronary heart disease event

639

4211

1.01

0.10

1.3

1.4

15.06

33.24

e6/l

2.17

524

3223

Benign neoplasm: Skin of trunk

280

1.07

0.10

1.2

1.4

3.76

20.27

e6/l

0.86

228

Malignant neoplasm of oral cavity

212

1.09

0.10

1.1

1.2

6.18

48.35

e6/l

0.84

164

Thoracic aortic aneurysm

921

0.97

0.10

1.7

1.3

15.14

24.18

e6/l

0.38

719

COPD, hospital admissions 3, with asthma pneumonia sepsis

170

1480

0.98

0.10

1.5

1.3

9.71

23.24

e6/l

1.62

127

1151

Acute inflammation of orbit

1.11

0.10

1.8

2.0

38.20

8.95

e6/l

—

Respiratory distress of newborn

179

1.09

0.10

5.9

4.9

53.38

7.03

e6/l

0.42

125

Deep bite

104

882

1.03

0.09

2.4

1.9

20.21

28.16

e6/l

0.24

673

277

1.07

0.09

2.3

4.1

39.20

13.96

e6/l

0.34

195

Exfoliative dermatitis

1.09

0.09

1.0

1.3

109.00

15.10

e6/l

—

Cardiovascular disorders originating in the perinatal period

1.04

0.09

2.0

6.1

171.00

3.25

e6/l

—

Leiomyoma of uterus

480

2669

1.01

0.09

1.3

25.47

32.58

e6/l

0.36

377

2090

Failed induction of labour

503

0.95

0.09

1.3

26.71

19.52

e6/l

0.17

385

Oral leukoplakia and related diseases

360

0.94

0.09

1.1

1.4

72.96

35.23

e6/l

0.23

274

Impacted cerumen

655

0.96

0.09

1.8

1.7

4.67

24.29

e6/l

1.40

510

Pityriasis rosea

1.11

0.09

1.0

1.5

100.83

2.70

e6/l

—

Other specified/unspecified nutritional deficiencies

1.09

0.09

1.0

1.1

1.17

3.00

e6/l

—

Type 1 diabetes, strict definition, subgroup 1

744

0.96

0.09

1.5

1.9

33.03

18.01

e6/l

0.53

584

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.07

0.08

1.0

1.2

3.67

2.84

e6/l

—

Benign neoplasm: Appendix

1.05

0.08

1.8

1.3

18.67

7.83

e6/l

—

Benign neoplasm: Skin of ear and external auricular canal

253

1.07

0.08

1.6

1.4

25.86

43.56

e6/l

0.26

201

Lesion of plantar nerve

410

1.05

0.08

1.2

1.3

10.71

31.72

e6/l

0.80

300

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

0.80

0.08

1.2

1.1

5.40

2.67

e6/l

—

Foreign body or object entering through skin

489

1.04

0.08

2.0

1.5

16.44

32.64

e6/l

0.38

377

Gastrointestinal stromal tumor and sarcoma

0.77

0.08

1.2

81.60

17.26

e6/l

—

Carcinoma in situ of skin, other sites/unspecified

1.10

0.08

1.6

1.2

2.43

2.85

e6/l

—

Secondary malignant neoplasm of other and unspecified sites

0.81

0.07

1.0

1.2

1.33

12.46

e6/l

—

Heart failure,strict

423

3086

0.99

0.07

1.4

12.62

32.59

e6/l

2.15

344

2383

Benign neoplasm: Bones of skull and face

1.07

0.07

1.1

2.63

4.22

e6/l

—

Suppurative and necrotic conditions of lower respiratory tract

327

0.95

0.07

3.0

1.4

73.87

32.08

e6/l

0.54

260

malignant neoplasm of female genital organs

975

0.97

0.07

1.2

1.4

12.77

37.63

e6/l

0.93

751

Other congenital malformations of limb(s)

1.03

0.07

1.5

2.6

1.50

7.03

e6/l

—

Benign neoplasm: Skin of lip

0.87

0.07

1.3

1.2

3.43

11.71

e6/l

—

Postmenopausal atrophic vaginitis

217

1285

1.02

0.07

1.5

1.4

25.64

29.58

e6/l

0.12

166

1013

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.83

0.07

5.3

1.1

4.29

72.36

e6/l

—

Graves ophthalmopathy, strict

157

1.08

0.07

1.4

1.5

11.30

6.36

e6/l

—

123

Motorcycle rider injured in other and unspecified transport accidents

452

1.04

0.07

1.2

1.5

14.32

12.19

e6/l

0.12

333

COPD, hospital admission 2, with asthma infections

216

1870

0.98

0.06

1.5

1.4

8.18

23.80

e6/l

2.72

164

1450

Isolated proteinuria

197

1.07

0.06

1.2

1.4

148.07

29.03

e6/l

0.44

156

Carcinoma in situ of skin of lower limb, including hip

109

1.10

0.06

1.1

1.2

3.67

80.07

e6/l

—

Unstable angina pectoris

289

2367

1.01

0.06

1.3

1.4

12.80

33.17

e6/l

1.68

242

1813

Juvenile rheumatoid arthirtis

158

1.08

0.06

1.4

1.8

50.08

12.06

e6/l

0.46

125

Malignant neoplasm of head and neck

493

1.03

0.06

1.4

7.03

28.42

e6/l

0.99

381

Maternal care for known or suspected disproportion

355

0.96

0.06

1.4

27.89

20.58

e6/l

0.15

275

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

612

1.03

0.06

1.2

1.3

3.14

22.61

e6/l

3.61

478

Ethmoidectomy

105

1072

0.98

0.06

1.3

1.4

54.16

24.48

e6/l

0.43

819

Oral lichen ruber planus

168

1.07

0.06

1.5

1.2

114.75

14.71

e6/l

0.41

127

Benign neoplasm: Tongue

182

0.93

0.05

1.4

1.2

1.22

52.02

e6/l

—

150

Benign neoplasm: Skin of upper limb, including shoulder

131

0.91

0.05

1.2

22.29

73.11

e6/l

—

106

Benign neoplasm: Skin of upper limb, including shoulder

131

0.91

0.05

1.2

22.29

13.11

e6/l

—

100

Tooth agenesis EXCLUDE clefts and syndromes

306

1.05

0.05

2.3

9.08

11.41

e6/l

0.18

235

Rubella [German measles]

247

1.05

0.05

1.8

1.3

28.88

36.34

e6/l

0.09

195

Contusion of other and unspecified parts of foot

405

1.04

0.05

1.5

1.8

3.66

21.21

e6/l

1.42

311

Benign neoplasm: Skin of other and unspecified parts of face

742

1.02

0.05

1.4

9.79

25.54

e6/l

0.93

568

Malignant neoplasm of bladder

364

0.96

0.05

1.3

22.50

33.53

e6/l

0.24

290

Other benign neoplasms of skin

303

3000

1.01

0.05

1.3

1.4

15.49

28.80

e6/l

1.32

227

2334

Ulcerative proctitis

485

1.03

0.05

1.1

1.4

206.67

35.81

e6/l

0.39

387

Amputation of toe

424

0.97

0.05

1.2

1.3

2.24

32.21

e6/l

1.41

332

Congenital malformations of eye, ear, face and neck

575

1.03

0.04

1.3

2.3

10.36

21.79

e6/l

0.73

434

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

126

1257

0.98

0.04

1.3

1.4

12.43

27.63

e6/l

0.96

995

Benign neoplasm: Skin of trunk

288

1.04

0.04

1.2

1.4

3.76

23.42

e6/l

1.06

226

Myocardial infarction, without ST-elevation

273

2495

1.01

0.04

1.3

14.76

25.30

e6/l

0.79

221

1923

Benign neoplasm of middle ear and respiratory system

526

1.03

0.04

1.5

1.3

22.88

22.77

e6/l

0.00

415

Glaucoma, exfoliation

574

0.98

0.04

1.5

1.3

17.65

27.50

e6/l

0.23

451

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

160

1.06

0.04

1.3

1.2

3.18

58.06

e6/l

0.84

125

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

170

1.06

0.04

1.2

22.58

56.01

e6/l

0.43

138

Cholangitis (primary sclerosing, PSC)

378

1.03

0.04

1.2

1.7

18.63

27.66

e6/l

0.21

300

Thyroiditis, unspecified

111

1.08

0.04

1.2

1.8

15.58

7.71

e6/l

0.29

Chronic suppurative otitis media

533

0.98

0.04

1.5

1.8

50.03

14.95

e6/l

0.37

414

Varicose veins

568

4268

1.01

0.04

1.4

29.20

34.46

e6/l

0.17

459

3308

Carcinoma in situ of skin

452

0.97

0.03

1.2

1.3

13.31

31.86

e6/l

0.66

356

Single spontaneous delivery

396

2094

1.01

0.03

1.2

1.4

18.72

30.62

e6/l

0.75

298

1604

ILD, hospital admissions 1, main diag only

826

1.02

0.03

1.2

1.4

20.28

22.91

e6/l

0.07

641

Benign neoplasm: Tongue

179

0.95

0.03

1.4

1.2

1.22

32.84

e6/l

—

141

All dysplastic lesions of the vagina

189

0.95

0.03

1.3

1.5

71.25

11.41

e6/l

0.67

149

Abrasion of teeth

241

1785

0.99

0.03

1.3

1.4

11.05

31.82

e6/l

1.81

177

1411

Autism

201

1.05

0.03

1.1

2.4

11.00

14.20

e6/l

0.13

150

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

742

0.98

0.03

1.2

1.3

3.40

25.27

e6/l

3.32

565

Malignant neoplasm of urinary organs

619

1.02

0.02

1.3

1.4

54.48

24.77

e6/l

0.29

482

Oral leukoplakia and related diseases, including avohilmo

620

0.98

0.02

1.4

1.3

45.62

27.35

e6/l

0.19

484

HSIL lesion of the cervix uteri, vagina or vulva

184

1827

1.01

0.02

1.2

1.3

82.23

23.81

e6/l

0.41

141

1422

COPD-related respiratory insufficiency

680

1.01

0.02

1.4

1.3

9.81

23.75

e6/l

0.77

534

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

720

1.01

0.02

1.2

1.3

3.40

20.74

e6/l

4.06

547

Right hemicolectomy

358

0.98

0.01

1.4

1.3

50.58

35.88

e6/l

0.16

283

Open bite

443

1.02

0.01

1.7

2.3

27.00

16.84

e6/l

0.17

343

Other ulcerative colitis

453

1.02

0.01

1.6

1.4

53.38

23.06

e6/l

0.38

354

Other appendicitis

653

1.01

0.01

1.3

1.4

11.74

32.39

e6/l

0.93

512

Multiple gestation

807

0.99

0.01

1.7

1.3

81.06

31.29

e6/l

0.32

623

Neonatal jaundice from other and unspecified causes

178

1.03

0.00

6.7

5.0

2.38

7.24

e6/l

0.59

126

Other other unspecified disorders of the circulatory system

244

1.03

0.00

1.3

1.7

29.53

45.32

e6/l

0.19

190

Long labour

240

2096

1.00

0.00

1.4

1.3

45.43

27.76

e6/l

0.31

174

1622

Fibrosis and cirrhosis of liver

475

0.99

0.00

1.5

1.4

14.26

31.45

e6/l

0.56

365

Scissor bite

242

0.99

0.00

2.0

2.6

11.89

17.96

e6/l

0.24

185

Overjet

228

1.00

0.00

4.2

2.9

3.83

11.03

e6/l

0.79

180

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

439

1.00

0.00

1.2

1.3

2.31

21.90

e6/l

1.89

341

Crowding of teeth, including avohilmo

726

1.00

0.00

2.9

2.0

5.86

24.88

e6/l

2.85

555

Malignant neoplasm of kidney, except renal pelvis

577

1.01

0.00

1.4

54.93

26.28

e6/l

0.25

450

Respiratory and cardiovascular disorders specific to the perinatal period

256

1.01

0.00

5.5

4.0

37.78

8.55

e6/l

0.37

183

Cystic kidney disease

224

0.98

0.00

1.3

1.8

7.33

51.09

e6/l

0.94

173

Other secondary coxarthrosis

234

0.98

0.00

1.3

1.4

2.22

25.41

e6/l

0.96

177

Golimumab

244

0.98

0.00

1.1

1.7

169.33

9.67

e6/l

0.46

193

Carcinoma in situ of other and unspecified digestive organs

167

1.02

0.00

1.5

1.2

2.09

33.83

e6/l

0.95

129

Complications of cardiac and vascular prosthetic devices, implants and grafts

128

1.02

0.00

1.2

1.3

19.31

33.27

e6/l

0.23

104

Benign neoplasm of middle ear and respiratory system

544

0.99

0.00

1.5

22.88

24.56

e6/l

0.04

426

Disorders of lacrimal system and orbit in diseases classified elsewhere

172

0.99

0.00

1.4

1.5

11.30

14.73

e6/l

—

133

Benign neoplasm: Long bones of lower limb

228

1.01

0.00

1.4

12.75

10.79

e6/l

0.07

177

FESS (DNB20)

103

1026

1.00

0.00

1.3

1.4

55.36

25.28

e6/l

0.43

784

Carcinoma in situ of skin

442

1.00

0.00

1.2

13.31

27.34

e6/l

0.45

351

Benign neoplasm: Skin of eyelid, including canthus

103

1033

1.00

0.00

1.3

21.32

27.14

e6/l

0.22

808

Polycythaemia vera

209

1.00

0.00

1.1

1.3

1.33

46.20

e6/l

0.98

171

Chronic suppurative otitis media, including avohilmo

616

1.01

0.00

1.4

1.9

94.46

26.46

e6/l

0.53

481

Ulcerative ileocolitis

301

1.00

0.00

1.0

1.4

22.32

18.93

e6/l

0.09

235

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

277

1.01

0.00

1.0

3.3

10.48

12.11

e6/l

0.07

206

Graves ophthalmopathy

173

0.98

0.00

1.4

1.5

11.30

9.88

e6/l

—

134

250

1.01

0.00

1.8

4.4

47.60

10.77

e6/l

0.42

180

Ulcerative enterocolitis

223

0.99

0.00

1.0

1.5

14.88

23.59

e6/l

0.18

177

Other noninflammatory disorders of uterus, except cervix

178

1218

1.00

0.00

1.5

1.4

97.99

30.76

e6/l

0.49

147

964

IgA nephropathy (IgA glomerulonephritis)

155

0.97

0.00

1.3

1.2

66.11

11.56

e6/l

—

124

Twin gestation

783

1.00

0.00

1.7

1.3

83.72

30.90

e6/l

0.33

605

Lipid storage disorder, other/unspecified

0.00

0.0

1.2

—

1.40

—

Myelofibrosis

0.00

0.0

1.0

—

1.40

—

Benign neoplasm: Oesophagus

0.96

0.00

1.1

1.4

1.63

15.51

e6/l

—

Other retinal disorders in diseases classified elsewhere

0.00

0.0

1.3

—

4.14

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.0

1.0

—

3.67

—

Choroidal degeneration

0.00

0.0

1.0

—

1.00

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.86

0.00

2.0

1.9

34.20

15.46

e6/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

1.0

—

2.20

—

Other birth injuries

0.00

0.0

1.0

—

1.50

—

Benign neoplasm: Long bones of lower limb

230

1.00

0.00

1.4

1.3

12.75

26.56

e6/l

0.37

182

Deficiency of other/unspecified nutrient elements

0.00

0.0

1.0

—

3.60

—

Other and unspecified disorders of pigmentation

0.98

0.00

1.4

1.0

2.60

3.10

e6/l

—

Other congenital malformations of intestine

0.91

0.00

1.9

2.6

66.57

2.75

e6/l

—

Traumatic amputation of forearm

0.00

0.0

1.2

—

1.50

—

Embedded teeth, including avohilmo

840

1.00

0.00

1.8

1.5

16.85

20.37

e6/l

0.11

654

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

1.13

—

Benign neoplasm: Oesophagus

0.92

0.00

1.1

1.63

4.93

e6/l

—

Benign neoplasm: Appendix

0.89

0.00

1.8

1.2

18.67

15.57

e6/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

2.7

—

1.29

—

Macular pucker, drug-induced

0.00

0.0

1.3

—

4.38

—

Acute myringitis

1.00

0.00

1.2

1.6

0.40

3.47

e6/l

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.0

—

3.33

—

Myxoedema coma

0.00

-0.00

0.0

1.0

—

2.67

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS